id	sid	tid	token	lemma	pos
iajs-3043	1	1	ihjpas	ihjpas	PROPN
iajs-3043	1	2	.	.	PUNCT
iajs-3043	2	1	36(2)2023	36(2)2023	NUM
iajs-3043	2	2	241	241	NUM
iajs-3043	2	3	this	this	DET
iajs-3043	2	4	work	work	NOUN
iajs-3043	2	5	is	be	AUX
iajs-3043	2	6	licensed	license	VERB
iajs-3043	2	7	under	under	ADP
iajs-3043	2	8	a	a	DET
iajs-3043	2	9	creative	creative	ADJ
iajs-3043	2	10	commons	common	NOUN
iajs-3043	2	11	attribution	attribution	NOUN
iajs-3043	2	12	4.0	4.0	NUM
iajs-3043	2	13	international	international	ADJ
iajs-3043	2	14	license	license	NOUN
iajs-3043	2	15	.	.	PUNCT
iajs-3043	3	1	abstract	abstract	ADJ
iajs-3043	3	2	non	non	ADJ
iajs-3043	3	3	-	-	ADJ
iajs-3043	3	4	alcoholic	alcoholic	ADJ
iajs-3043	3	5	fatty	fatty	NOUN
iajs-3043	3	6	liver	liver	NOUN
iajs-3043	3	7	disease	disease	NOUN
iajs-3043	3	8	(	(	PUNCT
iajs-3043	3	9	nafld	nafld	ADV
iajs-3043	3	10	)	)	PUNCT
iajs-3043	3	11	is	be	AUX
iajs-3043	3	12	one	one	NUM
iajs-3043	3	13	of	of	ADP
iajs-3043	3	14	chronic	chronic	ADJ
iajs-3043	3	15	liver	liver	NOUN
iajs-3043	3	16	and	and	CCONJ
iajs-3043	3	17	defines	define	NOUN
iajs-3043	3	18	by	by	ADP
iajs-3043	3	19	fat	fat	ADJ
iajs-3043	3	20	accumulation	accumulation	NOUN
iajs-3043	3	21	≥5	≥5	NUM
iajs-3043	3	22	%	%	NOUN
iajs-3043	3	23	in	in	ADP
iajs-3043	3	24	liver	liver	NOUN
iajs-3043	3	25	which	which	PRON
iajs-3043	3	26	can	can	AUX
iajs-3043	3	27	progresses	progress	VERB
iajs-3043	3	28	to	to	ADP
iajs-3043	3	29	non	non	ADJ
iajs-3043	3	30	-	-	ADJ
iajs-3043	3	31	alcoholic	alcoholic	ADJ
iajs-3043	3	32	steatohepatitis	steatohepatitis	NOUN
iajs-3043	3	33	(	(	PUNCT
iajs-3043	3	34	nash	nash	PROPN
iajs-3043	3	35	)	)	PUNCT
iajs-3043	3	36	.	.	PUNCT
iajs-3043	4	1	nafld	nafld	ADV
iajs-3043	4	2	related	relate	VERB
iajs-3043	4	3	to	to	ADP
iajs-3043	4	4	obesity	obesity	NOUN
iajs-3043	4	5	as	as	ADV
iajs-3043	4	6	well	well	ADV
iajs-3043	4	7	as	as	ADP
iajs-3043	4	8	non	non	ADJ
iajs-3043	4	9	obese	obese	ADJ
iajs-3043	4	10	individuals	individual	NOUN
iajs-3043	4	11	.	.	PUNCT
iajs-3043	5	1	adiponectin	adiponectin	NOUN
iajs-3043	5	2	is	be	AUX
iajs-3043	5	3	a	a	DET
iajs-3043	5	4	cytokine	cytokine	NOUN
iajs-3043	5	5	secreted	secrete	VERB
iajs-3043	5	6	from	from	ADP
iajs-3043	5	7	adipose	adipose	ADJ
iajs-3043	5	8	tissue	tissue	NOUN
iajs-3043	5	9	involved	involve	VERB
iajs-3043	5	10	nafld	nafld	ADJ
iajs-3043	5	11	pathogenesis	pathogenesis	NOUN
iajs-3043	5	12	and	and	CCONJ
iajs-3043	5	13	liked	like	VERB
iajs-3043	5	14	with	with	ADP
iajs-3043	5	15	obesity	obesity	NOUN
iajs-3043	5	16	.	.	PUNCT
iajs-3043	6	1	irisin	irisin	PROPN
iajs-3043	6	2	is	be	AUX
iajs-3043	6	3	a	a	DET
iajs-3043	6	4	myokine	myokine	NOUN
iajs-3043	6	5	,	,	PUNCT
iajs-3043	6	6	has	have	AUX
iajs-3043	6	7	a	a	DET
iajs-3043	6	8	convenient	convenient	ADJ
iajs-3043	6	9	effect	effect	NOUN
iajs-3043	6	10	against	against	ADP
iajs-3043	6	11	metabolic	metabolic	NOUN
iajs-3043	6	12	diseases	disease	NOUN
iajs-3043	6	13	such	such	ADJ
iajs-3043	6	14	as	as	ADP
iajs-3043	6	15	obesity	obesity	NOUN
iajs-3043	6	16	,	,	PUNCT
iajs-3043	6	17	disylipemia	disylipemia	NOUN
iajs-3043	6	18	diabetes	diabetes	NOUN
iajs-3043	6	19	type	type	NOUN
iajs-3043	6	20	2	2	NUM
iajs-3043	6	21	and	and	CCONJ
iajs-3043	6	22	reversed	reverse	VERB
iajs-3043	6	23	liver	liver	NOUN
iajs-3043	6	24	steatosis	steatosis	NOUN
iajs-3043	6	25	and	and	CCONJ
iajs-3043	6	26	may	may	AUX
iajs-3043	6	27	be	be	AUX
iajs-3043	6	28	related	relate	VERB
iajs-3043	6	29	with	with	ADP
iajs-3043	6	30	nafld	nafld	PROPN
iajs-3043	6	31	.	.	PUNCT
iajs-3043	7	1	vitamin	vitamin	NOUN
iajs-3043	7	2	d	d	NOUN
iajs-3043	7	3	is	be	AUX
iajs-3043	7	4	one	one	NUM
iajs-3043	7	5	of	of	ADP
iajs-3043	7	6	the	the	DET
iajs-3043	7	7	fat	fat	ADJ
iajs-3043	7	8	soluble	soluble	ADJ
iajs-3043	7	9	vitamins	vitamin	NOUN
iajs-3043	7	10	and	and	CCONJ
iajs-3043	7	11	more	more	ADV
iajs-3043	7	12	precisely	precisely	ADV
iajs-3043	7	13	as	as	ADP
iajs-3043	7	14	a	a	DET
iajs-3043	7	15	pro	pro	ADJ
iajs-3043	7	16	-	-	ADJ
iajs-3043	7	17	hormone	hormone	NOUN
iajs-3043	7	18	through	through	ADP
iajs-3043	7	19	its	its	PRON
iajs-3043	7	20	metabolite	metabolite	NOUN
iajs-3043	7	21	(	(	PUNCT
iajs-3043	7	22	1,25(oh)2	1,25(oh)2	NUM
iajs-3043	7	23	cholecalciferol	cholecalciferol	NOUN
iajs-3043	7	24	)	)	PUNCT
iajs-3043	7	25	the	the	DET
iajs-3043	7	26	major	major	ADJ
iajs-3043	7	27	steroid	steroid	ADJ
iajs-3043	7	28	hormone	hormone	NOUN
iajs-3043	7	29	.	.	PUNCT
iajs-3043	8	1	after	after	ADP
iajs-3043	8	2	the	the	DET
iajs-3043	8	3	skin	skin	NOUN
iajs-3043	8	4	exposure	exposure	NOUN
iajs-3043	8	5	to	to	ADP
iajs-3043	8	6	the	the	DET
iajs-3043	8	7	light	light	NOUN
iajs-3043	8	8	,	,	PUNCT
iajs-3043	8	9	vitamin	vitamin	NOUN
iajs-3043	8	10	d	d	NOUN
iajs-3043	8	11	undergoes	undergo	VERB
iajs-3043	8	12	to	to	PART
iajs-3043	8	13	activation	activation	NOUN
iajs-3043	8	14	through	through	ADP
iajs-3043	8	15	two	two	NUM
iajs-3043	8	16	successive	successive	ADJ
iajs-3043	8	17	hydroxylation	hydroxylation	NOUN
iajs-3043	8	18	reactions	reaction	NOUN
iajs-3043	8	19	in	in	ADP
iajs-3043	8	20	liver	liver	NOUN
iajs-3043	8	21	and	and	CCONJ
iajs-3043	8	22	kidney	kidney	NOUN
iajs-3043	8	23	.	.	PUNCT
iajs-3043	9	1	several	several	ADJ
iajs-3043	9	2	metabolic	metabolic	NOUN
iajs-3043	9	3	diseases	disease	NOUN
iajs-3043	9	4	such	such	ADJ
iajs-3043	9	5	as	as	ADP
iajs-3043	9	6	dyslipidaemia	dyslipidaemia	NOUN
iajs-3043	9	7	,	,	PUNCT
iajs-3043	9	8	obesity	obesity	NOUN
iajs-3043	9	9	,	,	PUNCT
iajs-3043	9	10	hypertension	hypertension	NOUN
iajs-3043	9	11	,	,	PUNCT
iajs-3043	9	12	t2d	t2d	NUM
iajs-3043	9	13	and	and	CCONJ
iajs-3043	9	14	metabolic	metabolic	NOUN
iajs-3043	9	15	syndrome	syndrome	NOUN
iajs-3043	9	16	(	(	PUNCT
iajs-3043	9	17	ms	ms	NOUN
iajs-3043	9	18	)	)	PUNCT
iajs-3043	9	19	have	have	AUX
iajs-3043	9	20	been	be	AUX
iajs-3043	9	21	related	relate	VERB
iajs-3043	9	22	to	to	ADP
iajs-3043	9	23	vitamin	vitamin	NOUN
iajs-3043	9	24	d	d	NOUN
iajs-3043	9	25	deficiency	deficiency	NOUN
iajs-3043	9	26	.	.	PUNCT
iajs-3043	10	1	keywords	keyword	NOUN
iajs-3043	10	2	:	:	PUNCT
iajs-3043	10	3	adiponectin	adiponectin	NOUN
iajs-3043	10	4	,	,	PUNCT
iajs-3043	10	5	irisin	irisin	NOUN
iajs-3043	10	6	,	,	PUNCT
iajs-3043	10	7	non	non	X
iajs-3043	10	8	alcoholic	alcoholic	ADJ
iajs-3043	10	9	fatty	fatty	NOUN
iajs-3043	10	10	liver	liver	NOUN
iajs-3043	10	11	disease	disease	NOUN
iajs-3043	10	12	.	.	PUNCT
iajs-3043	11	1	1	1	X
iajs-3043	11	2	.	.	X
iajs-3043	11	3	introduction	introduction	NOUN
iajs-3043	11	4	the	the	DET
iajs-3043	11	5	presence	presence	NOUN
iajs-3043	11	6	of	of	ADP
iajs-3043	11	7	more	more	ADJ
iajs-3043	11	8	than	than	ADP
iajs-3043	11	9	5	5	NUM
iajs-3043	11	10	%	%	NOUN
iajs-3043	11	11	hepatic	hepatic	ADJ
iajs-3043	11	12	steatosis	steatosis	NOUN
iajs-3043	11	13	without	without	ADP
iajs-3043	11	14	evidence	evidence	NOUN
iajs-3043	11	15	of	of	ADP
iajs-3043	11	16	hepatocellular	hepatocellular	ADJ
iajs-3043	11	17	injury	injury	NOUN
iajs-3043	11	18	is	be	AUX
iajs-3043	11	19	defined	define	VERB
iajs-3043	11	20	as	as	ADP
iajs-3043	11	21	nonalcoholic	nonalcoholic	NOUN
iajs-3043	11	22	fatty	fatty	NOUN
iajs-3043	11	23	liver	liver	NOUN
iajs-3043	11	24	(	(	PUNCT
iajs-3043	11	25	nafl	nafl	NOUN
iajs-3043	11	26	)	)	PUNCT
iajs-3043	11	27	,	,	PUNCT
iajs-3043	11	28	while	while	SCONJ
iajs-3043	11	29	the	the	DET
iajs-3043	11	30	more	more	ADV
iajs-3043	11	31	active	active	ADJ
iajs-3043	11	32	and	and	CCONJ
iajs-3043	11	33	aggressive	aggressive	ADJ
iajs-3043	11	34	form	form	NOUN
iajs-3043	11	35	of	of	ADP
iajs-3043	11	36	nafld	nafld	ADJ
iajs-3043	11	37	,	,	PUNCT
iajs-3043	11	38	nonalcoholic	nonalcoholic	PROPN
iajs-3043	11	39	steatohepatitis	steatohepatitis	PROPN
iajs-3043	11	40	(	(	PUNCT
iajs-3043	11	41	nash	nash	PROPN
iajs-3043	11	42	)	)	PUNCT
iajs-3043	11	43	includes	include	VERB
iajs-3043	11	44	ballooning	ballooning	NOUN
iajs-3043	11	45	of	of	ADP
iajs-3043	11	46	hepato	hepato	NOUN
iajs-3043	11	47	,	,	PUNCT
iajs-3043	11	48	steatosis	steatosis	NOUN
iajs-3043	11	49	and	and	CCONJ
iajs-3043	11	50	lobular	lobular	ADJ
iajs-3043	11	51	inflammation	inflammation	NOUN
iajs-3043	11	52	resulting	result	VERB
iajs-3043	11	53	cirrhosis	cirrhosis	NOUN
iajs-3043	11	54	,	,	PUNCT
iajs-3043	11	55	fibrosis	fibrosis	NOUN
iajs-3043	11	56	and	and	CCONJ
iajs-3043	11	57	hepatocellular	hepatocellular	ADJ
iajs-3043	11	58	carcinoma	carcinoma	NOUN
iajs-3043	11	59	,	,	PUNCT
iajs-3043	11	60	affects	affect	VERB
iajs-3043	11	61	around	around	ADP
iajs-3043	11	62	6.5	6.5	NUM
iajs-3043	11	63	of	of	ADP
iajs-3043	11	64	the	the	DET
iajs-3043	11	65	population	population	NOUN
iajs-3043	12	1	[	[	X
iajs-3043	12	2	1,2	1,2	NUM
iajs-3043	12	3	]	]	PUNCT
iajs-3043	12	4	.	.	PUNCT
iajs-3043	13	1	in	in	ADP
iajs-3043	13	2	most	most	ADJ
iajs-3043	13	3	patients	patient	NOUN
iajs-3043	13	4	,	,	PUNCT
iajs-3043	13	5	liver	liver	NOUN
iajs-3043	13	6	disease	disease	NOUN
iajs-3043	13	7	is	be	AUX
iajs-3043	13	8	stable	stable	ADJ
iajs-3043	13	9	or	or	CCONJ
iajs-3043	13	10	slowly	slowly	ADV
iajs-3043	13	11	progressive	progressive	ADJ
iajs-3043	13	12	and	and	CCONJ
iajs-3043	13	13	will	will	AUX
iajs-3043	13	14	not	not	PART
iajs-3043	13	15	result	result	VERB
iajs-3043	13	16	in	in	ADP
iajs-3043	13	17	cirrhosis	cirrhosis	NOUN
iajs-3043	13	18	or	or	CCONJ
iajs-3043	13	19	liver	liver	NOUN
iajs-3043	13	20	-	-	PUNCT
iajs-3043	13	21	related	relate	VERB
iajs-3043	13	22	death	death	NOUN
iajs-3043	13	23	,	,	PUNCT
iajs-3043	13	24	but	but	CCONJ
iajs-3043	13	25	a	a	DET
iajs-3043	13	26	small	small	ADJ
iajs-3043	13	27	proportion	proportion	NOUN
iajs-3043	13	28	of	of	ADP
iajs-3043	13	29	affected	affected	ADJ
iajs-3043	13	30	individuals	individual	NOUN
iajs-3043	13	31	developing	develop	VERB
iajs-3043	13	32	to	to	ADP
iajs-3043	13	33	advanced	advanced	ADJ
iajs-3043	13	34	fibrosis	fibrosis	NOUN
iajs-3043	13	35	and	and	CCONJ
iajs-3043	13	36	complicated	complicate	VERB
iajs-3043	13	37	to	to	ADP
iajs-3043	13	38	the	the	DET
iajs-3043	13	39	end	end	NOUN
iajs-3043	13	40	-	-	PUNCT
iajs-3043	13	41	stage	stage	NOUN
iajs-3043	13	42	liver	liver	NOUN
iajs-3043	13	43	disease	disease	NOUN
iajs-3043	13	44	and	and	CCONJ
iajs-3043	13	45	hepatocellular	hepatocellular	ADJ
iajs-3043	13	46	carcinoma	carcinoma	NOUN
iajs-3043	13	47	.	.	PUNCT
iajs-3043	14	1	doi.org/10.30526/36.2.3043	doi.org/10.30526/36.2.3043	NOUN
iajs-3043	14	2	article	article	NOUN
iajs-3043	14	3	history	history	NOUN
iajs-3043	14	4	:	:	PUNCT
iajs-3043	14	5	received	receive	VERB
iajs-3043	14	6	26	26	NUM
iajs-3043	14	7	september	september	PROPN
iajs-3043	14	8	2022	2022	NUM
iajs-3043	14	9	,	,	PUNCT
iajs-3043	14	10	accepted	accept	VERB
iajs-3043	14	11	23	23	NUM
iajs-3043	14	12	october	october	NOUN
iajs-3043	14	13	2022	2022	NUM
iajs-3043	14	14	,	,	PUNCT
iajs-3043	14	15	published	publish	VERB
iajs-3043	14	16	in	in	ADP
iajs-3043	14	17	april	april	PROPN
iajs-3043	14	18	2023	2023	NUM
iajs-3043	14	19	.	.	PUNCT
iajs-3043	15	1	ibn	ibn	PROPN
iajs-3043	15	2	al	al	PROPN
iajs-3043	15	3	-	-	PUNCT
iajs-3043	15	4	haitham	haitham	PROPN
iajs-3043	15	5	journal	journal	PROPN
iajs-3043	15	6	for	for	ADP
iajs-3043	15	7	pure	pure	ADJ
iajs-3043	15	8	and	and	CCONJ
iajs-3043	15	9	applied	applied	ADJ
iajs-3043	15	10	sciences	sciences	PROPN
iajs-3043	15	11	journal	journal	PROPN
iajs-3043	15	12	homepage	homepage	NOUN
iajs-3043	15	13	:	:	PUNCT
iajs-3043	15	14	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3043	15	15	evaluation	evaluation	NOUN
iajs-3043	15	16	of	of	ADP
iajs-3043	15	17	adiponectin	adiponectin	NOUN
iajs-3043	15	18	,	,	PUNCT
iajs-3043	15	19	irisin	irisin	NOUN
iajs-3043	15	20	,	,	PUNCT
iajs-3043	15	21	vitamin	vitamin	NOUN
iajs-3043	15	22	d	d	NOUN
iajs-3043	15	23	levels	level	NOUN
iajs-3043	15	24	and	and	CCONJ
iajs-3043	15	25	their	their	PRON
iajs-3043	15	26	relation	relation	NOUN
iajs-3043	15	27	in	in	ADP
iajs-3043	15	28	iraqi	iraqi	ADJ
iajs-3043	15	29	patients	patient	NOUN
iajs-3043	15	30	with	with	ADP
iajs-3043	15	31	non	non	ADJ
iajs-3043	15	32	alcoholic	alcoholic	ADJ
iajs-3043	15	33	fatty	fatty	NOUN
iajs-3043	15	34	liver	liver	NOUN
iajs-3043	15	35	disease	disease	NOUN
iajs-3043	15	36	warka'a	warka'a	NUM
iajs-3043	15	37	t.	t.	PROPN
iajs-3043	15	38	al	al	PROPN
iajs-3043	15	39	-	-	PUNCT
iajs-3043	15	40	sa'adi	sa'adi	PROPN
iajs-3043	15	41	department	department	NOUN
iajs-3043	15	42	of	of	ADP
iajs-3043	15	43	chemistry	chemistry	NOUN
iajs-3043	15	44	,	,	PUNCT
iajs-3043	15	45	college	college	NOUN
iajs-3043	15	46	of	of	ADP
iajs-3043	15	47	education	education	NOUN
iajs-3043	15	48	for	for	ADP
iajs-3043	15	49	pure	pure	ADJ
iajs-3043	15	50	science	science	NOUN
iajs-3043	15	51	ibn	ibn	PROPN
iajs-3043	15	52	al	al	PROPN
iajs-3043	15	53	haitham	haitham	PROPN
iajs-3043	15	54	,	,	PUNCT
iajs-3043	15	55	university	university	PROPN
iajs-3043	15	56	of	of	ADP
iajs-3043	15	57	baghdad	baghdad	PROPN
iajs-3043	15	58	,	,	PUNCT
iajs-3043	15	59	baghdad	baghdad	PROPN
iajs-3043	15	60	,	,	PUNCT
iajs-3043	15	61	iraq	iraq	PROPN
iajs-3043	15	62	.	.	PUNCT
iajs-3043	16	1	warkaaalsaadi@gmail.com	warkaaalsaadi@gmail.com	X
iajs-3043	17	1	alaa	alaa	PROPN
iajs-3043	17	2	abdul	abdul	PROPN
iajs-3043	17	3	sattar	sattar	PROPN
iajs-3043	17	4	f.	f.	PROPN
iajs-3043	17	5	department	department	PROPN
iajs-3043	17	6	of	of	ADP
iajs-3043	17	7	chemistry	chemistry	PROPN
iajs-3043	17	8	college	college	PROPN
iajs-3043	17	9	of	of	ADP
iajs-3043	17	10	education	education	NOUN
iajs-3043	17	11	for	for	ADP
iajs-3043	17	12	pure	pure	ADJ
iajs-3043	17	13	science	science	NOUN
iajs-3043	17	14	ibn	ibn	PROPN
iajs-3043	17	15	al	al	PROPN
iajs-3043	17	16	-	-	PUNCT
iajs-3043	17	17	haitham	haitham	PROPN
iajs-3043	17	18	,	,	PUNCT
iajs-3043	17	19	baghdad	baghdad	PROPN
iajs-3043	17	20	,	,	PUNCT
iajs-3043	17	21	university	university	NOUN
iajs-3043	17	22	of	of	ADP
iajs-3043	17	23	baghdad	baghdad	PROPN
iajs-3043	17	24	,	,	PUNCT
iajs-3043	17	25	iraq	iraq	PROPN
iajs-3043	17	26	.	.	PUNCT
iajs-3043	18	1	alaaabd199712@gmail.com	alaaabd199712@gmail.com	X
iajs-3043	19	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3043	19	2	mailto:warkaaalsaadi@gmail.com	mailto:warkaaalsaadi@gmail.com	PROPN
iajs-3043	19	3	mailto:alaaabd199712@gmail.com	mailto:alaaabd199712@gmail.com	PROPN
iajs-3043	19	4	ihjpas	ihjpas	PROPN
iajs-3043	19	5	.	.	PUNCT
iajs-3043	20	1	36(2)2023	36(2)2023	NUM
iajs-3043	20	2	242	242	NUM
iajs-3043	20	3	adiponectin	adiponectin	NOUN
iajs-3043	20	4	is	be	AUX
iajs-3043	20	5	a	a	DET
iajs-3043	20	6	protein	protein	NOUN
iajs-3043	20	7	generally	generally	ADV
iajs-3043	20	8	secreted	secrete	VERB
iajs-3043	20	9	by	by	ADP
iajs-3043	20	10	white	white	ADJ
iajs-3043	20	11	adipose	adipose	X
iajs-3043	20	12	tissue	tissue	NOUN
iajs-3043	20	13	(	(	PUNCT
iajs-3043	20	14	wat	wat	NOUN
iajs-3043	20	15	)	)	PUNCT
iajs-3043	20	16	and	and	CCONJ
iajs-3043	20	17	existent	existent	ADJ
iajs-3043	20	18	at	at	ADP
iajs-3043	20	19	high	high	ADJ
iajs-3043	20	20	levels	level	NOUN
iajs-3043	20	21	in	in	ADP
iajs-3043	20	22	circulation	circulation	NOUN
iajs-3043	20	23	[	[	X
iajs-3043	20	24	3,4	3,4	NUM
iajs-3043	20	25	]	]	PUNCT
iajs-3043	20	26	.	.	PUNCT
iajs-3043	21	1	also	also	ADV
iajs-3043	21	2	this	this	DET
iajs-3043	21	3	protein	protein	NOUN
iajs-3043	21	4	has	have	AUX
iajs-3043	21	5	been	be	AUX
iajs-3043	21	6	detected	detect	VERB
iajs-3043	21	7	in	in	ADP
iajs-3043	21	8	cardio	cardio	NOUN
iajs-3043	21	9	myocytes	myocyte	NOUN
iajs-3043	21	10	,	,	PUNCT
iajs-3043	21	11	skeletal	skeletal	ADJ
iajs-3043	21	12	muscle	muscle	NOUN
iajs-3043	21	13	,	,	PUNCT
iajs-3043	21	14	lymphocytes	lymphocyte	NOUN
iajs-3043	21	15	,	,	PUNCT
iajs-3043	21	16	pituitary	pituitary	ADJ
iajs-3043	21	17	gland	gland	NOUN
iajs-3043	21	18	,	,	PUNCT
iajs-3043	21	19	adrenal	adrenal	ADJ
iajs-3043	21	20	gland	gland	NOUN
iajs-3043	21	21	osteoblasts	osteoblast	NOUN
iajs-3043	21	22	,	,	PUNCT
iajs-3043	21	23	and	and	CCONJ
iajs-3043	21	24	liver	liver	NOUN
iajs-3043	21	25	tissue	tissue	NOUN
iajs-3043	21	26	[	[	X
iajs-3043	21	27	5	5	NUM
iajs-3043	21	28	]	]	PUNCT
iajs-3043	21	29	.	.	PUNCT
iajs-3043	22	1	scherer	scherer	PROPN
iajs-3043	22	2	et	et	PROPN
iajs-3043	22	3	al	al	PROPN
iajs-3043	22	4	,	,	PUNCT
iajs-3043	22	5	in	in	ADP
iajs-3043	22	6	1995	1995	NUM
iajs-3043	22	7	were	be	AUX
iajs-3043	22	8	distinguishing	distinguish	VERB
iajs-3043	22	9	this	this	DET
iajs-3043	22	10	protein	protein	NOUN
iajs-3043	22	11	from	from	ADP
iajs-3043	22	12	cell	cell	NOUN
iajs-3043	22	13	line	line	NOUN
iajs-3043	22	14	3t3	3t3	NOUN
iajs-3043	22	15	-	-	PUNCT
iajs-3043	22	16	l1	l1	NOUN
iajs-3043	22	17	by	by	ADP
iajs-3043	22	18	cdna	cdna	PROPN
iajs-3043	22	19	cloning	cloning	NOUN
iajs-3043	22	20	and	and	CCONJ
iajs-3043	22	21	its	its	PRON
iajs-3043	22	22	coding	code	VERB
iajs-3043	22	23	gene	gene	NOUN
iajs-3043	22	24	located	locate	VERB
iajs-3043	22	25	on	on	ADP
iajs-3043	22	26	the	the	DET
iajs-3043	22	27	3q27	3q27	NUM
iajs-3043	22	28	chromosome	chromosome	NOUN
iajs-3043	22	29	[	[	X
iajs-3043	22	30	5	5	NUM
iajs-3043	22	31	]	]	PUNCT
iajs-3043	22	32	.	.	PUNCT
iajs-3043	23	1	adiponectin	adiponectin	NOUN
iajs-3043	23	2	consists	consist	VERB
iajs-3043	23	3	of	of	ADP
iajs-3043	23	4	244	244	NUM
iajs-3043	23	5	amino	amino	NOUN
iajs-3043	23	6	acids	acid	NOUN
iajs-3043	23	7	with	with	ADP
iajs-3043	23	8	molecular	molecular	ADJ
iajs-3043	23	9	weight	weight	NOUN
iajs-3043	23	10	28	28	NUM
iajs-3043	23	11	kda	kda	NOUN
iajs-3043	23	12	showing	show	VERB
iajs-3043	23	13	similar	similar	ADJ
iajs-3043	23	14	structural	structural	NOUN
iajs-3043	23	15	to	to	ADP
iajs-3043	23	16	tnf	tnf	PROPN
iajs-3043	23	17	-	-	PUNCT
iajs-3043	23	18	α	α	PROPN
iajs-3043	23	19	and	and	CCONJ
iajs-3043	23	20	collagen	collagen	NOUN
iajs-3043	23	21	.	.	PUNCT
iajs-3043	24	1	adiponectin	adiponectin	NOUN
iajs-3043	24	2	also	also	ADV
iajs-3043	24	3	known	know	VERB
iajs-3043	24	4	as	as	ADP
iajs-3043	24	5	acrp30	acrp30	NOUN
iajs-3043	24	6	,	,	PUNCT
iajs-3043	24	7	adipoq	adipoq	PROPN
iajs-3043	24	8	,	,	PUNCT
iajs-3043	24	9	apm1	apm1	NOUN
iajs-3043	24	10	or	or	CCONJ
iajs-3043	24	11	gbp28	gbp28	NOUN
iajs-3043	24	12	[	[	PUNCT
iajs-3043	24	13	6	6	NUM
iajs-3043	24	14	]	]	PUNCT
iajs-3043	24	15	.	.	PUNCT
iajs-3043	25	1	the	the	DET
iajs-3043	25	2	biological	biological	ADJ
iajs-3043	25	3	function	function	NOUN
iajs-3043	25	4	of	of	ADP
iajs-3043	25	5	adiponectin	adiponectin	NOUN
iajs-3043	25	6	exert	exert	ADJ
iajs-3043	25	7	through	through	ADP
iajs-3043	25	8	two	two	NUM
iajs-3043	25	9	receptors	receptor	NOUN
iajs-3043	25	10	,	,	PUNCT
iajs-3043	25	11	(	(	PUNCT
iajs-3043	25	12	adipor1	adipor1	NOUN
iajs-3043	25	13	)	)	PUNCT
iajs-3043	25	14	mainly	mainly	ADV
iajs-3043	25	15	expressed	express	VERB
iajs-3043	25	16	in	in	ADP
iajs-3043	25	17	skeletal	skeletal	ADJ
iajs-3043	25	18	and	and	CCONJ
iajs-3043	25	19	(	(	PUNCT
iajs-3043	25	20	adipor2	adipor2	X
iajs-3043	25	21	)	)	PUNCT
iajs-3043	25	22	the	the	DET
iajs-3043	25	23	liver	liver	NOUN
iajs-3043	25	24	[	[	X
iajs-3043	25	25	5	5	NUM
iajs-3043	25	26	]	]	PUNCT
iajs-3043	25	27	.	.	PUNCT
iajs-3043	26	1	adiponectin	adiponectin	NOUN
iajs-3043	26	2	also	also	ADV
iajs-3043	26	3	called	call	VERB
iajs-3043	26	4	“	"	PUNCT
iajs-3043	26	5	adipokines	adipokine	NOUN
iajs-3043	26	6	or	or	CCONJ
iajs-3043	26	7	adipocytokines	adipocytokine	NOUN
iajs-3043	26	8	”	"	PUNCT
iajs-3043	26	9	,	,	PUNCT
iajs-3043	26	10	the	the	DET
iajs-3043	26	11	regulation	regulation	NOUN
iajs-3043	26	12	of	of	ADP
iajs-3043	26	13	adipocytokines	adipocytokine	NOUN
iajs-3043	26	14	is	be	AUX
iajs-3043	26	15	associated	associate	VERB
iajs-3043	26	16	and	and	CCONJ
iajs-3043	26	17	altered	alter	VERB
iajs-3043	26	18	in	in	ADP
iajs-3043	26	19	diseases	disease	NOUN
iajs-3043	26	20	like	like	ADP
iajs-3043	26	21	obesity	obesity	NOUN
iajs-3043	26	22	,	,	PUNCT
iajs-3043	26	23	atherosclerosis	atherosclerosis	NOUN
iajs-3043	26	24	,	,	PUNCT
iajs-3043	26	25	diabetes	diabetes	NOUN
iajs-3043	26	26	type2	type2	PROPN
iajs-3043	26	27	,	,	PUNCT
iajs-3043	26	28	and	and	CCONJ
iajs-3043	26	29	metabolic	metabolic	NOUN
iajs-3043	26	30	syndrome	syndrome	NOUN
iajs-3043	26	31	(	(	PUNCT
iajs-3043	26	32	ms	ms	NOUN
iajs-3043	26	33	)	)	PUNCT
iajs-3043	26	34	due	due	ADP
iajs-3043	26	35	to	to	ADP
iajs-3043	26	36	the	the	DET
iajs-3043	26	37	increase	increase	NOUN
iajs-3043	26	38	in	in	ADP
iajs-3043	26	39	the	the	DET
iajs-3043	26	40	mass	mass	NOUN
iajs-3043	26	41	of	of	ADP
iajs-3043	26	42	white	white	ADJ
iajs-3043	26	43	adipose	adipose	PRON
iajs-3043	26	44	tissue	tissue	NOUN
iajs-3043	26	45	[	[	X
iajs-3043	26	46	3	3	NUM
iajs-3043	26	47	]	]	PUNCT
iajs-3043	26	48	.	.	PUNCT
iajs-3043	27	1	irisin	irisin	PROPN
iajs-3043	27	2	is	be	AUX
iajs-3043	27	3	a	a	DET
iajs-3043	27	4	glycosylated	glycosylated	ADJ
iajs-3043	27	5	protein	protein	NOUN
iajs-3043	27	6	hormone	hormone	NOUN
iajs-3043	27	7	with	with	ADP
iajs-3043	27	8	a	a	DET
iajs-3043	27	9	molecular	molecular	ADJ
iajs-3043	27	10	weight	weight	NOUN
iajs-3043	27	11	about	about	ADV
iajs-3043	27	12	12	12	NUM
iajs-3043	27	13	kda	kda	NOUN
iajs-3043	27	14	,	,	PUNCT
iajs-3043	27	15	composed	compose	VERB
iajs-3043	27	16	of	of	ADP
iajs-3043	27	17	112	112	NUM
iajs-3043	27	18	amino	amino	ADJ
iajs-3043	27	19	acids	acid	NOUN
iajs-3043	27	20	residues	residue	NOUN
iajs-3043	27	21	[	[	X
iajs-3043	27	22	7	7	NUM
iajs-3043	27	23	]	]	PUNCT
iajs-3043	27	24	.	.	PUNCT
iajs-3043	28	1	irisin	irisin	VERB
iajs-3043	28	2	existing	exist	VERB
iajs-3043	28	3	a	a	DET
iajs-3043	28	4	homodimer	homodimer	NOUN
iajs-3043	28	5	form	form	NOUN
iajs-3043	28	6	and	and	CCONJ
iajs-3043	28	7	stabilized	stabilize	VERB
iajs-3043	28	8	by	by	ADP
iajs-3043	28	9	interaction	interaction	NOUN
iajs-3043	28	10	between	between	ADP
iajs-3043	28	11	side	side	NOUN
iajs-3043	28	12	chains	chain	NOUN
iajs-3043	28	13	.	.	PUNCT
iajs-3043	29	1	about	about	ADV
iajs-3043	29	2	72	72	NUM
iajs-3043	29	3	%	%	NOUN
iajs-3043	29	4	of	of	ADP
iajs-3043	29	5	the	the	DET
iajs-3043	29	6	total	total	ADJ
iajs-3043	29	7	amount	amount	NOUN
iajs-3043	29	8	irisin	irisin	NOUN
iajs-3043	29	9	in	in	ADP
iajs-3043	29	10	plasma	plasma	NOUN
iajs-3043	29	11	comes	come	VERB
iajs-3043	29	12	from	from	ADP
iajs-3043	29	13	skeletal	skeletal	ADJ
iajs-3043	29	14	muscle	muscle	NOUN
iajs-3043	29	15	and	and	CCONJ
iajs-3043	29	16	others	other	NOUN
iajs-3043	29	17	from	from	ADP
iajs-3043	29	18	white	white	ADJ
iajs-3043	29	19	adipocyte	adipocyte	NOUN
iajs-3043	29	20	cells	cell	NOUN
iajs-3043	29	21	[	[	X
iajs-3043	29	22	8	8	NUM
iajs-3043	29	23	]	]	PUNCT
iajs-3043	29	24	.	.	PUNCT
iajs-3043	30	1	through	through	ADP
iajs-3043	30	2	physical	physical	ADJ
iajs-3043	30	3	exercise	exercise	NOUN
iajs-3043	30	4	,	,	PUNCT
iajs-3043	30	5	the	the	DET
iajs-3043	30	6	extracellular	extracellular	ADJ
iajs-3043	30	7	membrane	membrane	NOUN
iajs-3043	30	8	protein	protein	NOUN
iajs-3043	30	9	fibronectin	fibronectin	NOUN
iajs-3043	30	10	type	type	NOUN
iajs-3043	30	11	iii	iii	NOUN
iajs-3043	30	12	domain‑containing	domain‑containe	VERB
iajs-3043	30	13	protein	protein	NOUN
iajs-3043	30	14	5	5	NUM
iajs-3043	30	15	(	(	PUNCT
iajs-3043	30	16	fndc5	fndc5	PROPN
iajs-3043	30	17	)	)	PUNCT
iajs-3043	30	18	undergoes	undergo	VERB
iajs-3043	30	19	proteolytic	proteolytic	ADJ
iajs-3043	30	20	cleavage	cleavage	NOUN
iajs-3043	30	21	and	and	CCONJ
iajs-3043	30	22	resulting	result	VERB
iajs-3043	30	23	irisin	irisin	ADJ
iajs-3043	30	24	secretion	secretion	NOUN
iajs-3043	30	25	[	[	X
iajs-3043	30	26	9	9	NUM
iajs-3043	30	27	]	]	PUNCT
iajs-3043	30	28	.	.	PUNCT
iajs-3043	31	1	irisin	irisin	PROPN
iajs-3043	31	2	has	have	VERB
iajs-3043	31	3	a	a	DET
iajs-3043	31	4	convenient	convenient	ADJ
iajs-3043	31	5	effect	effect	NOUN
iajs-3043	31	6	against	against	ADP
iajs-3043	31	7	metabolic	metabolic	NOUN
iajs-3043	31	8	diseases	disease	NOUN
iajs-3043	31	9	such	such	ADJ
iajs-3043	31	10	as	as	ADP
iajs-3043	31	11	obesity	obesity	NOUN
iajs-3043	31	12	,	,	PUNCT
iajs-3043	31	13	dislipemia	dislipemia	NOUN
iajs-3043	31	14	diabetes	diabetes	NOUN
iajs-3043	31	15	type	type	NOUN
iajs-3043	31	16	2	2	NUM
iajs-3043	31	17	and	and	CCONJ
iajs-3043	31	18	reversed	reverse	VERB
iajs-3043	31	19	liver	liver	NOUN
iajs-3043	31	20	steatosis	steatosis	NOUN
iajs-3043	32	1	[	[	X
iajs-3043	32	2	10]but	10]but	NUM
iajs-3043	32	3	still	still	ADV
iajs-3043	32	4	the	the	DET
iajs-3043	32	5	correlation	correlation	NOUN
iajs-3043	32	6	between	between	ADP
iajs-3043	32	7	nafld	nafld	PROPN
iajs-3043	32	8	and	and	CCONJ
iajs-3043	32	9	irisin	irisin	VERB
iajs-3043	32	10	in	in	ADP
iajs-3043	32	11	human	human	ADJ
iajs-3043	32	12	an	an	DET
iajs-3043	32	13	argumentative	argumentative	NOUN
iajs-3043	32	14	and	and	CCONJ
iajs-3043	32	15	unclear[11	unclear[11	ADP
iajs-3043	32	16	]	]	PUNCT
iajs-3043	32	17	.	.	PUNCT
iajs-3043	33	1	vitamin	vitamin	NOUN
iajs-3043	33	2	d	d	NOUN
iajs-3043	33	3	is	be	AUX
iajs-3043	33	4	one	one	NUM
iajs-3043	33	5	of	of	ADP
iajs-3043	33	6	the	the	DET
iajs-3043	33	7	fat	fat	ADJ
iajs-3043	33	8	soluble	soluble	ADJ
iajs-3043	33	9	vitamins	vitamin	NOUN
iajs-3043	33	10	and	and	CCONJ
iajs-3043	33	11	more	more	ADV
iajs-3043	33	12	precisely	precisely	ADV
iajs-3043	33	13	as	as	ADP
iajs-3043	33	14	a	a	DET
iajs-3043	33	15	pro	pro	ADJ
iajs-3043	33	16	-	-	ADJ
iajs-3043	33	17	hormone	hormone	NOUN
iajs-3043	33	18	through	through	ADP
iajs-3043	33	19	its	its	PRON
iajs-3043	33	20	metabolite	metabolite	NOUN
iajs-3043	33	21	cholecalciferol	cholecalciferol	NOUN
iajs-3043	33	22	(	(	PUNCT
iajs-3043	33	23	1,25(oh)2	1,25(oh)2	NOUN
iajs-3043	33	24	cholecalciferol	cholecalciferol	VERB
iajs-3043	33	25	the	the	DET
iajs-3043	33	26	major	major	ADJ
iajs-3043	33	27	steroid	steroid	NOUN
iajs-3043	33	28	hormone	hormone	NOUN
iajs-3043	33	29	)	)	PUNCT
iajs-3043	34	1	[	[	X
iajs-3043	34	2	12	12	NUM
iajs-3043	34	3	]	]	PUNCT
iajs-3043	34	4	.	.	PUNCT
iajs-3043	35	1	when	when	SCONJ
iajs-3043	35	2	the	the	DET
iajs-3043	35	3	skin	skin	NOUN
iajs-3043	35	4	exposure	exposure	NOUN
iajs-3043	35	5	to	to	ADP
iajs-3043	35	6	the	the	DET
iajs-3043	35	7	sun	sun	NOUN
iajs-3043	35	8	light	light	NOUN
iajs-3043	35	9	,	,	PUNCT
iajs-3043	35	10	vitamin	vitamin	NOUN
iajs-3043	35	11	d	d	NOUN
iajs-3043	35	12	undergoes	undergo	VERB
iajs-3043	35	13	to	to	PART
iajs-3043	35	14	activation	activation	NOUN
iajs-3043	35	15	through	through	ADP
iajs-3043	35	16	two	two	NUM
iajs-3043	35	17	successive	successive	ADJ
iajs-3043	35	18	hydroxylation	hydroxylation	NOUN
iajs-3043	35	19	reactions	reaction	NOUN
iajs-3043	35	20	in	in	ADP
iajs-3043	35	21	liver	liver	NOUN
iajs-3043	35	22	and	and	CCONJ
iajs-3043	35	23	kidney	kidney	NOUN
iajs-3043	35	24	[	[	X
iajs-3043	35	25	13	13	NUM
iajs-3043	35	26	]	]	PUNCT
iajs-3043	35	27	.	.	PUNCT
iajs-3043	36	1	vitamin	vitamin	NOUN
iajs-3043	36	2	d	d	NOUN
iajs-3043	36	3	has	have	VERB
iajs-3043	36	4	massive	massive	ADJ
iajs-3043	36	5	role	role	NOUN
iajs-3043	36	6	in	in	ADP
iajs-3043	36	7	calcium	calcium	NOUN
iajs-3043	36	8	regulation	regulation	NOUN
iajs-3043	36	9	and	and	CCONJ
iajs-3043	36	10	homeostasis	homeostasis	NOUN
iajs-3043	36	11	which	which	PRON
iajs-3043	36	12	aids	aid	VERB
iajs-3043	36	13	calcium	calcium	NOUN
iajs-3043	36	14	level	level	NOUN
iajs-3043	36	15	to	to	PART
iajs-3043	36	16	maintain	maintain	VERB
iajs-3043	36	17	in	in	ADP
iajs-3043	36	18	the	the	DET
iajs-3043	36	19	body	body	NOUN
iajs-3043	36	20	and	and	CCONJ
iajs-3043	36	21	bone	bone	NOUN
iajs-3043	36	22	health	health	NOUN
iajs-3043	37	1	[	[	X
iajs-3043	37	2	14	14	NUM
iajs-3043	37	3	]	]	X
iajs-3043	37	4	,	,	PUNCT
iajs-3043	37	5	anti	anti	ADJ
iajs-3043	37	6	-	-	ADJ
iajs-3043	37	7	inflammatory	inflammatory	ADJ
iajs-3043	37	8	effects	effect	NOUN
iajs-3043	37	9	,	,	PUNCT
iajs-3043	37	10	antifibrotic	antifibrotic	ADJ
iajs-3043	37	11	,	,	PUNCT
iajs-3043	37	12	and	and	CCONJ
iajs-3043	37	13	anti	anti	ADJ
iajs-3043	37	14	-	-	ADJ
iajs-3043	37	15	proliferative	proliferative	ADJ
iajs-3043	37	16	in	in	ADP
iajs-3043	37	17	the	the	DET
iajs-3043	37	18	liver	liver	NOUN
iajs-3043	37	19	[	[	X
iajs-3043	37	20	15	15	NUM
iajs-3043	37	21	]	]	PUNCT
iajs-3043	37	22	.	.	PUNCT
iajs-3043	38	1	several	several	ADJ
iajs-3043	38	2	metabolic	metabolic	NOUN
iajs-3043	38	3	diseases	disease	NOUN
iajs-3043	38	4	such	such	ADJ
iajs-3043	38	5	as	as	ADP
iajs-3043	38	6	dyslipidaemia	dyslipidaemia	NOUN
iajs-3043	38	7	,	,	PUNCT
iajs-3043	38	8	obesity	obesity	NOUN
iajs-3043	38	9	,	,	PUNCT
iajs-3043	38	10	hypertension	hypertension	NOUN
iajs-3043	38	11	,	,	PUNCT
iajs-3043	38	12	t2d	t2d	NUM
iajs-3043	38	13	and	and	CCONJ
iajs-3043	38	14	metabolic	metabolic	NOUN
iajs-3043	38	15	syndrome	syndrome	NOUN
iajs-3043	38	16	(	(	PUNCT
iajs-3043	38	17	ms	ms	NOUN
iajs-3043	38	18	)	)	PUNCT
iajs-3043	38	19	have	have	AUX
iajs-3043	38	20	been	be	AUX
iajs-3043	38	21	related	relate	VERB
iajs-3043	38	22	to	to	ADP
iajs-3043	38	23	vitamin	vitamin	NOUN
iajs-3043	38	24	d	d	NOUN
iajs-3043	38	25	deficiency	deficiency	NOUN
iajs-3043	38	26	[	[	X
iajs-3043	38	27	16	16	NUM
iajs-3043	38	28	-	-	SYM
iajs-3043	38	29	18	18	NUM
iajs-3043	38	30	]	]	PUNCT
iajs-3043	38	31	.	.	PUNCT
iajs-3043	39	1	this	this	DET
iajs-3043	39	2	research	research	NOUN
iajs-3043	39	3	aimed	aim	VERB
iajs-3043	39	4	to	to	PART
iajs-3043	39	5	evaluate	evaluate	VERB
iajs-3043	39	6	the	the	DET
iajs-3043	39	7	levels	level	NOUN
iajs-3043	39	8	of	of	ADP
iajs-3043	39	9	adiponectin	adiponectin	NOUN
iajs-3043	39	10	,	,	PUNCT
iajs-3043	39	11	irsin	irsin	NOUN
iajs-3043	39	12	and	and	CCONJ
iajs-3043	39	13	vitamin	vitamin	NOUN
iajs-3043	39	14	d3	d3	PROPN
iajs-3043	39	15	in	in	ADP
iajs-3043	39	16	obese	obese	NOUN
iajs-3043	39	17	and	and	CCONJ
iajs-3043	39	18	nonobese	nonobese	PRON
iajs-3043	39	19	nafld	nafld	ADJ
iajs-3043	39	20	iraqi	iraqi	ADJ
iajs-3043	39	21	patients	patient	NOUN
iajs-3043	39	22	.	.	PUNCT
iajs-3043	40	1	the	the	DET
iajs-3043	40	2	correlation	correlation	NOUN
iajs-3043	40	3	between	between	ADP
iajs-3043	40	4	adiponectin	adiponectin	NOUN
iajs-3043	40	5	with	with	ADP
iajs-3043	40	6	irisin	irisin	NOUN
iajs-3043	40	7	and	and	CCONJ
iajs-3043	40	8	vitamin	vitamin	NOUN
iajs-3043	40	9	d3	d3	PROPN
iajs-3043	40	10	in	in	ADP
iajs-3043	40	11	nafld	nafld	ADJ
iajs-3043	40	12	obese	obese	ADJ
iajs-3043	40	13	and	and	CCONJ
iajs-3043	40	14	non	non	ADJ
iajs-3043	40	15	-	-	ADJ
iajs-3043	40	16	obese	obese	ADJ
iajs-3043	40	17	iraqi	iraqi	ADJ
iajs-3043	40	18	patients	patient	NOUN
iajs-3043	40	19	were	be	AUX
iajs-3043	40	20	also	also	ADV
iajs-3043	40	21	included	include	VERB
iajs-3043	40	22	in	in	ADP
iajs-3043	40	23	this	this	DET
iajs-3043	40	24	research	research	NOUN
iajs-3043	40	25	.	.	PUNCT
iajs-3043	41	1	2	2	NUM
iajs-3043	41	2	-	-	PUNCT
iajs-3043	41	3	materials	material	NOUN
iajs-3043	41	4	and	and	CCONJ
iajs-3043	41	5	methods	method	NOUN
iajs-3043	41	6	between	between	ADP
iajs-3043	41	7	november	november	PROPN
iajs-3043	41	8	2021	2021	NUM
iajs-3043	41	9	and	and	CCONJ
iajs-3043	41	10	march	march	PROPN
iajs-3043	41	11	2022	2022	NUM
iajs-3043	41	12	,	,	PUNCT
iajs-3043	41	13	we	we	PRON
iajs-3043	41	14	collected	collect	VERB
iajs-3043	41	15	blood	blood	NOUN
iajs-3043	41	16	samples	sample	NOUN
iajs-3043	41	17	of	of	ADP
iajs-3043	41	18	90	90	NUM
iajs-3043	41	19	patients	patient	NOUN
iajs-3043	41	20	who	who	PRON
iajs-3043	41	21	visited	visit	VERB
iajs-3043	41	22	gastroenterology	gastroenterology	NOUN
iajs-3043	41	23	and	and	CCONJ
iajs-3043	41	24	liver	liver	NOUN
iajs-3043	41	25	teaching	teaching	NOUN
iajs-3043	41	26	hospital	hospital	NOUN
iajs-3043	41	27	and	and	CCONJ
iajs-3043	41	28	baghdad	baghdad	PROPN
iajs-3043	41	29	hospital	hospital	NOUN
iajs-3043	41	30	consultation	consultation	NOUN
iajs-3043	41	31	within	within	ADP
iajs-3043	41	32	the	the	DET
iajs-3043	41	33	medical	medical	ADJ
iajs-3043	41	34	city	city	PROPN
iajs-3043	41	35	department	department	PROPN
iajs-3043	41	36	.	.	PUNCT
iajs-3043	42	1	from	from	ADP
iajs-3043	42	2	them	they	PRON
iajs-3043	42	3	,	,	PUNCT
iajs-3043	42	4	60	60	NUM
iajs-3043	42	5	examinees	examinee	NOUN
iajs-3043	42	6	were	be	AUX
iajs-3043	42	7	diagnosed	diagnose	VERB
iajs-3043	42	8	with	with	ADP
iajs-3043	42	9	nafld	nafld	ADJ
iajs-3043	42	10	and	and	CCONJ
iajs-3043	42	11	30	30	NUM
iajs-3043	42	12	examinees	examinee	NOUN
iajs-3043	42	13	were	be	AUX
iajs-3043	42	14	fixed	fix	VERB
iajs-3043	42	15	as	as	ADP
iajs-3043	42	16	control	control	NOUN
iajs-3043	42	17	group	group	NOUN
iajs-3043	42	18	(	(	PUNCT
iajs-3043	42	19	g3	g3	PROPN
iajs-3043	42	20	)	)	PUNCT
iajs-3043	42	21	.	.	PUNCT
iajs-3043	43	1	the	the	DET
iajs-3043	43	2	nafld	nafld	ADJ
iajs-3043	43	3	patients	patient	NOUN
iajs-3043	43	4	group	group	NOUN
iajs-3043	43	5	was	be	AUX
iajs-3043	43	6	based	base	VERB
iajs-3043	43	7	on	on	ADP
iajs-3043	43	8	abdominal	abdominal	ADJ
iajs-3043	43	9	ultrasound	ultrasound	NOUN
iajs-3043	43	10	imaging	imaging	NOUN
iajs-3043	43	11	examine	examine	NOUN
iajs-3043	43	12	and	and	CCONJ
iajs-3043	43	13	divided	divide	VERB
iajs-3043	43	14	to	to	PART
iajs-3043	43	15	obese	obese	VERB
iajs-3043	43	16	nafld	nafld	ADJ
iajs-3043	43	17	group	group	NOUN
iajs-3043	43	18	34	34	NUM
iajs-3043	43	19	as	as	ADP
iajs-3043	43	20	(	(	PUNCT
iajs-3043	43	21	g1	g1	PROPN
iajs-3043	43	22	)	)	PUNCT
iajs-3043	43	23	and	and	CCONJ
iajs-3043	43	24	non	non	ADJ
iajs-3043	43	25	-	-	ADJ
iajs-3043	43	26	obese	obese	ADJ
iajs-3043	43	27	nafld	nafld	ADJ
iajs-3043	43	28	group	group	NOUN
iajs-3043	43	29	26	26	NUM
iajs-3043	43	30	as	as	ADP
iajs-3043	43	31	(	(	PUNCT
iajs-3043	43	32	g2	g2	PROPN
iajs-3043	43	33	)	)	PUNCT
iajs-3043	43	34	according	accord	VERB
iajs-3043	43	35	to	to	ADP
iajs-3043	43	36	the	the	DET
iajs-3043	43	37	body	body	NOUN
iajs-3043	43	38	mass	mass	NOUN
iajs-3043	43	39	index	index	NOUN
iajs-3043	43	40	(	(	PUNCT
iajs-3043	43	41	bmi	bmi	PROPN
iajs-3043	43	42	)	)	PUNCT
iajs-3043	43	43	by	by	ADP
iajs-3043	43	44	mathematical	mathematical	ADJ
iajs-3043	43	45	equation	equation	NOUN
iajs-3043	43	46	,	,	PUNCT
iajs-3043	43	47	bmi	bmi	NOUN
iajs-3043	43	48	=	=	SYM
iajs-3043	43	49	weight	weight	NOUN
iajs-3043	43	50	(	(	PUNCT
iajs-3043	43	51	kg)/high	kg)/high	PROPN
iajs-3043	43	52	(	(	PUNCT
iajs-3043	43	53	m²	m²	PROPN
iajs-3043	43	54	)	)	PUNCT
iajs-3043	44	1	[	[	X
iajs-3043	44	2	19	19	NUM
iajs-3043	44	3	]	]	PUNCT
iajs-3043	44	4	.	.	PUNCT
iajs-3043	45	1	the	the	DET
iajs-3043	45	2	patient	patient	NOUN
iajs-3043	45	3	suffering	suffering	NOUN
iajs-3043	45	4	from	from	ADP
iajs-3043	45	5	other	other	ADJ
iajs-3043	45	6	complications	complication	NOUN
iajs-3043	45	7	were	be	AUX
iajs-3043	45	8	excluded	exclude	VERB
iajs-3043	45	9	from	from	ADP
iajs-3043	45	10	this	this	DET
iajs-3043	45	11	research	research	NOUN
iajs-3043	45	12	.	.	PUNCT
iajs-3043	46	1	several	several	ADJ
iajs-3043	46	2	parameters	parameter	NOUN
iajs-3043	46	3	were	be	AUX
iajs-3043	46	4	assessed	assess	VERB
iajs-3043	46	5	like	like	ADP
iajs-3043	46	6	age	age	NOUN
iajs-3043	46	7	,	,	PUNCT
iajs-3043	46	8	sex	sex	NOUN
iajs-3043	46	9	,	,	PUNCT
iajs-3043	46	10	and	and	CCONJ
iajs-3043	46	11	clinical	clinical	ADJ
iajs-3043	46	12	laboratory	laboratory	NOUN
iajs-3043	46	13	tests	test	NOUN
iajs-3043	46	14	.	.	PUNCT
iajs-3043	47	1	we	we	PRON
iajs-3043	47	2	evaluated	evaluate	VERB
iajs-3043	47	3	serum	serum	NOUN
iajs-3043	47	4	levels	level	NOUN
iajs-3043	47	5	of	of	ADP
iajs-3043	47	6	adiponectin	adiponectin	NOUN
iajs-3043	47	7	and	and	CCONJ
iajs-3043	47	8	irisin	irisin	NOUN
iajs-3043	47	9	by	by	ADP
iajs-3043	47	10	sandwich	sandwich	NOUN
iajs-3043	47	11	-	-	PUNCT
iajs-3043	47	12	elisa	elisa	NOUN
iajs-3043	47	13	technique	technique	NOUN
iajs-3043	47	14	(	(	PUNCT
iajs-3043	47	15	elisa	elisa	PROPN
iajs-3043	47	16	kit	kit	PROPN
iajs-3043	47	17	,	,	PUNCT
iajs-3043	47	18	elabscince	elabscince	PROPN
iajs-3043	47	19	,	,	PUNCT
iajs-3043	47	20	usa	usa	PROPN
iajs-3043	47	21	)	)	PUNCT
iajs-3043	47	22	.	.	PUNCT
iajs-3043	48	1	a	a	DET
iajs-3043	48	2	vitamin	vitamin	NOUN
iajs-3043	48	3	d	d	NOUN
iajs-3043	48	4	level	level	NOUN
iajs-3043	48	5	was	be	AUX
iajs-3043	48	6	evaluated	evaluate	VERB
iajs-3043	48	7	as	as	ADP
iajs-3043	48	8	25	25	NUM
iajs-3043	48	9	-	-	PUNCT
iajs-3043	48	10	hydroxyvitamin	hydroxyvitamin	NOUN
iajs-3043	48	11	d	d	NOUN
iajs-3043	48	12	(	(	PUNCT
iajs-3043	48	13	25(oh	25(oh	NOUN
iajs-3043	48	14	)	)	PUNCT
iajs-3043	48	15	d	d	NOUN
iajs-3043	48	16	)	)	PUNCT
iajs-3043	48	17	by	by	ADP
iajs-3043	48	18	elisa	elisa	PROPN
iajs-3043	48	19	works	work	NOUN
iajs-3043	48	20	on	on	ADP
iajs-3043	48	21	ihjpas	ihjpa	NOUN
iajs-3043	48	22	.	.	PUNCT
iajs-3043	49	1	36(2)2023	36(2)2023	NUM
iajs-3043	49	2	243	243	NUM
iajs-3043	49	3	the	the	DET
iajs-3043	49	4	competitive	competitive	ADJ
iajs-3043	49	5	binding	bind	VERB
iajs-3043	49	6	concept	concept	NOUN
iajs-3043	49	7	(	(	PUNCT
iajs-3043	49	8	vitamin	vitamin	NOUN
iajs-3043	49	9	d	d	PROPN
iajs-3043	49	10	kit	kit	PROPN
iajs-3043	49	11	,	,	PUNCT
iajs-3043	49	12	sigma	sigma	PROPN
iajs-3043	49	13	-	-	PUNCT
iajs-3043	49	14	aldrigh	aldrigh	ADJ
iajs-3043	49	15	,	,	PUNCT
iajs-3043	49	16	usa	usa	PROPN
iajs-3043	49	17	)	)	PUNCT
iajs-3043	49	18	.	.	PUNCT
iajs-3043	50	1	liver	liver	NOUN
iajs-3043	50	2	enzymes	enzyme	NOUN
iajs-3043	50	3	alanine	alanine	NOUN
iajs-3043	50	4	aminotransferase	aminotransferase	PROPN
iajs-3043	50	5	(	(	PUNCT
iajs-3043	50	6	alt	alt	ADJ
iajs-3043	50	7	)	)	PUNCT
iajs-3043	50	8	and	and	CCONJ
iajs-3043	50	9	aspartate	aspartate	NOUN
iajs-3043	50	10	aminotransferase	aminotransferase	NOUN
iajs-3043	50	11	(	(	PUNCT
iajs-3043	50	12	ast	ast	PROPN
iajs-3043	50	13	)	)	PUNCT
iajs-3043	50	14	were	be	AUX
iajs-3043	50	15	evaluated	evaluate	VERB
iajs-3043	50	16	photometrically	photometrically	ADV
iajs-3043	50	17	(	(	PUNCT
iajs-3043	50	18	alt	alt	VERB
iajs-3043	50	19	and	and	CCONJ
iajs-3043	50	20	ast	ast	NOUN
iajs-3043	50	21	kits	kit	NOUN
iajs-3043	50	22	supplied	supply	VERB
iajs-3043	50	23	from	from	ADP
iajs-3043	50	24	linear	linear	PROPN
iajs-3043	50	25	company	company	NOUN
iajs-3043	50	26	,	,	PUNCT
iajs-3043	50	27	spain	spain	PROPN
iajs-3043	50	28	)	)	PUNCT
iajs-3043	50	29	.	.	PUNCT
iajs-3043	51	1	statistical	statistical	ADJ
iajs-3043	51	2	analysis	analysis	NOUN
iajs-3043	51	3	:	:	PUNCT
iajs-3043	51	4	descriptive	descriptive	ADJ
iajs-3043	51	5	analysis	analysis	NOUN
iajs-3043	51	6	for	for	ADP
iajs-3043	51	7	variables	variable	NOUN
iajs-3043	51	8	was	be	AUX
iajs-3043	51	9	statically	statically	ADV
iajs-3043	51	10	analyzed	analyze	VERB
iajs-3043	51	11	by	by	ADP
iajs-3043	51	12	variance	variance	NOUN
iajs-3043	51	13	anova	anova	PROPN
iajs-3043	51	14	using	use	VERB
iajs-3043	51	15	computer	computer	NOUN
iajs-3043	51	16	windows	window	NOUN
iajs-3043	51	17	desktop-83quv4r	desktop-83quv4r	PROPN
iajs-3043	51	18	program	program	NOUN
iajs-3043	51	19	microsoft	microsoft	PROPN
iajs-3043	51	20	office	office	PROPN
iajs-3043	51	21	excel	excel	VERB
iajs-3043	51	22	2010	2010	NUM
iajs-3043	51	23	and	and	CCONJ
iajs-3043	51	24	expressed	express	VERB
iajs-3043	51	25	as	as	ADP
iajs-3043	51	26	(	(	PUNCT
iajs-3043	51	27	mean±	mean±	PROPN
iajs-3043	51	28	sd	sd	NOUN
iajs-3043	51	29	)	)	PUNCT
iajs-3043	51	30	.	.	PUNCT
iajs-3043	52	1	for	for	ADP
iajs-3043	52	2	comparison	comparison	NOUN
iajs-3043	52	3	study	study	NOUN
iajs-3043	52	4	between	between	ADP
iajs-3043	52	5	nafld	nafld	ADJ
iajs-3043	52	6	and	and	CCONJ
iajs-3043	52	7	control	control	NOUN
iajs-3043	52	8	groups	group	NOUN
iajs-3043	52	9	we	we	PRON
iajs-3043	52	10	used	use	VERB
iajs-3043	52	11	ttest	tt	ADJ
iajs-3043	52	12	and	and	CCONJ
iajs-3043	52	13	p	p	NOUN
iajs-3043	52	14	≤	≤	NUM
iajs-3043	52	15	0.001	0.001	NUM
iajs-3043	52	16	was	be	AUX
iajs-3043	52	17	considered	consider	VERB
iajs-3043	52	18	as	as	ADP
iajs-3043	52	19	significant	significant	ADJ
iajs-3043	52	20	[	[	X
iajs-3043	52	21	20	20	NUM
iajs-3043	52	22	]	]	PUNCT
iajs-3043	52	23	.	.	PUNCT
iajs-3043	53	1	2.results	2.results	NUM
iajs-3043	53	2	and	and	CCONJ
iajs-3043	53	3	discussion	discussion	NOUN
iajs-3043	53	4	table	table	NOUN
iajs-3043	53	5	(	(	PUNCT
iajs-3043	53	6	1	1	X
iajs-3043	53	7	)	)	PUNCT
iajs-3043	53	8	displays	display	VERB
iajs-3043	53	9	the	the	DET
iajs-3043	53	10	obtained	obtain	VERB
iajs-3043	53	11	levels	level	NOUN
iajs-3043	53	12	of	of	ADP
iajs-3043	53	13	adiponectin	adiponectin	NOUN
iajs-3043	53	14	,	,	PUNCT
iajs-3043	53	15	irisin	irisin	NOUN
iajs-3043	53	16	and	and	CCONJ
iajs-3043	53	17	vitamin	vitamin	NOUN
iajs-3043	53	18	d3	d3	PROPN
iajs-3043	53	19	in	in	ADP
iajs-3043	53	20	obese	obese	NOUN
iajs-3043	53	21	and	and	CCONJ
iajs-3043	53	22	non	non	ADJ
iajs-3043	53	23	-	-	ADJ
iajs-3043	53	24	obese	obese	ADJ
iajs-3043	53	25	iraqi	iraqi	ADJ
iajs-3043	53	26	patients	patient	NOUN
iajs-3043	53	27	with	with	ADP
iajs-3043	53	28	nafld	nafld	ADJ
iajs-3043	53	29	and	and	CCONJ
iajs-3043	53	30	control	control	NOUN
iajs-3043	53	31	group	group	NOUN
iajs-3043	53	32	.	.	PUNCT
iajs-3043	54	1	the	the	DET
iajs-3043	54	2	body	body	NOUN
iajs-3043	54	3	mass	mass	PROPN
iajs-3043	54	4	index	index	NOUN
iajs-3043	54	5	(	(	PUNCT
iajs-3043	54	6	bmi	bmi	PROPN
iajs-3043	54	7	)	)	PUNCT
iajs-3043	54	8	was	be	AUX
iajs-3043	54	9	found	find	VERB
iajs-3043	54	10	(	(	PUNCT
iajs-3043	54	11	35.18±5.44	35.18±5.44	NUM
iajs-3043	54	12	)	)	PUNCT
iajs-3043	54	13	,	,	PUNCT
iajs-3043	54	14	(	(	PUNCT
iajs-3043	54	15	23.72±0.52	23.72±0.52	NUM
iajs-3043	54	16	)	)	PUNCT
iajs-3043	54	17	and	and	CCONJ
iajs-3043	54	18	(	(	PUNCT
iajs-3043	54	19	24.43±	24.43±	NUM
iajs-3043	54	20	2.30	2.30	NUM
iajs-3043	54	21	)	)	PUNCT
iajs-3043	54	22	for	for	ADP
iajs-3043	54	23	the	the	DET
iajs-3043	54	24	three	three	NUM
iajs-3043	54	25	groups	group	NOUN
iajs-3043	54	26	respectively	respectively	ADV
iajs-3043	54	27	.	.	PUNCT
iajs-3043	55	1	high	high	ADJ
iajs-3043	55	2	bmi	bmi	NOUN
iajs-3043	55	3	(	(	PUNCT
iajs-3043	55	4	obesity	obesity	NOUN
iajs-3043	55	5	/	/	SYM
iajs-3043	55	6	excess	excess	ADJ
iajs-3043	55	7	weight	weight	NOUN
iajs-3043	55	8	)	)	PUNCT
iajs-3043	55	9	has	have	VERB
iajs-3043	55	10	a	a	DET
iajs-3043	55	11	linear	linear	ADJ
iajs-3043	55	12	relationship	relationship	NOUN
iajs-3043	55	13	with	with	ADP
iajs-3043	55	14	fatty	fatty	NOUN
iajs-3043	55	15	liver	liver	NOUN
iajs-3043	55	16	disease	disease	NOUN
iajs-3043	55	17	.	.	PUNCT
iajs-3043	56	1	one	one	NUM
iajs-3043	56	2	of	of	ADP
iajs-3043	56	3	the	the	DET
iajs-3043	56	4	risk	risk	NOUN
iajs-3043	56	5	factor	factor	NOUN
iajs-3043	56	6	in	in	ADP
iajs-3043	56	7	nafld	nafld	ADJ
iajs-3043	56	8	development	development	NOUN
iajs-3043	56	9	is	be	AUX
iajs-3043	56	10	obesity	obesity	NOUN
iajs-3043	56	11	(	(	PUNCT
iajs-3043	56	12	nafld	nafld	ADJ
iajs-3043	56	13	prevalence	prevalence	NOUN
iajs-3043	56	14	>	>	NOUN
iajs-3043	56	15	23	23	NUM
iajs-3043	56	16	%	%	NOUN
iajs-3043	56	17	)	)	PUNCT
iajs-3043	56	18	even	even	ADV
iajs-3043	56	19	in	in	ADP
iajs-3043	56	20	absence	absence	NOUN
iajs-3043	56	21	of	of	ADP
iajs-3043	56	22	t2d	t2d	NOUN
iajs-3043	56	23	and	and	CCONJ
iajs-3043	56	24	insulin	insulin	NOUN
iajs-3043	56	25	resistance	resistance	NOUN
iajs-3043	56	26	although	although	SCONJ
iajs-3043	56	27	it	it	PRON
iajs-3043	56	28	is	be	AUX
iajs-3043	56	29	not	not	PART
iajs-3043	56	30	a	a	DET
iajs-3043	56	31	diagnostic	diagnostic	ADJ
iajs-3043	56	32	criteria	criterion	NOUN
iajs-3043	56	33	for	for	ADP
iajs-3043	56	34	nafld	nafld	ADJ
iajs-3043	57	1	[	[	X
iajs-3043	57	2	21	21	NUM
iajs-3043	57	3	]	]	PUNCT
iajs-3043	57	4	,	,	PUNCT
iajs-3043	57	5	but	but	CCONJ
iajs-3043	57	6	still	still	ADV
iajs-3043	57	7	there	there	PRON
iajs-3043	57	8	are	be	VERB
iajs-3043	57	9	many	many	ADJ
iajs-3043	57	10	nafla	nafla	ADJ
iajs-3043	57	11	patients	patient	NOUN
iajs-3043	57	12	with	with	ADP
iajs-3043	57	13	normal	normal	ADJ
iajs-3043	57	14	bmi	bmi	NOUN
iajs-3043	58	1	[	[	X
iajs-3043	58	2	23	23	NUM
iajs-3043	58	3	]	]	PUNCT
iajs-3043	58	4	.	.	PUNCT
iajs-3043	59	1	recent	recent	ADJ
iajs-3043	59	2	studies	study	NOUN
iajs-3043	59	3	have	have	AUX
iajs-3043	59	4	shown	show	VERB
iajs-3043	59	5	that	that	SCONJ
iajs-3043	59	6	non	non	ADJ
iajs-3043	59	7	-	-	ADJ
iajs-3043	59	8	obese	obese	ADJ
iajs-3043	59	9	people	people	NOUN
iajs-3043	59	10	with	with	ADP
iajs-3043	59	11	a	a	DET
iajs-3043	59	12	bmi	bmi	NOUN
iajs-3043	59	13	(	(	PUNCT
iajs-3043	59	14	<	<	X
iajs-3043	59	15	25	25	NUM
iajs-3043	59	16	kg	kg	NOUN
iajs-3043	59	17	/	/	SYM
iajs-3043	59	18	m2	m2	PROPN
iajs-3043	59	19	)	)	PUNCT
iajs-3043	59	20	and	and	CCONJ
iajs-3043	59	21	lean	lean	ADJ
iajs-3043	59	22	(	(	PUNCT
iajs-3043	59	23	<	<	X
iajs-3043	59	24	23kg	23kg	ADJ
iajs-3043	59	25	/	/	SYM
iajs-3043	59	26	m2	m2	NOUN
iajs-3043	59	27	)	)	PUNCT
iajs-3043	59	28	also	also	ADV
iajs-3043	59	29	have	have	VERB
iajs-3043	59	30	nafld	nafld	ADJ
iajs-3043	60	1	[	[	X
iajs-3043	60	2	23	23	NUM
iajs-3043	60	3	]	]	PUNCT
iajs-3043	60	4	.	.	PUNCT
iajs-3043	61	1	obesity	obesity	NOUN
iajs-3043	61	2	affects	affect	VERB
iajs-3043	61	3	nafld	nafld	ADV
iajs-3043	61	4	,	,	PUNCT
iajs-3043	61	5	and	and	CCONJ
iajs-3043	61	6	nafld	nafld	ADV
iajs-3043	61	7	may	may	AUX
iajs-3043	61	8	also	also	ADV
iajs-3043	61	9	affect	affect	VERB
iajs-3043	61	10	obesity	obesity	NOUN
iajs-3043	61	11	via	via	ADP
iajs-3043	61	12	multiple	multiple	ADJ
iajs-3043	61	13	mechanisms	mechanism	NOUN
iajs-3043	61	14	,	,	PUNCT
iajs-3043	61	15	including	include	VERB
iajs-3043	61	16	hepatic	hepatic	ADJ
iajs-3043	61	17	dysfunction	dysfunction	NOUN
iajs-3043	61	18	,	,	PUNCT
iajs-3043	61	19	hepatic	hepatic	ADJ
iajs-3043	61	20	ir	ir	NOUN
iajs-3043	61	21	,	,	PUNCT
iajs-3043	61	22	oxidative	oxidative	ADJ
iajs-3043	61	23	stress	stress	NOUN
iajs-3043	61	24	,	,	PUNCT
iajs-3043	61	25	glucotoxicity	glucotoxicity	NOUN
iajs-3043	61	26	and	and	CCONJ
iajs-3043	61	27	lipotoxicity	lipotoxicity	NOUN
iajs-3043	61	28	.	.	PUNCT
iajs-3043	62	1	the	the	DET
iajs-3043	62	2	data	datum	NOUN
iajs-3043	62	3	in	in	ADP
iajs-3043	62	4	this	this	DET
iajs-3043	62	5	study	study	NOUN
iajs-3043	62	6	showed	show	VERB
iajs-3043	62	7	a	a	DET
iajs-3043	62	8	significant	significant	ADJ
iajs-3043	62	9	increase	increase	NOUN
iajs-3043	62	10	in	in	ADP
iajs-3043	62	11	adiponectin	adiponectin	NOUN
iajs-3043	62	12	and	and	CCONJ
iajs-3043	62	13	irisin	irisin	NOUN
iajs-3043	62	14	in	in	ADP
iajs-3043	62	15	g1	g1	PROPN
iajs-3043	62	16	as	as	SCONJ
iajs-3043	62	17	compared	compare	VERB
iajs-3043	62	18	with	with	ADP
iajs-3043	62	19	g2	g2	PROPN
iajs-3043	62	20	and	and	CCONJ
iajs-3043	62	21	g3	g3	PROPN
iajs-3043	62	22	as	as	SCONJ
iajs-3043	62	23	showed	show	VERB
iajs-3043	62	24	in	in	ADP
iajs-3043	62	25	table	table	NOUN
iajs-3043	62	26	(	(	PUNCT
iajs-3043	62	27	1	1	NUM
iajs-3043	62	28	)	)	PUNCT
iajs-3043	62	29	.	.	PUNCT
iajs-3043	63	1	table	table	NOUN
iajs-3043	63	2	(	(	PUNCT
iajs-3043	63	3	1	1	NUM
iajs-3043	63	4	):	):	PUNCT
iajs-3043	63	5	the	the	DET
iajs-3043	63	6	(	(	PUNCT
iajs-3043	63	7	mean	mean	PROPN
iajs-3043	63	8	±	±	NUM
iajs-3043	63	9	sd	sd	NOUN
iajs-3043	63	10	)	)	PUNCT
iajs-3043	63	11	of	of	ADP
iajs-3043	63	12	adiponectinm	adiponectinm	PROPN
iajs-3043	63	13	,	,	PUNCT
iajs-3043	63	14	irisin	irisin	NOUN
iajs-3043	63	15	and	and	CCONJ
iajs-3043	63	16	vitamin	vitamin	NOUN
iajs-3043	63	17	d3	d3	PROPN
iajs-3043	63	18	.	.	PUNCT
iajs-3043	64	1	parameters	parameter	NOUN
iajs-3043	64	2	mean	mean	VERB
iajs-3043	64	3	±sd	±sd	NOUN
iajs-3043	64	4	p.value	p.value	NOUN
iajs-3043	64	5	g1	g1	NOUN
iajs-3043	64	6	=	=	NOUN
iajs-3043	64	7	no.34	no.34	NOUN
iajs-3043	64	8	g2	g2	PROPN
iajs-3043	64	9	=	=	ADJ
iajs-3043	64	10	no.26	no.26	ADJ
iajs-3043	64	11	g3	g3	NOUN
iajs-3043	64	12	=	=	NOUN
iajs-3043	64	13	no.30	no.30	PROPN
iajs-3043	64	14	g1	g1	NOUN
iajs-3043	64	15	vs.	vs.	ADP
iajs-3043	64	16	g2	g2	PROPN
iajs-3043	64	17	g1	g1	PROPN
iajs-3043	64	18	vs.g3	vs.g3	PROPN
iajs-3043	64	19	g2	g2	PROPN
iajs-3043	64	20	vs.g3	vs.g3	PROPN
iajs-3043	65	1	age	age	NOUN
iajs-3043	65	2	42.89±8.36	42.89±8.36	NUM
iajs-3043	65	3	38.6±13.68	38.6±13.68	NOUN
iajs-3043	65	4	41.36±11.96	41.36±11.96	PROPN
iajs-3043	65	5	0.529	0.529	SYM
iajs-3043	65	6	0.570	0.570	NUM
iajs-3043	65	7	0.68	0.68	NUM
iajs-3043	65	8	bmi(kg	bmi(kg	NOUN
iajs-3043	65	9	/	/	SYM
iajs-3043	65	10	m2	m2	PROPN
iajs-3043	65	11	)	)	PUNCT
iajs-3043	65	12	35.18±5.44	35.18±5.44	NUM
iajs-3043	65	13	23.72±0.52	23.72±0.52	NUM
iajs-3043	65	14	22.431±2.30	22.431±2.30	NUM
iajs-3043	65	15	0.001	0.001	NUM
iajs-3043	65	16	0.001	0.001	NUM
iajs-3043	65	17	0.15	0.15	NUM
iajs-3043	65	18	adiponectin	adiponectin	NOUN
iajs-3043	65	19	(	(	PUNCT
iajs-3043	65	20	ng	ng	NOUN
iajs-3043	65	21	/	/	SYM
iajs-3043	65	22	ml	ml	NOUN
iajs-3043	65	23	)	)	PUNCT
iajs-3043	65	24	3.53±1.26	3.53±1.26	PROPN
iajs-3043	65	25	3.19±0.57	3.19±0.57	NUM
iajs-3043	65	26	1.806±0.09	1.806±0.09	NUM
iajs-3043	65	27	0.396	0.396	NUM
iajs-3043	65	28	0.001	0.001	NUM
iajs-3043	65	29	0.002	0.002	NUM
iajs-3043	65	30	irisin	irisin	NOUN
iajs-3043	65	31	(	(	PUNCT
iajs-3043	65	32	pg	pg	NOUN
iajs-3043	65	33	/	/	SYM
iajs-3043	65	34	ml	ml	VERB
iajs-3043	65	35	)	)	PUNCT
iajs-3043	65	36	429.87±	429.87±	PROPN
iajs-3043	65	37	92.97	92.97	NUM
iajs-3043	65	38	404.68±86.49	404.68±86.49	NUM
iajs-3043	65	39	62.08±18.32	62.08±18.32	NUM
iajs-3043	65	40	0.627	0.627	NUM
iajs-3043	65	41	0.001	0.001	NUM
iajs-3043	65	42	0.001	0.001	NUM
iajs-3043	65	43	vitamin	vitamin	NOUN
iajs-3043	65	44	d3(ng	d3(ng	PROPN
iajs-3043	65	45	/	/	SYM
iajs-3043	65	46	ml	ml	NOUN
iajs-3043	65	47	)	)	PUNCT
iajs-3043	65	48	14.23±1.43	14.23±1.43	NUM
iajs-3043	65	49	15.97±3.87	15.97±3.87	NUM
iajs-3043	65	50	33.4±2.22	33.4±2.22	NUM
iajs-3043	65	51	0.035	0.035	NUM
iajs-3043	65	52	0.001	0.001	NUM
iajs-3043	65	53	0.001	0.001	NUM
iajs-3043	65	54	sgpt	sgpt	NOUN
iajs-3043	65	55	/	/	SYM
iajs-3043	65	56	alt	alt	PROPN
iajs-3043	65	57	(	(	PUNCT
iajs-3043	65	58	u	u	NOUN
iajs-3043	65	59	/	/	SYM
iajs-3043	65	60	l	l	NOUN
iajs-3043	65	61	)	)	PUNCT
iajs-3043	65	62	40.21±17.00	40.21±17.00	NUM
iajs-3043	66	1	130.97±56.65	130.97±56.65	ADV
iajs-3043	67	1	27.88±6.88	27.88±6.88	NUM
iajs-3043	67	2	0.373	0.373	NUM
iajs-3043	67	3	0.044	0.044	NUM
iajs-3043	67	4	0.250	0.250	NUM
iajs-3043	67	5	g1	g1	NOUN
iajs-3043	67	6	:	:	PUNCT
iajs-3043	67	7	obese	obese	PROPN
iajs-3043	67	8	nafld	nafld	ADV
iajs-3043	67	9	,	,	PUNCT
iajs-3043	67	10	g2	g2	PROPN
iajs-3043	67	11	:	:	PUNCT
iajs-3043	67	12	non	non	ADJ
iajs-3043	67	13	obese	obese	ADJ
iajs-3043	67	14	nafld	nafld	ADJ
iajs-3043	67	15	,	,	PUNCT
iajs-3043	67	16	g3	g3	PROPN
iajs-3043	67	17	:	:	PUNCT
iajs-3043	67	18	controls	control	VERB
iajs-3043	67	19	iraqi	iraqi	ADJ
iajs-3043	67	20	patients	patient	NOUN
iajs-3043	67	21	.	.	PUNCT
iajs-3043	68	1	the	the	DET
iajs-3043	68	2	expansion	expansion	NOUN
iajs-3043	68	3	of	of	ADP
iajs-3043	68	4	nafld	nafld	PROPN
iajs-3043	68	5	is	be	AUX
iajs-3043	68	6	15	15	NUM
iajs-3043	68	7	-	-	SYM
iajs-3043	68	8	30	30	NUM
iajs-3043	68	9	of	of	ADP
iajs-3043	68	10	the	the	DET
iajs-3043	68	11	common	common	ADJ
iajs-3043	68	12	population	population	NOUN
iajs-3043	68	13	and	and	CCONJ
iajs-3043	68	14	50	50	NUM
iajs-3043	68	15	-	-	SYM
iajs-3043	68	16	90	90	NUM
iajs-3043	68	17	%	%	NOUN
iajs-3043	68	18	in	in	ADP
iajs-3043	68	19	obese	obese	PROPN
iajs-3043	68	20	.	.	PUNCT
iajs-3043	69	1	the	the	DET
iajs-3043	69	2	important	important	ADJ
iajs-3043	69	3	risk	risk	NOUN
iajs-3043	69	4	factor	factor	NOUN
iajs-3043	69	5	to	to	ADP
iajs-3043	69	6	beginning	begin	VERB
iajs-3043	69	7	nafld	nafld	PROPN
iajs-3043	69	8	is	be	AUX
iajs-3043	69	9	visceral	visceral	ADJ
iajs-3043	69	10	obesity	obesity	NOUN
iajs-3043	69	11	[	[	X
iajs-3043	69	12	24	24	NUM
iajs-3043	69	13	]	]	PUNCT
iajs-3043	69	14	.	.	PUNCT
iajs-3043	70	1	adipose	adipose	ADP
iajs-3043	70	2	tissue	tissue	NOUN
iajs-3043	70	3	dysfunction	dysfunction	NOUN
iajs-3043	70	4	results	result	NOUN
iajs-3043	70	5	from	from	ADP
iajs-3043	70	6	visceral	visceral	ADJ
iajs-3043	70	7	obesity	obesity	NOUN
iajs-3043	70	8	and	and	CCONJ
iajs-3043	70	9	fatty	fatty	NOUN
iajs-3043	70	10	liver	liver	NOUN
iajs-3043	70	11	leads	lead	VERB
iajs-3043	70	12	to	to	PART
iajs-3043	70	13	increase	increase	VERB
iajs-3043	70	14	pro	pro	ADJ
iajs-3043	70	15	-	-	ADJ
iajs-3043	70	16	inflammatory	inflammatory	ADJ
iajs-3043	70	17	adiponectines	adiponectine	NOUN
iajs-3043	70	18	and	and	CCONJ
iajs-3043	70	19	decrease	decrease	VERB
iajs-3043	70	20	anti	anti	ADJ
iajs-3043	70	21	-	-	ADJ
iajs-3043	70	22	inflammatory	inflammatory	ADJ
iajs-3043	70	23	adipokines	adipokine	NOUN
iajs-3043	70	24	,	,	PUNCT
iajs-3043	70	25	therefore	therefore	ADV
iajs-3043	70	26	nafld	nafld	ADJ
iajs-3043	70	27	increases	increase	VERB
iajs-3043	70	28	with	with	ADP
iajs-3043	70	29	body	body	NOUN
iajs-3043	70	30	mass	mass	NOUN
iajs-3043	70	31	index	index	NOUN
iajs-3043	70	32	(	(	PUNCT
iajs-3043	70	33	bmi	bmi	NOUN
iajs-3043	70	34	)	)	PUNCT
iajs-3043	70	35	increase	increase	NOUN
iajs-3043	70	36	[	[	X
iajs-3043	70	37	25	25	NUM
iajs-3043	70	38	]	]	PUNCT
iajs-3043	70	39	.	.	PUNCT
iajs-3043	71	1	adiponectin	adiponectin	NOUN
iajs-3043	71	2	expression	expression	NOUN
iajs-3043	71	3	of	of	ADP
iajs-3043	71	4	nafld	nafld	ADJ
iajs-3043	71	5	is	be	AUX
iajs-3043	71	6	decreased	decrease	VERB
iajs-3043	71	7	by	by	ADP
iajs-3043	71	8	20%-40	20%-40	NUM
iajs-3043	71	9	%	%	NOUN
iajs-3043	71	10	during	during	ADP
iajs-3043	71	11	the	the	DET
iajs-3043	71	12	development	development	NOUN
iajs-3043	71	13	of	of	ADP
iajs-3043	71	14	nafld	nafld	ADJ
iajs-3043	71	15	and	and	CCONJ
iajs-3043	71	16	it	it	PRON
iajs-3043	71	17	lower	lower	ADV
iajs-3043	71	18	by	by	ADP
iajs-3043	71	19	more	more	ADJ
iajs-3043	71	20	than	than	ADP
iajs-3043	71	21	50	50	NUM
iajs-3043	71	22	%	%	NOUN
iajs-3043	71	23	in	in	ADP
iajs-3043	71	24	nash	nash	ADJ
iajs-3043	71	25	patients	patient	NOUN
iajs-3043	71	26	,	,	PUNCT
iajs-3043	71	27	from	from	ADP
iajs-3043	71	28	simple	simple	ADJ
iajs-3043	71	29	steatosis	steatosis	NOUN
iajs-3043	71	30	to	to	ADP
iajs-3043	71	31	nash	nash	PROPN
iajs-3043	71	32	.	.	PUNCT
iajs-3043	72	1	the	the	DET
iajs-3043	72	2	previous	previous	ADJ
iajs-3043	72	3	study	study	NOUN
iajs-3043	72	4	reveled	revel	VERB
iajs-3043	72	5	the	the	DET
iajs-3043	72	6	low	low	ADJ
iajs-3043	72	7	level	level	NOUN
iajs-3043	72	8	of	of	ADP
iajs-3043	72	9	adiponectin	adiponectin	NOUN
iajs-3043	72	10	in	in	ADP
iajs-3043	72	11	hepatic	hepatic	ADJ
iajs-3043	72	12	steatosis	steatosis	NOUN
iajs-3043	72	13	,	,	PUNCT
iajs-3043	72	14	nash	nash	NOUN
iajs-3043	72	15	and	and	CCONJ
iajs-3043	72	16	in	in	ADP
iajs-3043	72	17	obese	obese	NOUN
iajs-3043	72	18	especially	especially	ADV
iajs-3043	72	19	those	those	PRON
iajs-3043	72	20	with	with	ADP
iajs-3043	72	21	visceral	visceral	ADJ
iajs-3043	72	22	obesity	obesity	NOUN
iajs-3043	72	23	and	and	CCONJ
iajs-3043	72	24	correlate	correlate	VERB
iajs-3043	72	25	inversely	inversely	ADV
iajs-3043	72	26	with	with	ADP
iajs-3043	72	27	insulin	insulin	NOUN
iajs-3043	72	28	resistance	resistance	NOUN
iajs-3043	72	29	[	[	X
iajs-3043	72	30	26	26	NUM
iajs-3043	72	31	]	]	PUNCT
iajs-3043	72	32	.	.	PUNCT
iajs-3043	73	1	ihjpas	ihjpas	PROPN
iajs-3043	73	2	.	.	PUNCT
iajs-3043	74	1	36(2)2023	36(2)2023	NUM
iajs-3043	74	2	244	244	NUM
iajs-3043	74	3	other	other	ADJ
iajs-3043	74	4	study	study	NOUN
iajs-3043	74	5	showed	show	VERB
iajs-3043	74	6	that	that	SCONJ
iajs-3043	74	7	low	low	ADJ
iajs-3043	74	8	serum	serum	NOUN
iajs-3043	74	9	adiponectin	adiponectin	NOUN
iajs-3043	74	10	level	level	NOUN
iajs-3043	74	11	in	in	ADP
iajs-3043	74	12	nafld	nafld	ADJ
iajs-3043	74	13	and	and	CCONJ
iajs-3043	74	14	considered	consider	VERB
iajs-3043	74	15	adiponectin	adiponectin	NOUN
iajs-3043	74	16	as	as	ADP
iajs-3043	74	17	a	a	DET
iajs-3043	74	18	non	non	ADJ
iajs-3043	74	19	-	-	ADJ
iajs-3043	74	20	classical	classical	ADJ
iajs-3043	74	21	biomarker	biomarker	NOUN
iajs-3043	74	22	of	of	ADP
iajs-3043	74	23	metabolic	metabolic	NOUN
iajs-3043	74	24	complications	complication	NOUN
iajs-3043	74	25	with	with	ADP
iajs-3043	74	26	nafld	nafld	PROPN
iajs-3043	75	1	[	[	X
iajs-3043	75	2	27	27	NUM
iajs-3043	75	3	]	]	PUNCT
iajs-3043	75	4	.	.	PUNCT
iajs-3043	76	1	irisin	irisin	PROPN
iajs-3043	76	2	synthesized	synthesize	VERB
iajs-3043	76	3	in	in	ADP
iajs-3043	76	4	muscle	muscle	NOUN
iajs-3043	76	5	and	and	CCONJ
iajs-3043	76	6	a	a	DET
iajs-3043	76	7	higher	high	ADJ
iajs-3043	76	8	amount	amount	NOUN
iajs-3043	76	9	in	in	ADP
iajs-3043	76	10	adipose	adipose	ADJ
iajs-3043	76	11	tissues	tissue	NOUN
iajs-3043	76	12	thus	thus	ADV
iajs-3043	76	13	irisin	irisin	VERB
iajs-3043	76	14	level	level	NOUN
iajs-3043	76	15	correlation	correlation	NOUN
iajs-3043	76	16	positively	positively	ADV
iajs-3043	76	17	with	with	ADP
iajs-3043	76	18	obesity	obesity	NOUN
iajs-3043	76	19	and	and	CCONJ
iajs-3043	76	20	bmi	bmi	NOUN
iajs-3043	76	21	[	[	X
iajs-3043	76	22	28	28	NUM
iajs-3043	76	23	-	-	SYM
iajs-3043	76	24	29	29	NUM
iajs-3043	76	25	]	]	PUNCT
iajs-3043	76	26	.	.	PUNCT
iajs-3043	77	1	several	several	ADJ
iajs-3043	77	2	studies	study	NOUN
iajs-3043	77	3	cleared	clear	VERB
iajs-3043	77	4	the	the	DET
iajs-3043	77	5	relation	relation	NOUN
iajs-3043	77	6	between	between	ADP
iajs-3043	77	7	obesity	obesity	NOUN
iajs-3043	77	8	and	and	CCONJ
iajs-3043	77	9	disorder	disorder	NOUN
iajs-3043	77	10	of	of	ADP
iajs-3043	77	11	serum	serum	NOUN
iajs-3043	77	12	irisin	irisin	PROPN
iajs-3043	77	13	,	,	PUNCT
iajs-3043	77	14	since	since	SCONJ
iajs-3043	77	15	irisin	irisin	NOUN
iajs-3043	77	16	plays	play	VERB
iajs-3043	77	17	a	a	DET
iajs-3043	77	18	protective	protective	ADJ
iajs-3043	77	19	role	role	NOUN
iajs-3043	77	20	in	in	ADP
iajs-3043	77	21	obesity	obesity	NOUN
iajs-3043	77	22	,	,	PUNCT
iajs-3043	77	23	it	it	PRON
iajs-3043	77	24	might	might	AUX
iajs-3043	77	25	be	be	AUX
iajs-3043	77	26	expect	expect	VERB
iajs-3043	77	27	that	that	SCONJ
iajs-3043	77	28	levels	level	NOUN
iajs-3043	77	29	of	of	ADP
iajs-3043	77	30	irisin	irisin	NOUN
iajs-3043	77	31	would	would	AUX
iajs-3043	77	32	be	be	AUX
iajs-3043	77	33	lower	low	ADJ
iajs-3043	77	34	in	in	ADP
iajs-3043	77	35	populations	population	NOUN
iajs-3043	77	36	with	with	ADP
iajs-3043	77	37	obesity	obesity	NOUN
iajs-3043	77	38	.	.	PUNCT
iajs-3043	78	1	also	also	ADV
iajs-3043	78	2	clinical	clinical	ADJ
iajs-3043	78	3	studies	study	NOUN
iajs-3043	78	4	have	have	AUX
iajs-3043	78	5	been	be	AUX
iajs-3043	78	6	described	describe	VERB
iajs-3043	78	7	a	a	DET
iajs-3043	78	8	positive	positive	ADJ
iajs-3043	78	9	association	association	NOUN
iajs-3043	78	10	between	between	ADP
iajs-3043	78	11	circulating	circulate	VERB
iajs-3043	78	12	levels	level	NOUN
iajs-3043	78	13	of	of	ADP
iajs-3043	78	14	irisin	irisin	NOUN
iajs-3043	78	15	and	and	CCONJ
iajs-3043	78	16	bmi	bmi	X
iajs-3043	78	17	[	[	X
iajs-3043	78	18	30	30	NUM
iajs-3043	78	19	]	]	PUNCT
iajs-3043	78	20	.	.	PUNCT
iajs-3043	79	1	irisin	irisin	PROPN
iajs-3043	79	2	level	level	NOUN
iajs-3043	79	3	was	be	AUX
iajs-3043	79	4	significantly	significantly	ADV
iajs-3043	79	5	lower	low	ADJ
iajs-3043	79	6	in	in	ADP
iajs-3043	79	7	nafld	nafld	PROPN
iajs-3043	79	8	compared	compare	VERB
iajs-3043	79	9	with	with	ADP
iajs-3043	79	10	control[31	control[31	PROPN
iajs-3043	79	11	]	]	PUNCT
iajs-3043	79	12	,	,	PUNCT
iajs-3043	79	13	and	and	CCONJ
iajs-3043	79	14	lower	low	ADJ
iajs-3043	79	15	in	in	ADP
iajs-3043	79	16	obese	obese	NOUN
iajs-3043	79	17	nafld	nafld	ADV
iajs-3043	79	18	in	in	ADP
iajs-3043	79	19	adolescents[32	adolescents[32	NOUN
iajs-3043	79	20	]	]	PUNCT
iajs-3043	79	21	while	while	SCONJ
iajs-3043	79	22	another	another	DET
iajs-3043	79	23	study	study	NOUN
iajs-3043	79	24	revealed	reveal	VERB
iajs-3043	79	25	that	that	SCONJ
iajs-3043	79	26	irisin	irisin	NOUN
iajs-3043	79	27	level	level	NOUN
iajs-3043	79	28	increasing	increase	VERB
iajs-3043	79	29	with	with	ADP
iajs-3043	79	30	nafld	nafld	ADJ
iajs-3043	79	31	patients[33	patients[33	NOUN
iajs-3043	79	32	]	]	PUNCT
iajs-3043	79	33	.	.	PUNCT
iajs-3043	80	1	other	other	ADJ
iajs-3043	80	2	study	study	NOUN
iajs-3043	80	3	showed	show	VERB
iajs-3043	80	4	that	that	SCONJ
iajs-3043	80	5	irisin	irisin	NOUN
iajs-3043	80	6	levels	level	NOUN
iajs-3043	80	7	were	be	AUX
iajs-3043	80	8	higher	high	ADJ
iajs-3043	80	9	in	in	ADP
iajs-3043	80	10	the	the	DET
iajs-3043	80	11	nafld	nafld	ADJ
iajs-3043	80	12	patient	patient	ADJ
iajs-3043	80	13	group	group	NOUN
iajs-3043	80	14	than	than	ADP
iajs-3043	80	15	in	in	ADP
iajs-3043	80	16	healthy	healthy	ADJ
iajs-3043	80	17	group	group	NOUN
iajs-3043	80	18	in	in	ADP
iajs-3043	80	19	asians	asians	PROPN
iajs-3043	80	20	and	and	CCONJ
iajs-3043	80	21	the	the	DET
iajs-3043	80	22	level	level	NOUN
iajs-3043	80	23	was	be	AUX
iajs-3043	80	24	higher	high	ADJ
iajs-3043	80	25	in	in	ADP
iajs-3043	80	26	mild	mild	ADJ
iajs-3043	80	27	nafld	nafld	ADJ
iajs-3043	80	28	group	group	NOUN
iajs-3043	80	29	than	than	ADP
iajs-3043	80	30	in	in	ADP
iajs-3043	80	31	moderate	moderate	ADJ
iajs-3043	80	32	nafld	nafld	ADJ
iajs-3043	80	33	group[34	group[34	NOUN
iajs-3043	80	34	]	]	PUNCT
iajs-3043	80	35	.	.	PUNCT
iajs-3043	81	1	in	in	ADP
iajs-3043	81	2	early	early	ADJ
iajs-3043	81	3	stage	stage	NOUN
iajs-3043	81	4	of	of	ADP
iajs-3043	81	5	nafld	nafld	ADJ
iajs-3043	81	6	,	,	PUNCT
iajs-3043	81	7	irisin	irisin	ADJ
iajs-3043	81	8	level	level	NOUN
iajs-3043	81	9	was	be	AUX
iajs-3043	81	10	increased	increase	VERB
iajs-3043	81	11	temporarily	temporarily	ADV
iajs-3043	81	12	then	then	ADV
iajs-3043	81	13	stabilized	stabilize	VERB
iajs-3043	81	14	with	with	ADP
iajs-3043	81	15	aggravation	aggravation	NOUN
iajs-3043	81	16	of	of	ADP
iajs-3043	81	17	nafld	nafld	PROPN
iajs-3043	81	18	.	.	PUNCT
iajs-3043	82	1	in	in	ADP
iajs-3043	82	2	addition	addition	NOUN
iajs-3043	82	3	the	the	DET
iajs-3043	82	4	data	datum	NOUN
iajs-3043	82	5	in	in	ADP
iajs-3043	82	6	table	table	NOUN
iajs-3043	82	7	(	(	PUNCT
iajs-3043	82	8	1	1	X
iajs-3043	82	9	)	)	PUNCT
iajs-3043	82	10	showed	show	VERB
iajs-3043	82	11	a	a	DET
iajs-3043	82	12	significant	significant	ADJ
iajs-3043	82	13	decrease	decrease	NOUN
iajs-3043	82	14	in	in	ADP
iajs-3043	82	15	vitamin	vitamin	NOUN
iajs-3043	82	16	d3	d3	PROPN
iajs-3043	82	17	in	in	ADP
iajs-3043	82	18	g1	g1	PROPN
iajs-3043	82	19	as	as	SCONJ
iajs-3043	82	20	compared	compare	VERB
iajs-3043	82	21	with	with	ADP
iajs-3043	82	22	g2	g2	PROPN
iajs-3043	82	23	and	and	CCONJ
iajs-3043	82	24	g3	g3	PROPN
iajs-3043	82	25	.	.	PUNCT
iajs-3043	83	1	different	different	ADJ
iajs-3043	83	2	studies	study	NOUN
iajs-3043	83	3	have	have	AUX
iajs-3043	83	4	referred	refer	VERB
iajs-3043	83	5	that	that	SCONJ
iajs-3043	83	6	vitamin	vitamin	NOUN
iajs-3043	83	7	d	d	NOUN
iajs-3043	83	8	deficiency	deficiency	NOUN
iajs-3043	83	9	(	(	PUNCT
iajs-3043	83	10	vdd	vdd	PROPN
iajs-3043	83	11	)	)	PUNCT
iajs-3043	83	12	is	be	AUX
iajs-3043	83	13	associated	associate	VERB
iajs-3043	83	14	with	with	ADP
iajs-3043	83	15	the	the	DET
iajs-3043	83	16	seriousness	seriousness	NOUN
iajs-3043	83	17	and	and	CCONJ
iajs-3043	83	18	disease	disease	NOUN
iajs-3043	83	19	progression	progression	NOUN
iajs-3043	83	20	in	in	ADP
iajs-3043	83	21	nafld	nafld	ADJ
iajs-3043	83	22	/	/	SYM
iajs-3043	83	23	nash	nash	NOUN
iajs-3043	83	24	patients	patient	NOUN
iajs-3043	83	25	and	and	CCONJ
iajs-3043	83	26	hepatic	hepatic	ADJ
iajs-3043	83	27	steatosis	steatosis	NOUN
iajs-3043	84	1	[	[	PUNCT
iajs-3043	84	2	35	35	NUM
iajs-3043	84	3	-	-	SYM
iajs-3043	84	4	42	42	NUM
iajs-3043	84	5	]	]	PUNCT
iajs-3043	84	6	.	.	PUNCT
iajs-3043	85	1	vitamin	vitamin	NOUN
iajs-3043	85	2	d3	d3	PROPN
iajs-3043	85	3	regulates	regulate	VERB
iajs-3043	85	4	free	free	ADJ
iajs-3043	85	5	fatty	fatty	NOUN
iajs-3043	85	6	acids	acids	ADJ
iajs-3043	85	7	metabolism	metabolism	NOUN
iajs-3043	85	8	via	via	ADP
iajs-3043	85	9	peroxisome	peroxisome	PROPN
iajs-3043	85	10	proliferatoractivated	proliferatoractivate	VERB
iajs-3043	85	11	receptor	receptor	NOUN
iajs-3043	85	12	gamma	gamma	NOUN
iajs-3043	85	13	(	(	PUNCT
iajs-3043	85	14	ppar	ppar	NOUN
iajs-3043	85	15	-	-	PUNCT
iajs-3043	85	16	g	g	NOUN
iajs-3043	85	17	)	)	PUNCT
iajs-3043	85	18	which	which	PRON
iajs-3043	85	19	induced	induce	VERB
iajs-3043	85	20	ir	ir	PROPN
iajs-3043	85	21	in	in	ADP
iajs-3043	85	22	vitro	vitro	X
iajs-3043	85	23	,	,	PUNCT
iajs-3043	85	24	the	the	DET
iajs-3043	85	25	increased	increase	VERB
iajs-3043	85	26	free	free	ADJ
iajs-3043	85	27	fatty	fatty	NOUN
iajs-3043	85	28	acids	acid	NOUN
iajs-3043	85	29	levels	level	NOUN
iajs-3043	85	30	in	in	ADP
iajs-3043	85	31	bloodstream	bloodstream	NOUN
iajs-3043	85	32	enhance	enhance	VERB
iajs-3043	85	33	fat	fat	ADJ
iajs-3043	85	34	storage	storage	NOUN
iajs-3043	85	35	in	in	ADP
iajs-3043	85	36	the	the	DET
iajs-3043	85	37	liver	liver	NOUN
iajs-3043	85	38	this	this	PRON
iajs-3043	85	39	will	will	AUX
iajs-3043	85	40	development	development	NOUN
iajs-3043	85	41	of	of	ADP
iajs-3043	85	42	nafld	nafld	PROPN
iajs-3043	86	1	[	[	X
iajs-3043	86	2	43	43	NUM
iajs-3043	86	3	]	]	PUNCT
iajs-3043	86	4	.	.	PUNCT
iajs-3043	87	1	this	this	PRON
iajs-3043	87	2	is	be	AUX
iajs-3043	87	3	in	in	ADP
iajs-3043	87	4	agreement	agreement	NOUN
iajs-3043	87	5	with	with	ADP
iajs-3043	87	6	other	other	ADJ
iajs-3043	87	7	studies	study	NOUN
iajs-3043	87	8	that	that	PRON
iajs-3043	87	9	lean	lean	VERB
iajs-3043	87	10	to	to	ADP
iajs-3043	87	11	an	an	DET
iajs-3043	87	12	association	association	NOUN
iajs-3043	87	13	between	between	ADP
iajs-3043	87	14	low	low	ADJ
iajs-3043	87	15	levels	level	NOUN
iajs-3043	87	16	of	of	ADP
iajs-3043	87	17	vitamin	vitamin	NOUN
iajs-3043	87	18	d3	d3	PROPN
iajs-3043	87	19	and	and	CCONJ
iajs-3043	87	20	nafld	nafld	ADJ
iajs-3043	88	1	[	[	X
iajs-3043	88	2	44	44	NUM
iajs-3043	88	3	-	-	SYM
iajs-3043	88	4	46	46	NUM
iajs-3043	88	5	]	]	PUNCT
iajs-3043	88	6	.	.	PUNCT
iajs-3043	89	1	resent	resent	PROPN
iajs-3043	89	2	epidemiological	epidemiological	ADJ
iajs-3043	89	3	studies	study	NOUN
iajs-3043	89	4	have	have	AUX
iajs-3043	89	5	demonstrated	demonstrate	VERB
iajs-3043	89	6	the	the	DET
iajs-3043	89	7	existence	existence	NOUN
iajs-3043	89	8	of	of	ADP
iajs-3043	89	9	vitamin	vitamin	NOUN
iajs-3043	89	10	d3	d3	PROPN
iajs-3043	89	11	deficiency	deficiency	NOUN
iajs-3043	89	12	and	and	CCONJ
iajs-3043	89	13	nafld	nafld	ADV
iajs-3043	89	14	shared	share	VERB
iajs-3043	89	15	with	with	ADP
iajs-3043	89	16	multiple	multiple	ADJ
iajs-3043	89	17	risk	risk	NOUN
iajs-3043	89	18	factors	factor	NOUN
iajs-3043	89	19	and	and	CCONJ
iajs-3043	89	20	about	about	ADV
iajs-3043	89	21	55	55	NUM
iajs-3043	89	22	%	%	NOUN
iajs-3043	89	23	occurs	occur	VERB
iajs-3043	89	24	with	with	ADP
iajs-3043	89	25	nafld	nafld	ADJ
iajs-3043	89	26	patients	patient	NOUN
iajs-3043	90	1	[	[	X
iajs-3043	90	2	39	39	NUM
iajs-3043	90	3	]	]	PUNCT
iajs-3043	90	4	.	.	PUNCT
iajs-3043	91	1	liver	liver	NOUN
iajs-3043	91	2	enzymes	enzyme	NOUN
iajs-3043	91	3	(	(	PUNCT
iajs-3043	91	4	alt	alt	VERB
iajs-3043	91	5	and	and	CCONJ
iajs-3043	91	6	ast	ast	VERB
iajs-3043	91	7	)	)	PUNCT
iajs-3043	91	8	gave	give	VERB
iajs-3043	91	9	a	a	DET
iajs-3043	91	10	significant	significant	ADJ
iajs-3043	91	11	increase	increase	NOUN
iajs-3043	91	12	in	in	ADP
iajs-3043	91	13	g2	g2	PROPN
iajs-3043	91	14	when	when	SCONJ
iajs-3043	91	15	compared	compare	VERB
iajs-3043	91	16	with	with	ADP
iajs-3043	91	17	g1	g1	NOUN
iajs-3043	91	18	and	and	CCONJ
iajs-3043	91	19	g3	g3	PROPN
iajs-3043	91	20	.	.	PUNCT
iajs-3043	92	1	alt	alt	PROPN
iajs-3043	92	2	is	be	AUX
iajs-3043	92	3	exists	exist	NOUN
iajs-3043	92	4	in	in	ADP
iajs-3043	92	5	the	the	DET
iajs-3043	92	6	cytosol	cytosol	NOUN
iajs-3043	92	7	of	of	ADP
iajs-3043	92	8	hepatocytes	hepatocyte	NOUN
iajs-3043	92	9	,	,	PUNCT
iajs-3043	92	10	its	its	PRON
iajs-3043	92	11	level	level	NOUN
iajs-3043	92	12	increased	increase	VERB
iajs-3043	92	13	in	in	ADP
iajs-3043	92	14	blood	blood	NOUN
iajs-3043	92	15	stream	stream	NOUN
iajs-3043	92	16	during	during	ADP
iajs-3043	92	17	hepatic	hepatic	ADJ
iajs-3043	92	18	inflammation	inflammation	NOUN
iajs-3043	92	19	and	and	CCONJ
iajs-3043	92	20	liver	liver	NOUN
iajs-3043	92	21	injury	injury	NOUN
iajs-3043	92	22	.	.	PUNCT
iajs-3043	93	1	alt	alt	AUX
iajs-3043	93	2	consider	consider	VERB
iajs-3043	93	3	as	as	ADP
iajs-3043	93	4	standard	standard	ADJ
iajs-3043	93	5	indicator	indicator	NOUN
iajs-3043	93	6	for	for	ADP
iajs-3043	93	7	liver	liver	NOUN
iajs-3043	93	8	function	function	NOUN
iajs-3043	93	9	assessment	assessment	NOUN
iajs-3043	93	10	and	and	CCONJ
iajs-3043	93	11	monitoring	monitor	VERB
iajs-3043	93	12	the	the	DET
iajs-3043	93	13	patients	patient	NOUN
iajs-3043	93	14	with	with	ADP
iajs-3043	93	15	liver	liver	NOUN
iajs-3043	93	16	diseases	disease	NOUN
iajs-3043	93	17	[	[	X
iajs-3043	93	18	47	47	NUM
iajs-3043	93	19	]	]	PUNCT
iajs-3043	93	20	.	.	PUNCT
iajs-3043	94	1	many	many	ADJ
iajs-3043	94	2	studies	study	NOUN
iajs-3043	94	3	pointed	point	VERB
iajs-3043	94	4	to	to	ADP
iajs-3043	94	5	the	the	DET
iajs-3043	94	6	alt	alt	ADJ
iajs-3043	94	7	level	level	NOUN
iajs-3043	94	8	increased	increase	VERB
iajs-3043	94	9	with	with	ADP
iajs-3043	94	10	nafld[48	nafld[48	NOUN
iajs-3043	94	11	-	-	SYM
iajs-3043	94	12	51	51	NUM
iajs-3043	94	13	]	]	PUNCT
iajs-3043	94	14	and	and	CCONJ
iajs-3043	94	15	the	the	DET
iajs-3043	94	16	elevation	elevation	NOUN
iajs-3043	94	17	is	be	AUX
iajs-3043	94	18	associated	associate	VERB
iajs-3043	94	19	with	with	ADP
iajs-3043	94	20	nash	nash	NOUN
iajs-3043	94	21	and	and	CCONJ
iajs-3043	94	22	advanced	advanced	ADJ
iajs-3043	94	23	fibrosis[52	fibrosis[52	NOUN
iajs-3043	94	24	]	]	PUNCT
iajs-3043	94	25	.	.	PUNCT
iajs-3043	95	1	other	other	ADJ
iajs-3043	95	2	study	study	NOUN
iajs-3043	95	3	referred	refer	VERB
iajs-3043	95	4	that	that	SCONJ
iajs-3043	95	5	the	the	DET
iajs-3043	95	6	patients	patient	NOUN
iajs-3043	95	7	with	with	ADP
iajs-3043	95	8	nafld	nafld	ADJ
iajs-3043	95	9	have	have	VERB
iajs-3043	95	10	normal	normal	ADJ
iajs-3043	95	11	levels	level	NOUN
iajs-3043	95	12	of	of	ADP
iajs-3043	95	13	alt	alt	NOUN
iajs-3043	95	14	especially	especially	ADV
iajs-3043	95	15	as	as	SCONJ
iajs-3043	95	16	the	the	DET
iajs-3043	95	17	disease	disease	NOUN
iajs-3043	95	18	progresses	progress	VERB
iajs-3043	95	19	and	and	CCONJ
iajs-3043	95	20	more	more	ADJ
iajs-3043	95	21	than	than	ADP
iajs-3043	95	22	half	half	NOUN
iajs-3043	95	23	of	of	ADP
iajs-3043	95	24	patients	patient	NOUN
iajs-3043	95	25	with	with	ADP
iajs-3043	95	26	nafld	nafld	ADJ
iajs-3043	95	27	have	have	VERB
iajs-3043	95	28	normal	normal	ADJ
iajs-3043	95	29	liver	liver	NOUN
iajs-3043	95	30	enzyme	enzyme	NOUN
iajs-3043	95	31	concentrations	concentration	NOUN
iajs-3043	95	32	[	[	X
iajs-3043	95	33	53	53	NUM
iajs-3043	95	34	-	-	SYM
iajs-3043	95	35	55	55	NUM
iajs-3043	95	36	]	]	PUNCT
iajs-3043	95	37	.	.	PUNCT
iajs-3043	96	1	table	table	NOUN
iajs-3043	96	2	(	(	PUNCT
iajs-3043	96	3	2	2	X
iajs-3043	96	4	)	)	PUNCT
iajs-3043	96	5	illustrated	illustrate	VERB
iajs-3043	96	6	the	the	DET
iajs-3043	96	7	correlations	correlation	NOUN
iajs-3043	96	8	between	between	ADP
iajs-3043	96	9	adiponectin	adiponectin	NOUN
iajs-3043	96	10	with	with	ADP
iajs-3043	96	11	irisin	irisin	NOUN
iajs-3043	96	12	,	,	PUNCT
iajs-3043	96	13	and	and	CCONJ
iajs-3043	96	14	vitamin	vitamin	NOUN
iajs-3043	96	15	d3	d3	PROPN
iajs-3043	96	16	in	in	ADP
iajs-3043	96	17	obese	obese	ADJ
iajs-3043	96	18	nafld	nafld	ADJ
iajs-3043	96	19	iraqi	iraqi	ADJ
iajs-3043	96	20	patients	patient	NOUN
iajs-3043	96	21	.	.	PUNCT
iajs-3043	97	1	table	table	NOUN
iajs-3043	97	2	(	(	PUNCT
iajs-3043	97	3	2	2	NUM
iajs-3043	97	4	):	):	PUNCT
iajs-3043	97	5	the	the	DET
iajs-3043	97	6	correlation	correlation	NOUN
iajs-3043	97	7	of	of	ADP
iajs-3043	97	8	adiponectin	adiponectin	NOUN
iajs-3043	97	9	with	with	ADP
iajs-3043	97	10	irisin	irisin	NOUN
iajs-3043	97	11	and	and	CCONJ
iajs-3043	97	12	vitamin	vitamin	NOUN
iajs-3043	97	13	d3	d3	PROPN
iajs-3043	97	14	in	in	ADP
iajs-3043	97	15	obese	obese	ADJ
iajs-3043	97	16	nafld	nafld	ADJ
iajs-3043	97	17	iraqi	iraqi	ADJ
iajs-3043	97	18	patients	patient	NOUN
iajs-3043	97	19	.	.	PUNCT
iajs-3043	98	1	adiponectin	adiponectin	NOUN
iajs-3043	98	2	parameters	parameter	NOUN
iajs-3043	98	3	p.value	p.value	NOUN
iajs-3043	98	4	r	r	NOUN
iajs-3043	98	5	irisin	irisin	VERB
iajs-3043	98	6	0.001	0.001	NUM
iajs-3043	98	7	0.404	0.404	NUM
iajs-3043	98	8	vitamin	vitamin	NOUN
iajs-3043	98	9	d3	d3	PROPN
iajs-3043	98	10	0.001	0.001	NUM
iajs-3043	98	11	-0.068	-0.068	NOUN
iajs-3043	98	12	ihjpas	ihjpas	PROPN
iajs-3043	98	13	.	.	PUNCT
iajs-3043	99	1	36(2)2023	36(2)2023	NUM
iajs-3043	99	2	245	245	NUM
iajs-3043	99	3	this	this	DET
iajs-3043	99	4	study	study	NOUN
iajs-3043	99	5	revealed	reveal	VERB
iajs-3043	99	6	the	the	DET
iajs-3043	99	7	correlation	correlation	NOUN
iajs-3043	99	8	between	between	ADP
iajs-3043	99	9	adiponectin	adiponectin	NOUN
iajs-3043	99	10	and	and	CCONJ
iajs-3043	99	11	irisin	irisin	NOUN
iajs-3043	99	12	,	,	PUNCT
iajs-3043	99	13	which	which	PRON
iajs-3043	99	14	gave	give	VERB
iajs-3043	99	15	a	a	DET
iajs-3043	99	16	non	non	ADJ
iajs-3043	99	17	significant	significant	ADJ
iajs-3043	99	18	positive	positive	ADJ
iajs-3043	99	19	correlation	correlation	NOUN
iajs-3043	99	20	while	while	SCONJ
iajs-3043	99	21	a	a	DET
iajs-3043	99	22	non	non	ADJ
iajs-3043	99	23	signifivant	signifivant	ADJ
iajs-3043	99	24	negative	negative	ADJ
iajs-3043	99	25	correlation	correlation	NOUN
iajs-3043	99	26	was	be	AUX
iajs-3043	99	27	obtained	obtain	VERB
iajs-3043	99	28	between	between	ADP
iajs-3043	99	29	adiponectin	adiponectin	NOUN
iajs-3043	99	30	and	and	CCONJ
iajs-3043	99	31	vitamin	vitamin	NOUN
iajs-3043	99	32	d3	d3	PROPN
iajs-3043	99	33	as	as	ADP
iajs-3043	99	34	in	in	ADP
iajs-3043	99	35	figures	figure	NOUN
iajs-3043	99	36	(	(	PUNCT
iajs-3043	99	37	1	1	NUM
iajs-3043	99	38	)	)	PUNCT
iajs-3043	99	39	and	and	CCONJ
iajs-3043	99	40	(	(	PUNCT
iajs-3043	99	41	2	2	NUM
iajs-3043	99	42	)	)	PUNCT
iajs-3043	99	43	.	.	PUNCT
iajs-3043	100	1	figure	figure	NOUN
iajs-3043	100	2	(	(	PUNCT
iajs-3043	100	3	1	1	NUM
iajs-3043	100	4	):	):	PUNCT
iajs-3043	100	5	correlation	correlation	NOUN
iajs-3043	100	6	between	between	ADP
iajs-3043	100	7	adiponectin	adiponectin	NOUN
iajs-3043	100	8	with	with	ADP
iajs-3043	100	9	irisin	irisin	NOUN
iajs-3043	100	10	in	in	ADP
iajs-3043	100	11	obese	obese	ADJ
iajs-3043	100	12	nafld	nafld	ADJ
iajs-3043	100	13	iraqi	iraqi	ADJ
iajs-3043	100	14	patients	patient	NOUN
iajs-3043	100	15	.	.	PUNCT
iajs-3043	101	1	figure	figure	NOUN
iajs-3043	101	2	(	(	PUNCT
iajs-3043	101	3	2	2	NUM
iajs-3043	101	4	):	):	PUNCT
iajs-3043	101	5	correlation	correlation	NOUN
iajs-3043	101	6	between	between	ADP
iajs-3043	101	7	irisin	irisin	NOUN
iajs-3043	101	8	and	and	CCONJ
iajs-3043	101	9	vitamin	vitamin	NOUN
iajs-3043	101	10	d3	d3	PROPN
iajs-3043	101	11	in	in	ADP
iajs-3043	101	12	obese	obese	NOUN
iajs-3043	101	13	nafld	nafld	PROPN
iajs-3043	101	14	.	.	PUNCT
iajs-3043	102	1	this	this	DET
iajs-3043	102	2	study	study	NOUN
iajs-3043	102	3	also	also	ADV
iajs-3043	102	4	investigated	investigate	VERB
iajs-3043	102	5	the	the	DET
iajs-3043	102	6	correlation	correlation	NOUN
iajs-3043	102	7	between	between	ADP
iajs-3043	102	8	adiponectin	adiponectin	NOUN
iajs-3043	102	9	,	,	PUNCT
iajs-3043	102	10	with	with	ADP
iajs-3043	102	11	irisin	irisin	NOUN
iajs-3043	102	12	and	and	CCONJ
iajs-3043	102	13	vitamin	vitamin	NOUN
iajs-3043	102	14	d3	d3	PROPN
iajs-3043	102	15	in	in	ADP
iajs-3043	102	16	non	non	ADJ
iajs-3043	102	17	obese	obese	ADJ
iajs-3043	102	18	nafld	nafld	ADJ
iajs-3043	102	19	iraqi	iraqi	ADJ
iajs-3043	102	20	patients	patient	NOUN
iajs-3043	102	21	,	,	PUNCT
iajs-3043	102	22	the	the	DET
iajs-3043	102	23	data	datum	NOUN
iajs-3043	102	24	were	be	AUX
iajs-3043	102	25	illustrated	illustrate	VERB
iajs-3043	102	26	in	in	ADP
iajs-3043	102	27	the	the	DET
iajs-3043	102	28	table	table	NOUN
iajs-3043	102	29	(	(	PUNCT
iajs-3043	102	30	3	3	NUM
iajs-3043	102	31	)	)	PUNCT
iajs-3043	102	32	.	.	PUNCT
iajs-3043	103	1	table	table	NOUN
iajs-3043	103	2	(	(	PUNCT
iajs-3043	103	3	3	3	NUM
iajs-3043	103	4	):	):	PUNCT
iajs-3043	103	5	the	the	DET
iajs-3043	103	6	correlation	correlation	NOUN
iajs-3043	103	7	of	of	ADP
iajs-3043	103	8	adiponectin	adiponectin	NOUN
iajs-3043	103	9	with	with	ADP
iajs-3043	103	10	irisin	irisin	NOUN
iajs-3043	103	11	and	and	CCONJ
iajs-3043	103	12	vitamin	vitamin	NOUN
iajs-3043	103	13	d3	d3	PROPN
iajs-3043	103	14	in	in	ADP
iajs-3043	103	15	non	non	ADJ
iajs-3043	103	16	obese	obese	ADJ
iajs-3043	103	17	nafld	nafld	ADJ
iajs-3043	103	18	patients	patient	NOUN
iajs-3043	103	19	.	.	PUNCT
iajs-3043	104	1	adiponectin	adiponectin	NOUN
iajs-3043	104	2	parameters	parameter	NOUN
iajs-3043	104	3	p.	p.	NOUN
iajs-3043	104	4	value	value	NOUN
iajs-3043	104	5	r	r	NOUN
iajs-3043	104	6	irisin	irisin	VERB
iajs-3043	104	7	0.001	0.001	NUM
iajs-3043	104	8	-0.237	-0.237	PUNCT
iajs-3043	104	9	vitamin	vitamin	NOUN
iajs-3043	104	10	d3	d3	PROPN
iajs-3043	104	11	0.001	0.001	NUM
iajs-3043	104	12	-0.067	-0.067	NOUN
iajs-3043	104	13	adiponectin	adiponectin	NOUN
iajs-3043	104	14	gave	give	VERB
iajs-3043	104	15	a	a	DET
iajs-3043	104	16	high	high	ADJ
iajs-3043	104	17	significant	significant	ADJ
iajs-3043	104	18	negative	negative	ADJ
iajs-3043	104	19	correlation	correlation	NOUN
iajs-3043	104	20	with	with	ADP
iajs-3043	104	21	irisin	irisin	NOUN
iajs-3043	104	22	as	as	ADV
iajs-3043	104	23	well	well	ADV
iajs-3043	104	24	as	as	ADP
iajs-3043	104	25	with	with	ADP
iajs-3043	104	26	vitamin	vitamin	NOUN
iajs-3043	104	27	d3	d3	PROPN
iajs-3043	104	28	as	as	ADP
iajs-3043	104	29	in	in	ADP
iajs-3043	104	30	figure	figure	NOUN
iajs-3043	104	31	(	(	PUNCT
iajs-3043	104	32	3	3	NUM
iajs-3043	104	33	)	)	PUNCT
iajs-3043	104	34	and	and	CCONJ
iajs-3043	104	35	(	(	PUNCT
iajs-3043	104	36	4	4	NUM
iajs-3043	104	37	)	)	PUNCT
iajs-3043	104	38	.	.	PUNCT
iajs-3043	105	1	y	y	NOUN
iajs-3043	105	2	=	=	PUNCT
iajs-3043	105	3	31.073x	31.073x	NUM
iajs-3043	106	1	+	+	PUNCT
iajs-3043	106	2	317.78	317.78	NUM
iajs-3043	106	3	r²	r²	NOUN
iajs-3043	106	4	=	=	PUNCT
iajs-3043	106	5	0.1638	0.1638	NUM
iajs-3043	106	6	200	200	NUM
iajs-3043	106	7	250	250	NUM
iajs-3043	106	8	300	300	NUM
iajs-3043	106	9	350	350	NUM
iajs-3043	106	10	400	400	NUM
iajs-3043	106	11	450	450	NUM
iajs-3043	106	12	500	500	NUM
iajs-3043	106	13	550	550	NUM
iajs-3043	106	14	600	600	NUM
iajs-3043	106	15	650	650	NUM
iajs-3043	106	16	0	0	NUM
iajs-3043	106	17	2	2	NUM
iajs-3043	106	18	4	4	NUM
iajs-3043	106	19	6	6	NUM
iajs-3043	106	20	8	8	NUM
iajs-3043	106	21	10	10	NUM
iajs-3043	106	22	ir	ir	NOUN
iajs-3043	106	23	is	be	AUX
iajs-3043	106	24	in	in	ADP
iajs-3043	106	25	(	(	PUNCT
iajs-3043	106	26	p	p	NOUN
iajs-3043	106	27	g	g	PROPN
iajs-3043	106	28	/m	/m	PROPN
iajs-3043	106	29	l	l	NOUN
iajs-3043	106	30	)	)	PUNCT
iajs-3043	106	31	adiponectin	adiponectin	NOUN
iajs-3043	106	32	(	(	PUNCT
iajs-3043	106	33	ng	ng	NOUN
iajs-3043	106	34	/	/	SYM
iajs-3043	106	35	ml	ml	PROPN
iajs-3043	106	36	)	)	PUNCT
iajs-3043	107	1	y	y	NOUN
iajs-3043	107	2	=	=	PUNCT
iajs-3043	107	3	-0.083x	-0.083x	PROPN
iajs-3043	108	1	+	+	NUM
iajs-3043	108	2	14.524	14.524	NUM
iajs-3043	108	3	r²	r²	NOUN
iajs-3043	108	4	=	=	NOUN
iajs-3043	108	5	0.0047	0.0047	NUM
iajs-3043	108	6	10	10	NUM
iajs-3043	108	7	11	11	NUM
iajs-3043	108	8	12	12	NUM
iajs-3043	108	9	13	13	NUM
iajs-3043	108	10	14	14	NUM
iajs-3043	108	11	15	15	NUM
iajs-3043	108	12	16	16	NUM
iajs-3043	108	13	17	17	NUM
iajs-3043	108	14	0	0	NUM
iajs-3043	108	15	2	2	NUM
iajs-3043	108	16	4	4	NUM
iajs-3043	108	17	6	6	NUM
iajs-3043	108	18	8	8	NUM
iajs-3043	108	19	10v	10v	NOUN
iajs-3043	108	20	it	it	PRON
iajs-3043	108	21	a	a	DET
iajs-3043	108	22	m	m	VERB
iajs-3043	108	23	in	in	ADP
iajs-3043	108	24	d	d	PROPN
iajs-3043	108	25	3	3	NUM
iajs-3043	108	26	c	c	NOUN
iajs-3043	108	27	o	o	NOUN
iajs-3043	108	28	n	n	X
iajs-3043	108	29	c.	c.	NOUN
iajs-3043	108	30	(	(	PUNCT
iajs-3043	108	31	n	n	CCONJ
iajs-3043	108	32	g	g	PROPN
iajs-3043	108	33	/m	/m	SYM
iajs-3043	108	34	l	l	NOUN
iajs-3043	108	35	)	)	PUNCT
iajs-3043	108	36	adiponectin	adiponectin	NOUN
iajs-3043	108	37	conc.(ng	conc.(ng	NOUN
iajs-3043	108	38	/	/	SYM
iajs-3043	108	39	ml	ml	NOUN
iajs-3043	108	40	)	)	PUNCT
iajs-3043	108	41	ihjpas	ihjpa	NOUN
iajs-3043	108	42	.	.	PUNCT
iajs-3043	109	1	36(2)2023	36(2)2023	NUM
iajs-3043	109	2	246	246	NUM
iajs-3043	109	3	figure	figure	NOUN
iajs-3043	109	4	(	(	PUNCT
iajs-3043	109	5	3	3	NUM
iajs-3043	109	6	):	):	PUNCT
iajs-3043	109	7	correlation	correlation	NOUN
iajs-3043	109	8	of	of	ADP
iajs-3043	109	9	adiponectin	adiponectin	NOUN
iajs-3043	109	10	with	with	ADP
iajs-3043	109	11	irisin	irisin	NOUN
iajs-3043	109	12	in	in	ADP
iajs-3043	109	13	non	non	ADJ
iajs-3043	109	14	obese	obese	ADJ
iajs-3043	109	15	nafld	nafld	ADJ
iajs-3043	109	16	iraqi	iraqi	ADJ
iajs-3043	109	17	patients	patient	NOUN
iajs-3043	109	18	.	.	PUNCT
iajs-3043	110	1	figure	figure	NOUN
iajs-3043	110	2	(	(	PUNCT
iajs-3043	110	3	4	4	NUM
iajs-3043	110	4	):	):	PUNCT
iajs-3043	110	5	correlation	correlation	NOUN
iajs-3043	110	6	of	of	ADP
iajs-3043	110	7	adiponectin	adiponectin	NOUN
iajs-3043	110	8	with	with	ADP
iajs-3043	110	9	vitamin	vitamin	NOUN
iajs-3043	110	10	d3	d3	PROPN
iajs-3043	110	11	in	in	ADP
iajs-3043	110	12	non	non	ADJ
iajs-3043	110	13	obese	obese	NOUN
iajs-3043	110	14	nafld	nafld	ADV
iajs-3043	110	15	.	.	PUNCT
iajs-3043	111	1	3.conclusion	3.conclusion	NUM
iajs-3043	111	2	adiponectin	adiponectin	NOUN
iajs-3043	111	3	and	and	CCONJ
iajs-3043	111	4	irisin	irisin	NOUN
iajs-3043	111	5	is	be	AUX
iajs-3043	111	6	a	a	DET
iajs-3043	111	7	good	good	ADJ
iajs-3043	111	8	predictor	predictor	NOUN
iajs-3043	111	9	for	for	ADP
iajs-3043	111	10	nafld	nafld	ADV
iajs-3043	111	11	and	and	CCONJ
iajs-3043	111	12	may	may	AUX
iajs-3043	111	13	be	be	AUX
iajs-3043	111	14	used	use	VERB
iajs-3043	111	15	as	as	ADP
iajs-3043	111	16	a	a	DET
iajs-3043	111	17	biomarker	biomarker	NOUN
iajs-3043	111	18	for	for	ADP
iajs-3043	111	19	the	the	DET
iajs-3043	111	20	patients	patient	NOUN
iajs-3043	111	21	with	with	ADP
iajs-3043	111	22	nafld	nafld	PROPN
iajs-3043	111	23	.	.	PUNCT
iajs-3043	112	1	while	while	SCONJ
iajs-3043	112	2	vitamin	vitamin	NOUN
iajs-3043	112	3	d3	d3	PROPN
iajs-3043	112	4	may	may	AUX
iajs-3043	112	5	be	be	AUX
iajs-3043	112	6	a	a	DET
iajs-3043	112	7	risk	risk	NOUN
iajs-3043	112	8	factor	factor	NOUN
iajs-3043	112	9	in	in	ADP
iajs-3043	112	10	nafld	nafld	PROPN
iajs-3043	112	11	.	.	PUNCT
iajs-3043	113	1	references	reference	NOUN
iajs-3043	113	2	1	1	NUM
iajs-3043	113	3	.	.	PUNCT
iajs-3043	114	1	grgurevic	grgurevic	PROPN
iajs-3043	114	2	,	,	PUNCT
iajs-3043	114	3	ivica	ivica	PROPN
iajs-3043	114	4	;	;	PUNCT
iajs-3043	114	5	et	et	PROPN
iajs-3043	114	6	al	al	PROPN
iajs-3043	114	7	.	.	PROPN
iajs-3043	114	8	natural	natural	ADJ
iajs-3043	114	9	history	history	NOUN
iajs-3043	114	10	of	of	ADP
iajs-3043	114	11	nonalcoholic	nonalcoholic	ADJ
iajs-3043	114	12	fatty	fatty	NOUN
iajs-3043	114	13	liver	liver	NOUN
iajs-3043	114	14	disease	disease	NOUN
iajs-3043	114	15	:	:	PUNCT
iajs-3043	114	16	implications	implication	NOUN
iajs-3043	114	17	for	for	ADP
iajs-3043	114	18	clinical	clinical	ADJ
iajs-3043	114	19	practice	practice	NOUN
iajs-3043	114	20	and	and	CCONJ
iajs-3043	114	21	an	an	DET
iajs-3043	114	22	individualized	individualized	ADJ
iajs-3043	114	23	approach	approach	NOUN
iajs-3043	114	24	.	.	PUNCT
iajs-3043	115	1	canadian	canadian	ADJ
iajs-3043	115	2	journal	journal	PROPN
iajs-3043	115	3	of	of	ADP
iajs-3043	115	4	gastroenterology	gastroenterology	NOUN
iajs-3043	115	5	and	and	CCONJ
iajs-3043	115	6	hepatology	hepatology	NOUN
iajs-3043	115	7	,	,	PUNCT
iajs-3043	115	8	2020	2020	NUM
iajs-3043	115	9	,	,	PUNCT
iajs-3043	115	10	2020	2020	NUM
iajs-3043	115	11	.	.	PUNCT
iajs-3043	116	1	2	2	X
iajs-3043	116	2	.	.	X
iajs-3043	116	3	mikolasevic	mikolasevic	PROPN
iajs-3043	116	4	,	,	PUNCT
iajs-3043	116	5	ivana	ivana	PROPN
iajs-3043	116	6	;	;	PUNCT
iajs-3043	116	7	et	et	PROPN
iajs-3043	116	8	al	al	PROPN
iajs-3043	116	9	.	.	PUNCT
iajs-3043	117	1	"	"	PUNCT
iajs-3043	117	2	nonalcoholic	nonalcoholic	ADJ
iajs-3043	117	3	fatty	fatty	NOUN
iajs-3043	117	4	liver	liver	NOUN
iajs-3043	117	5	disease	disease	NOUN
iajs-3043	117	6	and	and	CCONJ
iajs-3043	117	7	liver	liver	NOUN
iajs-3043	117	8	transplantation	transplantation	NOUN
iajs-3043	117	9	-	-	PUNCT
iajs-3043	117	10	where	where	SCONJ
iajs-3043	117	11	do	do	AUX
iajs-3043	117	12	we	we	PRON
iajs-3043	117	13	stand	stand	VERB
iajs-3043	117	14	?	?	PUNCT
iajs-3043	117	15	"	"	PUNCT
iajs-3043	117	16	world	world	PROPN
iajs-3043	117	17	journal	journal	NOUN
iajs-3043	117	18	of	of	ADP
iajs-3043	117	19	gastroenterology	gastroenterology	NOUN
iajs-3043	117	20	24.14	24.14	NUM
iajs-3043	117	21	,	,	PUNCT
iajs-3043	117	22	2018	2018	NUM
iajs-3043	117	23	:	:	PUNCT
iajs-3043	117	24	1491	1491	NUM
iajs-3043	117	25	.	.	PUNCT
iajs-3043	118	1	3	3	X
iajs-3043	118	2	.	.	X
iajs-3043	118	3	yibby	yibby	PROPN
iajs-3043	118	4	,	,	PUNCT
iajs-3043	118	5	maría	maría	PROPN
iajs-3043	118	6	luz	luz	PROPN
iajs-3043	118	7	gunturiz	gunturiz	PROPN
iajs-3043	118	8	albarracína	albarracína	PROPN
iajs-3043	118	9	ana	ana	PROPN
iajs-3043	118	10	,	,	PUNCT
iajs-3043	118	11	and	and	CCONJ
iajs-3043	118	12	forero	forero	PROPN
iajs-3043	118	13	torresb	torresb	PROPN
iajs-3043	118	14	.	.	PUNCT
iajs-3043	119	1	"	"	PUNCT
iajs-3043	119	2	adiponectin	adiponectin	NOUN
iajs-3043	119	3	and	and	CCONJ
iajs-3043	119	4	leptin	leptin	NOUN
iajs-3043	119	5	adipocytokines	adipocytokine	NOUN
iajs-3043	119	6	in	in	ADP
iajs-3043	119	7	metabolic	metabolic	NOUN
iajs-3043	119	8	syndrome	syndrome	NOUN
iajs-3043	119	9	:	:	PUNCT
iajs-3043	119	10	what	what	PRON
iajs-3043	119	11	is	be	AUX
iajs-3043	119	12	its	its	PRON
iajs-3043	119	13	importance	importance	NOUN
iajs-3043	119	14	?	?	PUNCT
iajs-3043	120	1	dubai	dubai	NOUN
iajs-3043	120	2	diabetes	diabetes	NOUN
iajs-3043	120	3	endocrinol	endocrinol	VERB
iajs-3043	120	4	j	j	PROPN
iajs-3043	120	5	2020;26:93–102	2020;26:93–102	NUM
iajs-3043	120	6	.	.	PUNCT
iajs-3043	121	1	4	4	X
iajs-3043	121	2	.	.	X
iajs-3043	121	3	choi	choi	NOUN
iajs-3043	121	4	,	,	PUNCT
iajs-3043	121	5	hyung	hyung	PROPN
iajs-3043	121	6	muk	muk	PROPN
iajs-3043	121	7	;	;	PUNCT
iajs-3043	121	8	doss	doss	PROPN
iajs-3043	121	9	,	,	PUNCT
iajs-3043	121	10	hari	hari	PROPN
iajs-3043	121	11	madhuri	madhuri	PROPN
iajs-3043	121	12	;	;	PUNCT
iajs-3043	121	13	kim	kim	PROPN
iajs-3043	121	14	,	,	PUNCT
iajs-3043	121	15	kyoung	kyoung	PROPN
iajs-3043	121	16	soo	soo	PROPN
iajs-3043	121	17	.	.	PROPN
iajs-3043	121	18	multifaceted	multifaceted	ADJ
iajs-3043	121	19	physiological	physiological	ADJ
iajs-3043	121	20	roles	role	NOUN
iajs-3043	121	21	of	of	ADP
iajs-3043	121	22	adiponectin	adiponectin	NOUN
iajs-3043	121	23	in	in	ADP
iajs-3043	121	24	inflammation	inflammation	NOUN
iajs-3043	121	25	and	and	CCONJ
iajs-3043	121	26	diseases	disease	NOUN
iajs-3043	121	27	.	.	PUNCT
iajs-3043	122	1	international	international	ADJ
iajs-3043	122	2	journal	journal	NOUN
iajs-3043	122	3	of	of	ADP
iajs-3043	122	4	molecular	molecular	ADJ
iajs-3043	122	5	sciences	science	NOUN
iajs-3043	122	6	,	,	PUNCT
iajs-3043	122	7	2020	2020	NUM
iajs-3043	122	8	,	,	PUNCT
iajs-3043	122	9	21.4	21.4	NUM
iajs-3043	122	10	:	:	SYM
iajs-3043	122	11	1219	1219	NUM
iajs-3043	122	12	.	.	PUNCT
iajs-3043	123	1	y	y	NOUN
iajs-3043	123	2	=	=	PUNCT
iajs-3043	124	1	-27.64x	-27.64x	PROPN
iajs-3043	125	1	+	+	NUM
iajs-3043	125	2	492.57	492.57	NUM
iajs-3043	125	3	r²	r²	NOUN
iajs-3043	125	4	=	=	PUNCT
iajs-3043	125	5	0.0564	0.0564	NUM
iajs-3043	125	6	100	100	NUM
iajs-3043	125	7	200	200	NUM
iajs-3043	125	8	300	300	NUM
iajs-3043	125	9	400	400	NUM
iajs-3043	125	10	500	500	NUM
iajs-3043	125	11	600	600	NUM
iajs-3043	125	12	2	2	NUM
iajs-3043	125	13	2.5	2.5	NUM
iajs-3043	125	14	3	3	NUM
iajs-3043	125	15	3.5	3.5	NUM
iajs-3043	125	16	4	4	NUM
iajs-3043	125	17	4.5	4.5	NUM
iajs-3043	125	18	ir	ir	NOUN
iajs-3043	125	19	is	be	AUX
iajs-3043	125	20	in	in	ADP
iajs-3043	125	21	(	(	PUNCT
iajs-3043	125	22	p	p	NOUN
iajs-3043	125	23	g	g	PROPN
iajs-3043	125	24	/m	/m	SYM
iajs-3043	125	25	l	l	NOUN
iajs-3043	125	26	)	)	PUNCT
iajs-3043	125	27	adiponectin(ng	adiponectin(ng	NOUN
iajs-3043	125	28	/	/	SYM
iajs-3043	125	29	ml	ml	NOUN
iajs-3043	125	30	)	)	PUNCT
iajs-3043	125	31	y	y	NOUN
iajs-3043	125	32	=	=	PUNCT
iajs-3043	125	33	-0.4451x	-0.4451x	X
iajs-3043	126	1	+	+	NUM
iajs-3043	126	2	17.407	17.407	NUM
iajs-3043	126	3	r²	r²	NOUN
iajs-3043	126	4	=	=	SYM
iajs-3043	126	5	0.0045	0.0045	NUM
iajs-3043	126	6	10	10	NUM
iajs-3043	126	7	12	12	NUM
iajs-3043	126	8	14	14	NUM
iajs-3043	126	9	16	16	NUM
iajs-3043	126	10	18	18	NUM
iajs-3043	126	11	20	20	NUM
iajs-3043	126	12	22	22	NUM
iajs-3043	126	13	24	24	NUM
iajs-3043	126	14	2	2	NUM
iajs-3043	126	15	2.5	2.5	NUM
iajs-3043	126	16	3	3	NUM
iajs-3043	126	17	3.5	3.5	NUM
iajs-3043	126	18	4	4	NUM
iajs-3043	126	19	4.5	4.5	NUM
iajs-3043	126	20	v	v	ADP
iajs-3043	126	21	it	it	PRON
iajs-3043	126	22	a	a	DET
iajs-3043	126	23	m	m	VERB
iajs-3043	126	24	in	in	ADP
iajs-3043	126	25	d	d	PROPN
iajs-3043	126	26	3	3	NUM
iajs-3043	126	27	c	c	NOUN
iajs-3043	126	28	o	o	NOUN
iajs-3043	126	29	n	n	X
iajs-3043	126	30	c.	c.	NOUN
iajs-3043	126	31	(	(	PUNCT
iajs-3043	126	32	n	n	CCONJ
iajs-3043	126	33	g	g	PROPN
iajs-3043	126	34	/m	/m	SYM
iajs-3043	126	35	l	l	NOUN
iajs-3043	126	36	)	)	PUNCT
iajs-3043	126	37	adiponectin	adiponectin	NOUN
iajs-3043	126	38	conc.(ng	conc.(ng	NOUN
iajs-3043	126	39	/	/	SYM
iajs-3043	126	40	ml	ml	NOUN
iajs-3043	126	41	)	)	PUNCT
iajs-3043	126	42	ihjpas	ihjpa	NOUN
iajs-3043	126	43	.	.	PUNCT
iajs-3043	127	1	36(2)2023	36(2)2023	NUM
iajs-3043	127	2	247	247	NUM
iajs-3043	127	3	5	5	NUM
iajs-3043	127	4	.	.	PUNCT
iajs-3043	127	5	nguyen	nguyen	NOUN
iajs-3043	128	1	;	;	PUNCT
iajs-3043	128	2	thi	thi	VERB
iajs-3043	128	3	mong	mong	PROPN
iajs-3043	128	4	diep	diep	PROPN
iajs-3043	128	5	.	.	PUNCT
iajs-3043	129	1	adiponectin	adiponectin	NOUN
iajs-3043	129	2	:	:	PUNCT
iajs-3043	129	3	role	role	NOUN
iajs-3043	129	4	in	in	ADP
iajs-3043	129	5	physiology	physiology	NOUN
iajs-3043	129	6	and	and	CCONJ
iajs-3043	129	7	pathophysiology	pathophysiology	NOUN
iajs-3043	129	8	.	.	PUNCT
iajs-3043	130	1	international	international	ADJ
iajs-3043	130	2	journal	journal	NOUN
iajs-3043	130	3	of	of	ADP
iajs-3043	130	4	preventive	preventive	ADJ
iajs-3043	130	5	medicine	medicine	NOUN
iajs-3043	130	6	,	,	PUNCT
iajs-3043	130	7	2020	2020	NUM
iajs-3043	130	8	,	,	PUNCT
iajs-3043	130	9	11	11	NUM
iajs-3043	130	10	.	.	NOUN
iajs-3043	131	1	6	6	NUM
iajs-3043	131	2	.	.	X
iajs-3043	131	3	enrique	enrique	PROPN
iajs-3043	131	4	,	,	PUNCT
iajs-3043	131	5	z	z	NOUN
iajs-3043	131	6	fisman	fisman	NOUN
iajs-3043	131	7	;	;	PUNCT
iajs-3043	131	8	alexander	alexander	PROPN
iajs-3043	131	9	,	,	PUNCT
iajs-3043	131	10	tenenbaum	tenenbaum	PROPN
iajs-3043	131	11	.	.	PUNCT
iajs-3043	132	1	adiponectin	adiponectin	NOUN
iajs-3043	132	2	:	:	PUNCT
iajs-3043	132	3	a	a	DET
iajs-3043	132	4	manifold	manifold	ADJ
iajs-3043	132	5	therapeutic	therapeutic	ADJ
iajs-3043	132	6	target	target	NOUN
iajs-3043	132	7	for	for	ADP
iajs-3043	132	8	metabolic	metabolic	NOUN
iajs-3043	132	9	syndrome	syndrome	NOUN
iajs-3043	132	10	,	,	PUNCT
iajs-3043	132	11	diabetes	diabetes	NOUN
iajs-3043	132	12	,	,	PUNCT
iajs-3043	132	13	and	and	CCONJ
iajs-3043	132	14	coronary	coronary	ADJ
iajs-3043	132	15	disease	disease	NOUN
iajs-3043	132	16	?	?	PUNCT
iajs-3043	133	1	cardiovascular	cardiovascular	ADJ
iajs-3043	133	2	diabetology	diabetology	NOUN
iajs-3043	133	3	2014	2014	NUM
iajs-3043	133	4	,	,	PUNCT
iajs-3043	133	5	13:103	13:103	NUM
iajs-3043	133	6	7	7	NUM
iajs-3043	133	7	.	.	PUNCT
iajs-3043	134	1	leustean	leustean	PROPN
iajs-3043	134	2	,	,	PUNCT
iajs-3043	134	3	letitia	letitia	PROPN
iajs-3043	134	4	;	;	PUNCT
iajs-3043	134	5	et	et	PROPN
iajs-3043	134	6	al	al	PROPN
iajs-3043	134	7	.	.	PROPN
iajs-3043	134	8	role	role	NOUN
iajs-3043	134	9	of	of	ADP
iajs-3043	134	10	irisin	irisin	NOUN
iajs-3043	134	11	in	in	ADP
iajs-3043	134	12	endocrine	endocrine	NOUN
iajs-3043	134	13	and	and	CCONJ
iajs-3043	134	14	metabolic	metabolic	NOUN
iajs-3043	134	15	disorders	disorder	NOUN
iajs-3043	134	16	—	—	PUNCT
iajs-3043	134	17	possible	possible	ADJ
iajs-3043	134	18	new	new	ADJ
iajs-3043	134	19	therapeutic	therapeutic	ADJ
iajs-3043	134	20	agent	agent	NOUN
iajs-3043	134	21	?	?	PUNCT
iajs-3043	134	22	.	.	PUNCT
iajs-3043	135	1	applied	apply	VERB
iajs-3043	135	2	sciences	science	NOUN
iajs-3043	135	3	11.12	11.12	NUM
iajs-3043	135	4	,	,	PUNCT
iajs-3043	135	5	2021	2021	NUM
iajs-3043	135	6	:	:	PUNCT
iajs-3043	135	7	5579	5579	NUM
iajs-3043	135	8	.	.	PUNCT
iajs-3043	136	1	8	8	X
iajs-3043	136	2	.	.	X
iajs-3043	137	1	marrano	marrano	PROPN
iajs-3043	137	2	,	,	PUNCT
iajs-3043	137	3	nicola	nicola	PROPN
iajs-3043	137	4	;	;	PUNCT
iajs-3043	137	5	et	et	PROPN
iajs-3043	137	6	al	al	PROPN
iajs-3043	137	7	.	.	PUNCT
iajs-3043	138	1	"	"	PUNCT
iajs-3043	138	2	irisin	irisin	VERB
iajs-3043	138	3	and	and	CCONJ
iajs-3043	138	4	incretin	incretin	ADJ
iajs-3043	138	5	hormones	hormone	NOUN
iajs-3043	138	6	:	:	PUNCT
iajs-3043	139	1	similarities	similarity	NOUN
iajs-3043	139	2	,	,	PUNCT
iajs-3043	139	3	differences	difference	NOUN
iajs-3043	139	4	,	,	PUNCT
iajs-3043	139	5	and	and	CCONJ
iajs-3043	139	6	implications	implication	NOUN
iajs-3043	139	7	in	in	ADP
iajs-3043	139	8	type	type	NOUN
iajs-3043	139	9	2	2	NUM
iajs-3043	139	10	diabetes	diabetes	NOUN
iajs-3043	139	11	and	and	CCONJ
iajs-3043	139	12	obesity	obesity	NOUN
iajs-3043	139	13	.	.	PUNCT
iajs-3043	139	14	"	"	PUNCT
iajs-3043	140	1	biomolecules	biomolecule	NOUN
iajs-3043	140	2	11.2	11.2	NUM
iajs-3043	140	3	,	,	PUNCT
iajs-3043	140	4	2021	2021	NUM
iajs-3043	140	5	:	:	PUNCT
iajs-3043	140	6	286	286	NUM
iajs-3043	140	7	.	.	NOUN
iajs-3043	140	8	9	9	NUM
iajs-3043	140	9	.	.	X
iajs-3043	140	10	ulualan	ulualan	PROPN
iajs-3043	140	11	,	,	PUNCT
iajs-3043	140	12	gökçen	gökçen	PROPN
iajs-3043	140	13	,	,	PUNCT
iajs-3043	140	14	z.	z.	PROPN
iajs-3043	140	15	e.	e.	PROPN
iajs-3043	140	16	y.	y.	PROPN
iajs-3043	140	17	n.	n.	PROPN
iajs-3043	141	1	e.	e.	PROPN
iajs-3043	141	2	p.	p.	PROPN
iajs-3043	141	3	küskü	küskü	ADV
iajs-3043	142	1	ki̇raz	ki̇raz	NOUN
iajs-3043	142	2	;	;	PUNCT
iajs-3043	142	3	bi̇rgül	bi̇rgül	ADJ
iajs-3043	142	4	kirel	kirel	NOUN
iajs-3043	142	5	.	.	PUNCT
iajs-3043	143	1	relation	relation	NOUN
iajs-3043	143	2	of	of	ADP
iajs-3043	143	3	serum	serum	PROPN
iajs-3043	143	4	irisin	irisin	PROPN
iajs-3043	143	5	levels	level	NOUN
iajs-3043	143	6	to	to	ADP
iajs-3043	143	7	obesity	obesity	NOUN
iajs-3043	143	8	and	and	CCONJ
iajs-3043	143	9	non	non	ADJ
iajs-3043	143	10	-	-	ADJ
iajs-3043	143	11	alcoholic	alcoholic	ADJ
iajs-3043	143	12	fatty	fatty	NOUN
iajs-3043	143	13	liver	liver	NOUN
iajs-3043	143	14	disease	disease	NOUN
iajs-3043	143	15	.	.	PUNCT
iajs-3043	144	1	turkish	turkish	ADJ
iajs-3043	144	2	journal	journal	NOUN
iajs-3043	144	3	of	of	ADP
iajs-3043	144	4	pediatrics	pediatric	NOUN
iajs-3043	144	5	64.2	64.2	NUM
iajs-3043	144	6	2022	2022	NUM
iajs-3043	144	7	.	.	PUNCT
iajs-3043	145	1	10	10	NUM
iajs-3043	145	2	.	.	PUNCT
iajs-3043	146	1	polyzos	polyzos	PROPN
iajs-3043	146	2	,	,	PUNCT
iajs-3043	146	3	s.a	s.a	PROPN
iajs-3043	146	4	.	.	PROPN
iajs-3043	146	5	;	;	PUNCT
iajs-3043	146	6	anastasilakis	anastasilakis	PROPN
iajs-3043	146	7	,	,	PUNCT
iajs-3043	146	8	a.d	a.d	PROPN
iajs-3043	146	9	.	.	PROPN
iajs-3043	146	10	;	;	PUNCT
iajs-3043	146	11	efstathiadou	efstathiadou	PROPN
iajs-3043	146	12	,	,	PUNCT
iajs-3043	146	13	z.a	z.a	PROPN
iajs-3043	146	14	.	.	PROPN
iajs-3043	146	15	;	;	PUNCT
iajs-3043	146	16	makras	makras	PROPN
iajs-3043	146	17	,	,	PUNCT
iajs-3043	146	18	p.	p.	NOUN
iajs-3043	146	19	;	;	PUNCT
iajs-3043	146	20	perakakis	perakaki	NOUN
iajs-3043	146	21	,	,	PUNCT
iajs-3043	146	22	n.	n.	NOUN
iajs-3043	146	23	;	;	PUNCT
iajs-3043	146	24	kountouras	kountouras	PROPN
iajs-3043	146	25	,	,	PUNCT
iajs-3043	146	26	j.	j.	PROPN
iajs-3043	146	27	;	;	PUNCT
iajs-3043	146	28	mantzoros	mantzoros	PROPN
iajs-3043	146	29	,	,	PUNCT
iajs-3043	146	30	c.s	c.s	PROPN
iajs-3043	146	31	.	.	PROPN
iajs-3043	146	32	irisin	irisin	PROPN
iajs-3043	146	33	in	in	ADP
iajs-3043	146	34	metabolic	metabolic	NOUN
iajs-3043	146	35	diseases	disease	NOUN
iajs-3043	146	36	.	.	PUNCT
iajs-3043	147	1	endocrine	endocrine	PROPN
iajs-3043	147	2	2018	2018	NUM
iajs-3043	147	3	,	,	PUNCT
iajs-3043	147	4	59	59	NUM
iajs-3043	147	5	,	,	PUNCT
iajs-3043	147	6	260–274	260–274	NUM
iajs-3043	147	7	.	.	NOUN
iajs-3043	147	8	11	11	NUM
iajs-3043	147	9	.	.	PUNCT
iajs-3043	148	1	hu	hu	PROPN
iajs-3043	148	2	,	,	PUNCT
iajs-3043	148	3	jie	jie	PROPN
iajs-3043	148	4	,	,	PUNCT
iajs-3043	148	5	et	et	PROPN
iajs-3043	148	6	al	al	PROPN
iajs-3043	148	7	.	.	PROPN
iajs-3043	148	8	circulating	circulate	VERB
iajs-3043	148	9	irisin	irisin	PROPN
iajs-3043	148	10	levels	level	NOUN
iajs-3043	148	11	in	in	ADP
iajs-3043	148	12	patients	patient	NOUN
iajs-3043	148	13	with	with	ADP
iajs-3043	148	14	nonalcoholic	nonalcoholic	NOUN
iajs-3043	148	15	fatty	fatty	NOUN
iajs-3043	148	16	liver	liver	NOUN
iajs-3043	148	17	disease	disease	NOUN
iajs-3043	148	18	:	:	PUNCT
iajs-3043	148	19	a	a	DET
iajs-3043	148	20	systematic	systematic	ADJ
iajs-3043	148	21	review	review	NOUN
iajs-3043	148	22	and	and	CCONJ
iajs-3043	148	23	meta	meta	ADJ
iajs-3043	148	24	-	-	PUNCT
iajs-3043	148	25	analysis	analysis	NOUN
iajs-3043	148	26	.	.	PUNCT
iajs-3043	149	1	gastroenterology	gastroenterology	NOUN
iajs-3043	149	2	research	research	NOUN
iajs-3043	149	3	and	and	CCONJ
iajs-3043	149	4	practice	practice	NOUN
iajs-3043	149	5	,	,	PUNCT
iajs-3043	149	6	2020	2020	NUM
iajs-3043	149	7	,	,	PUNCT
iajs-3043	149	8	8818191	8818191	NUM
iajs-3043	149	9	.	.	PUNCT
iajs-3043	150	1	12	12	NUM
iajs-3043	150	2	.	.	PUNCT
iajs-3043	150	3	dahiya	dahiya	PROPN
iajs-3043	150	4	,	,	PUNCT
iajs-3043	150	5	kiran	kiran	PROPN
iajs-3043	150	6	;	;	PUNCT
iajs-3043	150	7	pal	pal	ADJ
iajs-3043	150	8	,	,	PUNCT
iajs-3043	150	9	sanghapriya	sanghapriya	PROPN
iajs-3043	150	10	;	;	PUNCT
iajs-3043	150	11	dhankhar	dhankhar	PROPN
iajs-3043	150	12	,	,	PUNCT
iajs-3043	150	13	rakesh.vitamin	rakesh.vitamin	PROPN
iajs-3043	150	14	d	d	PROPN
iajs-3043	150	15	in	in	ADP
iajs-3043	150	16	physiological	physiological	ADJ
iajs-3043	150	17	and	and	CCONJ
iajs-3043	150	18	pathological	pathological	ADJ
iajs-3043	150	19	conditions	condition	NOUN
iajs-3043	150	20	.	.	PUNCT
iajs-3043	151	1	meddocs	meddoc	NOUN
iajs-3043	151	2	ebooks	ebooks	PROPN
iajs-3043	151	3	,	,	PUNCT
iajs-3043	151	4	resent	resent	ADJ
iajs-3043	151	5	trends	trend	NOUN
iajs-3043	151	6	in	in	ADP
iajs-3043	151	7	biochemistry	biochemistry	NOUN
iajs-3043	151	8	.	.	PUNCT
iajs-3043	152	1	2020	2020	NUM
iajs-3043	152	2	.	.	PUNCT
iajs-3043	153	1	13.angle	13.angle	X
iajs-3043	153	2	gil	gil	PROPN
iajs-3043	153	3	;	;	PUNCT
iajs-3043	153	4	julio	julio	PROPN
iajs-3043	153	5	plaz	plaz	PROPN
iajs-3043	153	6	-	-	PROPN
iajs-3043	153	7	diaz	diaz	PROPN
iajs-3043	153	8	and	and	CCONJ
iajs-3043	153	9	maria	maria	PROPN
iajs-3043	153	10	dolores	dolores	PROPN
iajs-3043	153	11	mesa	mesa	PROPN
iajs-3043	153	12	.	.	PUNCT
iajs-3043	154	1	vitamin	vitamin	PROPN
iajs-3043	154	2	d	d	NOUN
iajs-3043	154	3	:	:	PUNCT
iajs-3043	154	4	classic	classic	ADJ
iajs-3043	154	5	and	and	CCONJ
iajs-3043	154	6	novel	novel	ADJ
iajs-3043	154	7	actions	action	NOUN
iajs-3043	154	8	.	.	PUNCT
iajs-3043	155	1	ann	ann	PROPN
iajs-3043	155	2	nutr	nutr	PROPN
iajs-3043	155	3	metab	metab	PROPN
iajs-3043	155	4	.	.	PUNCT
iajs-3043	156	1	2018,72	2018,72	NUM
iajs-3043	156	2	:	:	PUNCT
iajs-3043	156	3	87	87	NUM
iajs-3043	156	4	-	-	SYM
iajs-3043	156	5	95	95	NUM
iajs-3043	156	6	.	.	PUNCT
iajs-3043	157	1	14	14	NUM
iajs-3043	157	2	.	.	PUNCT
iajs-3043	158	1	mary	mary	PROPN
iajs-3043	158	2	s.	s.	PROPN
iajs-3043	158	3	matsui	matsui	PROPN
iajs-3043	158	4	.	.	PUNCT
iajs-3043	159	1	vitamin	vitamin	NOUN
iajs-3043	159	2	d	d	NOUN
iajs-3043	159	3	update	update	NOUN
iajs-3043	159	4	.	.	PUNCT
iajs-3043	160	1	current	current	ADJ
iajs-3043	160	2	dermatology	dermatology	NOUN
iajs-3043	160	3	reports	report	NOUN
iajs-3043	160	4	:	:	PUNCT
iajs-3043	160	5	2020	2020	NUM
iajs-3043	160	6	,	,	PUNCT
iajs-3043	160	7	9	9	NUM
iajs-3043	160	8	:	:	SYM
iajs-3043	160	9	323	323	NUM
iajs-3043	160	10	-	-	SYM
iajs-3043	160	11	330	330	NUM
iajs-3043	160	12	15	15	NUM
iajs-3043	160	13	.	.	PUNCT
iajs-3043	161	1	abramovitch	abramovitch	PROPN
iajs-3043	161	2	s	s	PROPN
iajs-3043	161	3	,	,	PUNCT
iajs-3043	161	4	shirley	shirley	PROPN
iajs-3043	161	5	,	,	PUNCT
iajs-3043	161	6	et	et	PROPN
iajs-3043	161	7	al	al	PROPN
iajs-3043	161	8	.	.	PUNCT
iajs-3043	162	1	vitamin	vitamin	PROPN
iajs-3043	162	2	d	d	NOUN
iajs-3043	162	3	inhibits	inhibit	VERB
iajs-3043	162	4	proliferation	proliferation	NOUN
iajs-3043	162	5	and	and	CCONJ
iajs-3043	162	6	profibrotic	profibrotic	ADJ
iajs-3043	162	7	marker	marker	NOUN
iajs-3043	162	8	expression	expression	NOUN
iajs-3043	162	9	in	in	ADP
iajs-3043	162	10	hepatic	hepatic	ADJ
iajs-3043	162	11	stellate	stellate	ADJ
iajs-3043	162	12	cells	cell	NOUN
iajs-3043	162	13	and	and	CCONJ
iajs-3043	162	14	decreases	decrease	VERB
iajs-3043	162	15	thioacetamide	thioacetamide	ADV
iajs-3043	162	16	-	-	PUNCT
iajs-3043	162	17	induced	induce	VERB
iajs-3043	162	18	liver	liver	NOUN
iajs-3043	162	19	fibrosis	fibrosis	NOUN
iajs-3043	162	20	in	in	ADP
iajs-3043	162	21	rats	rat	NOUN
iajs-3043	162	22	.	.	PUNCT
iajs-3043	163	1	gut	gut	VERB
iajs-3043	163	2	,	,	PUNCT
iajs-3043	163	3	2011	2011	NUM
iajs-3043	163	4	,	,	PUNCT
iajs-3043	163	5	60.12	60.12	NUM
iajs-3043	163	6	:	:	PUNCT
iajs-3043	163	7	1728	1728	NUM
iajs-3043	163	8	-	-	SYM
iajs-3043	163	9	1737	1737	NUM
iajs-3043	163	10	.	.	PUNCT
iajs-3043	164	1	16	16	NUM
iajs-3043	164	2	.	.	PUNCT
iajs-3043	165	1	borges	borge	NOUN
iajs-3043	165	2	-	-	PUNCT
iajs-3043	165	3	canha	canha	NOUN
iajs-3043	165	4	,	,	PUNCT
iajs-3043	165	5	marta	marta	PROPN
iajs-3043	165	6	,	,	PUNCT
iajs-3043	165	7	et	et	PROPN
iajs-3043	165	8	al	al	PROPN
iajs-3043	165	9	.	.	PUNCT
iajs-3043	166	1	the	the	DET
iajs-3043	166	2	impact	impact	NOUN
iajs-3043	166	3	of	of	ADP
iajs-3043	166	4	vitamin	vitamin	NOUN
iajs-3043	166	5	d	d	NOUN
iajs-3043	166	6	in	in	ADP
iajs-3043	166	7	non	non	ADJ
iajs-3043	166	8	-	-	ADJ
iajs-3043	166	9	alcoholic	alcoholic	ADJ
iajs-3043	166	10	fatty	fatty	NOUN
iajs-3043	166	11	liver	liver	NOUN
iajs-3043	166	12	disease	disease	NOUN
iajs-3043	166	13	:	:	PUNCT
iajs-3043	166	14	a	a	DET
iajs-3043	166	15	cross	cross	ADJ
iajs-3043	166	16	-	-	ADJ
iajs-3043	166	17	sectional	sectional	ADJ
iajs-3043	166	18	study	study	NOUN
iajs-3043	166	19	in	in	ADP
iajs-3043	166	20	patients	patient	NOUN
iajs-3043	166	21	with	with	ADP
iajs-3043	166	22	morbid	morbid	ADJ
iajs-3043	166	23	obesity	obesity	NOUN
iajs-3043	166	24	.	.	PUNCT
iajs-3043	167	1	diabetes	diabetes	NOUN
iajs-3043	167	2	,	,	PUNCT
iajs-3043	167	3	metabolic	metabolic	NOUN
iajs-3043	167	4	syndrome	syndrome	NOUN
iajs-3043	167	5	and	and	CCONJ
iajs-3043	167	6	obesity	obesity	NOUN
iajs-3043	167	7	:	:	PUNCT
iajs-3043	167	8	targets	target	NOUN
iajs-3043	167	9	and	and	CCONJ
iajs-3043	167	10	therapy	therapy	NOUN
iajs-3043	167	11	,	,	PUNCT
iajs-3043	167	12	2021	2021	NUM
iajs-3043	167	13	,	,	PUNCT
iajs-3043	167	14	14	14	NUM
iajs-3043	167	15	:	:	SYM
iajs-3043	167	16	487	487	NUM
iajs-3043	167	17	.	.	NOUN
iajs-3043	167	18	17	17	NUM
iajs-3043	167	19	.	.	PUNCT
iajs-3043	167	20	cimini	cimini	PROPN
iajs-3043	167	21	,	,	PUNCT
iajs-3043	167	22	flavia	flavia	PROPN
iajs-3043	167	23	a.	a.	PROPN
iajs-3043	167	24	,	,	PUNCT
iajs-3043	167	25	et	et	PROPN
iajs-3043	167	26	al	al	PROPN
iajs-3043	167	27	.	.	PROPN
iajs-3043	167	28	relationship	relationship	NOUN
iajs-3043	167	29	between	between	ADP
iajs-3043	167	30	adipose	adipose	ADJ
iajs-3043	167	31	tissue	tissue	NOUN
iajs-3043	167	32	dysfunction	dysfunction	NOUN
iajs-3043	167	33	,	,	PUNCT
iajs-3043	167	34	vitamin	vitamin	NOUN
iajs-3043	167	35	d	d	NOUN
iajs-3043	167	36	deficiency	deficiency	NOUN
iajs-3043	167	37	and	and	CCONJ
iajs-3043	167	38	the	the	DET
iajs-3043	167	39	pathogenesis	pathogenesis	NOUN
iajs-3043	167	40	of	of	ADP
iajs-3043	167	41	non	non	ADJ
iajs-3043	167	42	-	-	ADJ
iajs-3043	167	43	alcoholic	alcoholic	ADJ
iajs-3043	167	44	fatty	fatty	NOUN
iajs-3043	167	45	liver	liver	NOUN
iajs-3043	167	46	disease	disease	NOUN
iajs-3043	167	47	.	.	PUNCT
iajs-3043	168	1	world	world	PROPN
iajs-3043	168	2	journal	journal	PROPN
iajs-3043	168	3	of	of	ADP
iajs-3043	168	4	gastroenterology	gastroenterology	NOUN
iajs-3043	168	5	,	,	PUNCT
iajs-3043	168	6	2017	2017	NUM
iajs-3043	168	7	,	,	PUNCT
iajs-3043	168	8	23.19	23.19	NUM
iajs-3043	168	9	:	:	SYM
iajs-3043	168	10	3407	3407	NUM
iajs-3043	168	11	.	.	PUNCT
iajs-3043	169	1	18	18	NUM
iajs-3043	169	2	.	.	PUNCT
iajs-3043	169	3	wimalawansa	wimalawansa	PROPN
iajs-3043	169	4	sj	sj	PROPN
iajs-3043	169	5	.	.	PUNCT
iajs-3043	170	1	associations	association	NOUN
iajs-3043	170	2	of	of	ADP
iajs-3043	170	3	vitamin	vitamin	NOUN
iajs-3043	170	4	d	d	NOUN
iajs-3043	170	5	with	with	ADP
iajs-3043	170	6	insulin	insulin	NOUN
iajs-3043	170	7	resistance	resistance	NOUN
iajs-3043	170	8	,	,	PUNCT
iajs-3043	170	9	obesity	obesity	NOUN
iajs-3043	170	10	,	,	PUNCT
iajs-3043	170	11	type	type	NOUN
iajs-3043	170	12	2	2	NUM
iajs-3043	170	13	diabetes	diabetes	NOUN
iajs-3043	170	14	,	,	PUNCT
iajs-3043	170	15	and	and	CCONJ
iajs-3043	170	16	metabolic	metabolic	NOUN
iajs-3043	170	17	syndrome	syndrome	NOUN
iajs-3043	170	18	.	.	PUNCT
iajs-3043	171	1	j	j	PROPN
iajs-3043	171	2	steroid	steroid	PROPN
iajs-3043	171	3	biochem	biochem	PROPN
iajs-3043	171	4	mol	mol	ADP
iajs-3043	171	5	biol	biol	PROPN
iajs-3043	171	6	,	,	PUNCT
iajs-3043	171	7	2018	2018	NUM
iajs-3043	171	8	;	;	PUNCT
iajs-3043	171	9	175	175	NUM
iajs-3043	171	10	:	:	PUNCT
iajs-3043	171	11	177–189	177–189	NUM
iajs-3043	171	12	.	.	PUNCT
iajs-3043	172	1	19	19	NUM
iajs-3043	172	2	.	.	X
iajs-3043	172	3	nuttall	nuttall	PROPN
iajs-3043	172	4	,	,	PUNCT
iajs-3043	172	5	frank	frank	PROPN
iajs-3043	172	6	q.	q.	PROPN
iajs-3043	172	7	body	body	PROPN
iajs-3043	172	8	mass	mass	PROPN
iajs-3043	172	9	index	index	NOUN
iajs-3043	172	10	:	:	PUNCT
iajs-3043	172	11	obesity	obesity	NOUN
iajs-3043	172	12	,	,	PUNCT
iajs-3043	172	13	bmi	bmi	NOUN
iajs-3043	172	14	,	,	PUNCT
iajs-3043	172	15	and	and	CCONJ
iajs-3043	172	16	health	health	NOUN
iajs-3043	172	17	:	:	PUNCT
iajs-3043	172	18	a	a	DET
iajs-3043	172	19	critical	critical	ADJ
iajs-3043	172	20	review	review	NOUN
iajs-3043	172	21	.	.	PUNCT
iajs-3043	173	1	nutrition	nutrition	NOUN
iajs-3043	173	2	today	today	NOUN
iajs-3043	173	3	,	,	PUNCT
iajs-3043	173	4	2015	2015	NUM
iajs-3043	173	5	,	,	PUNCT
iajs-3043	173	6	50.3	50.3	NUM
iajs-3043	173	7	:	:	SYM
iajs-3043	173	8	117	117	NUM
iajs-3043	173	9	.	.	NOUN
iajs-3043	173	10	20	20	NUM
iajs-3043	173	11	.	.	PUNCT
iajs-3043	174	1	daniel	daniel	PROPN
iajs-3043	174	2	,	,	PUNCT
iajs-3043	174	3	wayne	wayne	PROPN
iajs-3043	174	4	w.	w.	PROPN
iajs-3043	174	5	,	,	PUNCT
iajs-3043	174	6	and	and	CCONJ
iajs-3043	174	7	chad	chad	PROPN
iajs-3043	174	8	l.	l.	PROPN
iajs-3043	174	9	cross	cross	PROPN
iajs-3043	174	10	.	.	PUNCT
iajs-3043	175	1	biostatistics	biostatistic	NOUN
iajs-3043	175	2	:	:	PUNCT
iajs-3043	175	3	a	a	DET
iajs-3043	175	4	foundation	foundation	NOUN
iajs-3043	175	5	for	for	ADP
iajs-3043	175	6	analysis	analysis	NOUN
iajs-3043	175	7	in	in	ADP
iajs-3043	175	8	the	the	DET
iajs-3043	175	9	health	health	NOUN
iajs-3043	175	10	sciences	science	NOUN
iajs-3043	175	11	.	.	PUNCT
iajs-3043	176	1	2018	2018	NUM
iajs-3043	176	2	.	.	PUNCT
iajs-3043	177	1	21	21	NUM
iajs-3043	177	2	.	.	PUNCT
iajs-3043	178	1	johanna	johanna	PROPN
iajs-3043	178	2	k.	k.	PROPN
iajs-3043	178	3	disefano	disefano	PROPN
iajs-3043	178	4	,	,	PUNCT
iajs-3043	178	5	glenn	glenn	PROPN
iajs-3043	178	6	s.	s.	PROPN
iajs-3043	178	7	gerhard	gerhard	PROPN
iajs-3043	178	8	.	.	PUNCT
iajs-3043	179	1	nafld	nafld	ADV
iajs-3043	179	2	in	in	ADP
iajs-3043	179	3	normal	normal	ADJ
iajs-3043	179	4	weight	weight	NOUN
iajs-3043	179	5	individuals	individual	NOUN
iajs-3043	179	6	.	.	PUNCT
iajs-3043	180	1	diabetology	diabetology	NOUN
iajs-3043	180	2	and	and	CCONJ
iajs-3043	180	3	metabolic	metabolic	NOUN
iajs-3043	180	4	syndrome	syndrome	NOUN
iajs-3043	180	5	.	.	PUNCT
iajs-3043	181	1	(	(	PUNCT
iajs-3043	181	2	2022).14	2022).14	NUM
iajs-3043	181	3	:	:	PUNCT
iajs-3043	181	4	45	45	NUM
iajs-3043	181	5	22	22	NUM
iajs-3043	181	6	.	.	PUNCT
iajs-3043	182	1	zou	zou	PROPN
iajs-3043	182	2	,	,	PUNCT
iajs-3043	182	3	yang	yang	PROPN
iajs-3043	182	4	,	,	PUNCT
iajs-3043	182	5	et	et	PROPN
iajs-3043	182	6	al	al	PROPN
iajs-3043	182	7	.	.	PROPN
iajs-3043	182	8	association	association	PROPN
iajs-3043	182	9	between	between	ADP
iajs-3043	182	10	the	the	DET
iajs-3043	182	11	alanine	alanine	NOUN
iajs-3043	182	12	aminotransferase	aminotransferase	NOUN
iajs-3043	182	13	/	/	SYM
iajs-3043	182	14	aspartate	aspartate	NOUN
iajs-3043	182	15	aminotransferase	aminotransferase	NOUN
iajs-3043	182	16	ratio	ratio	NOUN
iajs-3043	182	17	and	and	CCONJ
iajs-3043	182	18	new	new	ADJ
iajs-3043	182	19	-	-	PUNCT
iajs-3043	182	20	onset	onset	ADJ
iajs-3043	182	21	non	non	ADJ
iajs-3043	182	22	-	-	ADJ
iajs-3043	182	23	alcoholic	alcoholic	ADJ
iajs-3043	182	24	fatty	fatty	NOUN
iajs-3043	182	25	liver	liver	NOUN
iajs-3043	182	26	disease	disease	NOUN
iajs-3043	182	27	in	in	ADP
iajs-3043	182	28	a	a	DET
iajs-3043	182	29	nonobese	nonobese	ADJ
iajs-3043	182	30	chinese	chinese	ADJ
iajs-3043	182	31	population	population	NOUN
iajs-3043	182	32	:	:	PUNCT
iajs-3043	182	33	a	a	DET
iajs-3043	182	34	population	population	NOUN
iajs-3043	182	35	-	-	PUNCT
iajs-3043	182	36	based	base	VERB
iajs-3043	182	37	longitudinal	longitudinal	ADJ
iajs-3043	182	38	study	study	NOUN
iajs-3043	182	39	.	.	PUNCT
iajs-3043	183	1	lipids	lipid	NOUN
iajs-3043	183	2	in	in	ADP
iajs-3043	183	3	health	health	NOUN
iajs-3043	183	4	and	and	CCONJ
iajs-3043	183	5	disease	disease	NOUN
iajs-3043	183	6	,	,	PUNCT
iajs-3043	183	7	2020	2020	NUM
iajs-3043	183	8	,	,	PUNCT
iajs-3043	183	9	19.1	19.1	NUM
iajs-3043	183	10	:	:	SYM
iajs-3043	183	11	1	1	NUM
iajs-3043	183	12	-	-	SYM
iajs-3043	183	13	10	10	NUM
iajs-3043	183	14	.	.	PUNCT
iajs-3043	184	1	ihjpas	ihjpas	PROPN
iajs-3043	184	2	.	.	PUNCT
iajs-3043	185	1	36(2)2023	36(2)2023	NUM
iajs-3043	185	2	248	248	NUM
iajs-3043	185	3	23	23	NUM
iajs-3043	185	4	.	.	PUNCT
iajs-3043	186	1	lee	lee	PROPN
iajs-3043	186	2	,	,	PUNCT
iajs-3043	186	3	so	so	ADV
iajs-3043	186	4	-	-	PUNCT
iajs-3043	186	5	ryoung	ryoung	NOUN
iajs-3043	186	6	,	,	PUNCT
iajs-3043	186	7	et	et	PROPN
iajs-3043	186	8	al	al	PROPN
iajs-3043	186	9	.	.	PROPN
iajs-3043	186	10	nonalcoholic	nonalcoholic	PROPN
iajs-3043	186	11	fatty	fatty	NOUN
iajs-3043	186	12	liver	liver	NOUN
iajs-3043	186	13	disease	disease	NOUN
iajs-3043	186	14	and	and	CCONJ
iajs-3043	186	15	the	the	DET
iajs-3043	186	16	risk	risk	NOUN
iajs-3043	186	17	of	of	ADP
iajs-3043	186	18	atrial	atrial	ADJ
iajs-3043	186	19	fibrillation	fibrillation	NOUN
iajs-3043	186	20	stratified	stratify	VERB
iajs-3043	186	21	by	by	ADP
iajs-3043	186	22	body	body	NOUN
iajs-3043	186	23	mass	mass	PROPN
iajs-3043	186	24	index	index	NOUN
iajs-3043	186	25	:	:	PUNCT
iajs-3043	186	26	a	a	DET
iajs-3043	186	27	nationwide	nationwide	ADJ
iajs-3043	186	28	population	population	NOUN
iajs-3043	186	29	-	-	PUNCT
iajs-3043	186	30	based	base	VERB
iajs-3043	186	31	study	study	NOUN
iajs-3043	186	32	.	.	PUNCT
iajs-3043	187	1	scientific	scientific	ADJ
iajs-3043	187	2	reports	report	NOUN
iajs-3043	187	3	,	,	PUNCT
iajs-3043	187	4	2021	2021	NUM
iajs-3043	187	5	,	,	PUNCT
iajs-3043	187	6	11.1	11.1	NUM
iajs-3043	187	7	:	:	SYM
iajs-3043	187	8	1	1	NUM
iajs-3043	187	9	-	-	SYM
iajs-3043	187	10	9	9	NUM
iajs-3043	187	11	.	.	NUM
iajs-3043	187	12	24	24	NUM
iajs-3043	187	13	.	.	PUNCT
iajs-3043	188	1	divella	divella	PROPN
iajs-3043	188	2	,	,	PUNCT
iajs-3043	188	3	rosa	rosa	PROPN
iajs-3043	188	4	,	,	PUNCT
iajs-3043	188	5	et	et	PROPN
iajs-3043	188	6	al	al	PROPN
iajs-3043	188	7	.	.	PUNCT
iajs-3043	188	8	obesity	obesity	PROPN
iajs-3043	188	9	,	,	PUNCT
iajs-3043	188	10	nonalcoholic	nonalcoholic	NOUN
iajs-3043	188	11	fatty	fatty	NOUN
iajs-3043	188	12	liver	liver	NOUN
iajs-3043	188	13	disease	disease	NOUN
iajs-3043	188	14	and	and	CCONJ
iajs-3043	188	15	adipocytokines	adipocytokine	NOUN
iajs-3043	188	16	network	network	NOUN
iajs-3043	188	17	in	in	ADP
iajs-3043	188	18	promotion	promotion	NOUN
iajs-3043	188	19	of	of	ADP
iajs-3043	188	20	cancer	cancer	NOUN
iajs-3043	188	21	.	.	PUNCT
iajs-3043	189	1	international	international	ADJ
iajs-3043	189	2	journal	journal	PROPN
iajs-3043	189	3	of	of	ADP
iajs-3043	189	4	biological	biological	ADJ
iajs-3043	189	5	sciences	science	NOUN
iajs-3043	189	6	,	,	PUNCT
iajs-3043	189	7	2019	2019	NUM
iajs-3043	189	8	,	,	PUNCT
iajs-3043	189	9	15.3	15.3	NUM
iajs-3043	189	10	:	:	PUNCT
iajs-3043	189	11	610	610	NUM
iajs-3043	189	12	.	.	X
iajs-3043	189	13	25	25	NUM
iajs-3043	189	14	.	.	PUNCT
iajs-3043	190	1	hohenester	hohenester	PROPN
iajs-3043	190	2	,	,	PUNCT
iajs-3043	190	3	simon	simon	PROPN
iajs-3043	190	4	,	,	PUNCT
iajs-3043	190	5	et	et	PROPN
iajs-3043	190	6	al	al	PROPN
iajs-3043	190	7	.	.	PUNCT
iajs-3043	191	1	lifestyle	lifestyle	PROPN
iajs-3043	191	2	intervention	intervention	NOUN
iajs-3043	191	3	for	for	ADP
iajs-3043	191	4	morbid	morbid	ADJ
iajs-3043	191	5	obesity	obesity	NOUN
iajs-3043	191	6	:	:	PUNCT
iajs-3043	191	7	effects	effect	NOUN
iajs-3043	191	8	on	on	ADP
iajs-3043	191	9	liver	liver	NOUN
iajs-3043	191	10	steatosis	steatosis	NOUN
iajs-3043	191	11	,	,	PUNCT
iajs-3043	191	12	inflammation	inflammation	NOUN
iajs-3043	191	13	,	,	PUNCT
iajs-3043	191	14	and	and	CCONJ
iajs-3043	191	15	fibrosis	fibrosis	NOUN
iajs-3043	191	16	.	.	PUNCT
iajs-3043	192	1	american	american	ADJ
iajs-3043	192	2	journal	journal	PROPN
iajs-3043	192	3	of	of	ADP
iajs-3043	192	4	physiology	physiology	NOUN
iajs-3043	192	5	-	-	PUNCT
iajs-3043	192	6	gastrointestinal	gastrointestinal	ADJ
iajs-3043	192	7	and	and	CCONJ
iajs-3043	192	8	liver	liver	NOUN
iajs-3043	192	9	physiology	physiology	NOUN
iajs-3043	192	10	,	,	PUNCT
iajs-3043	192	11	2018	2018	NUM
iajs-3043	192	12	,	,	PUNCT
iajs-3043	192	13	315.3	315.3	NUM
iajs-3043	192	14	:	:	PUNCT
iajs-3043	192	15	g329	g329	PROPN
iajs-3043	192	16	-	-	PUNCT
iajs-3043	192	17	g338	g338	PROPN
iajs-3043	192	18	.	.	PROPN
iajs-3043	193	1	26	26	NUM
iajs-3043	193	2	.	.	PUNCT
iajs-3043	194	1	yamauchi	yamauchi	PROPN
iajs-3043	194	2	,	,	PUNCT
iajs-3043	194	3	toshimasa	toshimasa	PROPN
iajs-3043	194	4	;	;	PUNCT
iajs-3043	194	5	kadowaki	kadowaki	PROPN
iajs-3043	194	6	,	,	PUNCT
iajs-3043	194	7	takashi	takashi	PROPN
iajs-3043	194	8	.	.	PUNCT
iajs-3043	195	1	adiponectin	adiponectin	NOUN
iajs-3043	195	2	receptor	receptor	NOUN
iajs-3043	195	3	as	as	ADP
iajs-3043	195	4	a	a	DET
iajs-3043	195	5	key	key	ADJ
iajs-3043	195	6	player	player	NOUN
iajs-3043	195	7	in	in	ADP
iajs-3043	195	8	healthy	healthy	ADJ
iajs-3043	195	9	longevity	longevity	NOUN
iajs-3043	195	10	and	and	CCONJ
iajs-3043	195	11	obesity	obesity	NOUN
iajs-3043	195	12	-	-	PUNCT
iajs-3043	195	13	related	relate	VERB
iajs-3043	195	14	diseases	disease	NOUN
iajs-3043	195	15	.	.	PUNCT
iajs-3043	196	1	cell	cell	NOUN
iajs-3043	196	2	metabolism	metabolism	NOUN
iajs-3043	196	3	,	,	PUNCT
iajs-3043	196	4	2013	2013	NUM
iajs-3043	196	5	,	,	PUNCT
iajs-3043	196	6	17.2	17.2	NUM
iajs-3043	196	7	:	:	SYM
iajs-3043	196	8	185	185	NUM
iajs-3043	196	9	-	-	SYM
iajs-3043	196	10	196	196	NUM
iajs-3043	196	11	.	.	PUNCT
iajs-3043	197	1	27	27	NUM
iajs-3043	197	2	.	.	PUNCT
iajs-3043	198	1	mohamed	mohamed	PROPN
iajs-3043	198	2	,	,	PUNCT
iajs-3043	198	3	manal	manal	PROPN
iajs-3043	198	4	sabry	sabry	PROPN
iajs-3043	198	5	,	,	PUNCT
iajs-3043	198	6	et	et	PROPN
iajs-3043	198	7	al	al	PROPN
iajs-3043	198	8	.	.	PROPN
iajs-3043	198	9	correlation	correlation	NOUN
iajs-3043	198	10	between	between	ADP
iajs-3043	198	11	adiponectin	adiponectin	NOUN
iajs-3043	198	12	level	level	NOUN
iajs-3043	198	13	and	and	CCONJ
iajs-3043	198	14	the	the	DET
iajs-3043	198	15	degree	degree	NOUN
iajs-3043	198	16	of	of	ADP
iajs-3043	198	17	fibrosis	fibrosis	NOUN
iajs-3043	198	18	in	in	ADP
iajs-3043	198	19	patients	patient	NOUN
iajs-3043	198	20	with	with	ADP
iajs-3043	198	21	non	non	ADJ
iajs-3043	198	22	-	-	ADJ
iajs-3043	198	23	alcoholic	alcoholic	ADJ
iajs-3043	198	24	fatty	fatty	NOUN
iajs-3043	198	25	liver	liver	NOUN
iajs-3043	198	26	disease	disease	NOUN
iajs-3043	198	27	.	.	PUNCT
iajs-3043	199	1	egyptian	egyptian	ADJ
iajs-3043	199	2	liver	liver	PROPN
iajs-3043	199	3	journal	journal	NOUN
iajs-3043	199	4	,	,	PUNCT
iajs-3043	199	5	2021	2021	NUM
iajs-3043	199	6	,	,	PUNCT
iajs-3043	199	7	11.1	11.1	NUM
iajs-3043	199	8	:	:	SYM
iajs-3043	199	9	110	110	NUM
iajs-3043	199	10	.	.	X
iajs-3043	199	11	28	28	NUM
iajs-3043	199	12	.	.	PUNCT
iajs-3043	200	1	palacios‐gonzález	palacios‐gonzález	PROPN
iajs-3043	200	2	,	,	PUNCT
iajs-3043	200	3	berenice	berenice	PROPN
iajs-3043	200	4	,	,	PUNCT
iajs-3043	200	5	et	et	PROPN
iajs-3043	200	6	al	al	PROPN
iajs-3043	200	7	.	.	PROPN
iajs-3043	200	8	irisin	irisin	PROPN
iajs-3043	200	9	levels	level	NOUN
iajs-3043	200	10	before	before	ADP
iajs-3043	200	11	and	and	CCONJ
iajs-3043	200	12	after	after	ADP
iajs-3043	200	13	physical	physical	ADJ
iajs-3043	200	14	activity	activity	NOUN
iajs-3043	200	15	among	among	ADP
iajs-3043	200	16	school‐age	school‐age	NOUN
iajs-3043	200	17	children	child	NOUN
iajs-3043	200	18	with	with	ADP
iajs-3043	200	19	different	different	ADJ
iajs-3043	200	20	bmi	bmi	NOUN
iajs-3043	200	21	:	:	PUNCT
iajs-3043	200	22	a	a	DET
iajs-3043	200	23	direct	direct	ADJ
iajs-3043	200	24	relation	relation	NOUN
iajs-3043	200	25	with	with	ADP
iajs-3043	200	26	leptin	leptin	NOUN
iajs-3043	200	27	.	.	PUNCT
iajs-3043	201	1	obesity	obesity	NOUN
iajs-3043	201	2	,	,	PUNCT
iajs-3043	201	3	2015	2015	NUM
iajs-3043	201	4	,	,	PUNCT
iajs-3043	201	5	23.4	23.4	NUM
iajs-3043	201	6	:	:	PUNCT
iajs-3043	201	7	729	729	NUM
iajs-3043	201	8	-	-	SYM
iajs-3043	201	9	732	732	NUM
iajs-3043	201	10	.	.	PUNCT
iajs-3043	201	11	29	29	NUM
iajs-3043	201	12	.	.	PUNCT
iajs-3043	202	1	hu	hu	PROPN
iajs-3043	202	2	,	,	PUNCT
iajs-3043	202	3	jie	jie	PROPN
iajs-3043	202	4	,	,	PUNCT
iajs-3043	202	5	et	et	PROPN
iajs-3043	202	6	al	al	PROPN
iajs-3043	202	7	.	.	PROPN
iajs-3043	202	8	circulating	circulate	VERB
iajs-3043	202	9	irisin	irisin	PROPN
iajs-3043	202	10	levels	level	NOUN
iajs-3043	202	11	in	in	ADP
iajs-3043	202	12	patients	patient	NOUN
iajs-3043	202	13	with	with	ADP
iajs-3043	202	14	nonalcoholic	nonalcoholic	NOUN
iajs-3043	202	15	fatty	fatty	NOUN
iajs-3043	202	16	liver	liver	NOUN
iajs-3043	202	17	disease	disease	NOUN
iajs-3043	202	18	:	:	PUNCT
iajs-3043	202	19	a	a	DET
iajs-3043	202	20	systematic	systematic	ADJ
iajs-3043	202	21	review	review	NOUN
iajs-3043	202	22	and	and	CCONJ
iajs-3043	202	23	meta	meta	ADJ
iajs-3043	202	24	-	-	PUNCT
iajs-3043	202	25	analysis	analysis	NOUN
iajs-3043	202	26	.	.	PUNCT
iajs-3043	203	1	gastroenterology	gastroenterology	NOUN
iajs-3043	203	2	research	research	NOUN
iajs-3043	203	3	and	and	CCONJ
iajs-3043	203	4	practice	practice	NOUN
iajs-3043	203	5	,	,	PUNCT
iajs-3043	203	6	2020	2020	NUM
iajs-3043	203	7	,	,	PUNCT
iajs-3043	203	8	2020	2020	NUM
iajs-3043	203	9	.	.	PUNCT
iajs-3043	204	1	30	30	NUM
iajs-3043	204	2	.	.	PUNCT
iajs-3043	205	1	wang	wang	PROPN
iajs-3043	205	2	,	,	PUNCT
iajs-3043	205	3	ya	ya	PROPN
iajs-3043	205	4	-	-	PUNCT
iajs-3043	205	5	di	di	PROPN
iajs-3043	205	6	,	,	PUNCT
iajs-3043	205	7	et	et	PROPN
iajs-3043	205	8	al	al	PROPN
iajs-3043	205	9	.	.	PUNCT
iajs-3043	206	1	new	new	ADJ
iajs-3043	206	2	insight	insight	NOUN
iajs-3043	206	3	of	of	ADP
iajs-3043	206	4	obesity	obesity	NOUN
iajs-3043	206	5	-	-	PUNCT
iajs-3043	206	6	associated	associate	VERB
iajs-3043	206	7	nafld	nafld	ADV
iajs-3043	206	8	:	:	PUNCT
iajs-3043	206	9	dysregulated	dysregulate	VERB
iajs-3043	206	10	“	"	PUNCT
iajs-3043	206	11	crosstalk	crosstalk	NOUN
iajs-3043	206	12	”	"	PUNCT
iajs-3043	206	13	between	between	ADP
iajs-3043	206	14	multi	multi	ADJ
iajs-3043	206	15	-	-	ADJ
iajs-3043	206	16	organ	organ	ADJ
iajs-3043	206	17	and	and	CCONJ
iajs-3043	206	18	the	the	DET
iajs-3043	206	19	liver	liver	NOUN
iajs-3043	206	20	?	?	PUNCT
iajs-3043	206	21	.	.	PUNCT
iajs-3043	207	1	genes	gene	NOUN
iajs-3043	207	2	&	&	CCONJ
iajs-3043	207	3	diseases	disease	NOUN
iajs-3043	207	4	,	,	PUNCT
iajs-3043	207	5	2022	2022	NUM
iajs-3043	207	6	.	.	PUNCT
iajs-3043	208	1	31	31	NUM
iajs-3043	208	2	.	.	PUNCT
iajs-3043	209	1	shanaki	shanaki	PROPN
iajs-3043	209	2	,	,	PUNCT
iajs-3043	209	3	mehrnoosh	mehrnoosh	PROPN
iajs-3043	209	4	,	,	PUNCT
iajs-3043	209	5	et	et	PROPN
iajs-3043	209	6	al	al	PROPN
iajs-3043	209	7	.	.	PUNCT
iajs-3043	210	1	lower	low	ADJ
iajs-3043	210	2	circulating	circulate	VERB
iajs-3043	210	3	irisin	irisin	NOUN
iajs-3043	210	4	is	be	AUX
iajs-3043	210	5	associated	associate	VERB
iajs-3043	210	6	with	with	ADP
iajs-3043	210	7	nonalcoholic	nonalcoholic	NOUN
iajs-3043	210	8	fatty	fatty	NOUN
iajs-3043	210	9	liver	liver	NOUN
iajs-3043	210	10	disease	disease	NOUN
iajs-3043	210	11	and	and	CCONJ
iajs-3043	210	12	type	type	NOUN
iajs-3043	210	13	2	2	NUM
iajs-3043	210	14	diabetes	diabetes	NOUN
iajs-3043	210	15	.	.	PUNCT
iajs-3043	211	1	diabetes	diabetes	NOUN
iajs-3043	211	2	&	&	CCONJ
iajs-3043	211	3	metabolic	metabolic	PROPN
iajs-3043	211	4	syndrome	syndrome	PROPN
iajs-3043	211	5	:	:	PUNCT
iajs-3043	211	6	clinical	clinical	ADJ
iajs-3043	211	7	research	research	NOUN
iajs-3043	211	8	&	&	CCONJ
iajs-3043	211	9	reviews	review	NOUN
iajs-3043	211	10	,	,	PUNCT
iajs-3043	211	11	2017	2017	NUM
iajs-3043	211	12	,	,	PUNCT
iajs-3043	211	13	11	11	NUM
iajs-3043	211	14	:	:	PUNCT
iajs-3043	211	15	s467	s467	PROPN
iajs-3043	211	16	-	-	PUNCT
iajs-3043	211	17	s472	s472	PROPN
iajs-3043	211	18	.	.	PUNCT
iajs-3043	212	1	32	32	NUM
iajs-3043	212	2	.	.	X
iajs-3043	213	1	ulualan	ulualan	PROPN
iajs-3043	213	2	,	,	PUNCT
iajs-3043	213	3	gökçen	gökçen	PROPN
iajs-3043	213	4	;	;	PUNCT
iajs-3043	213	5	küskü	küskü	ADV
iajs-3043	213	6	ki̇raz	ki̇raz	NOUN
iajs-3043	213	7	,	,	PUNCT
iajs-3043	213	8	zeynep	zeynep	NOUN
iajs-3043	213	9	;	;	PUNCT
iajs-3043	213	10	kirel	kirel	NOUN
iajs-3043	213	11	,	,	PUNCT
iajs-3043	213	12	bi̇rgül	bi̇rgül	NOUN
iajs-3043	213	13	.	.	PUNCT
iajs-3043	214	1	relation	relation	NOUN
iajs-3043	214	2	of	of	ADP
iajs-3043	214	3	serum	serum	PROPN
iajs-3043	214	4	irisin	irisin	PROPN
iajs-3043	214	5	levels	level	NOUN
iajs-3043	214	6	to	to	ADP
iajs-3043	214	7	obesity	obesity	NOUN
iajs-3043	214	8	and	and	CCONJ
iajs-3043	214	9	non	non	ADJ
iajs-3043	214	10	-	-	ADJ
iajs-3043	214	11	alcoholic	alcoholic	ADJ
iajs-3043	214	12	fatty	fatty	NOUN
iajs-3043	214	13	liver	liver	NOUN
iajs-3043	214	14	disease	disease	NOUN
iajs-3043	214	15	.	.	PUNCT
iajs-3043	215	1	turkish	turkish	ADJ
iajs-3043	215	2	journal	journal	NOUN
iajs-3043	215	3	of	of	ADP
iajs-3043	215	4	pediatrics	pediatric	NOUN
iajs-3043	215	5	,	,	PUNCT
iajs-3043	215	6	2022	2022	NUM
iajs-3043	215	7	,	,	PUNCT
iajs-3043	215	8	64.2	64.2	NUM
iajs-3043	215	9	.	.	PUNCT
iajs-3043	216	1	33	33	NUM
iajs-3043	216	2	.	.	PUNCT
iajs-3043	217	1	jiang	jiang	PROPN
iajs-3043	217	2	q.	q.	PROPN
iajs-3043	217	3	;	;	PUNCT
iajs-3043	217	4	p.yan	p.yan	NUM
iajs-3043	217	5	;	;	PUNCT
iajs-3043	217	6	y	y	PROPN
iajs-3043	217	7	,	,	PUNCT
iajs-3043	217	8	yang	yang	PROPN
iajs-3043	217	9	and	and	CCONJ
iajs-3043	217	10	s.	s.	PROPN
iajs-3043	217	11	dai	dai	PROPN
iajs-3043	217	12	,	,	PUNCT
iajs-3043	217	13	y.	y.	PROPN
iajs-3043	217	14	luo	luo	PROPN
iajs-3043	217	15	.	.	PUNCT
iajs-3043	218	1	correlation	correlation	NOUN
iajs-3043	218	2	between	between	ADP
iajs-3043	218	3	irisin	irisin	NOUN
iajs-3043	218	4	level	level	NOUN
iajs-3043	218	5	and	and	CCONJ
iajs-3043	218	6	insulin	insulin	NOUN
iajs-3043	218	7	resistance	resistance	NOUN
iajs-3043	218	8	in	in	ADP
iajs-3043	218	9	patients	patient	NOUN
iajs-3043	218	10	with	with	ADP
iajs-3043	218	11	fatty	fatty	NOUN
iajs-3043	218	12	liver	liver	NOUN
iajs-3043	218	13	disease	disease	NOUN
iajs-3043	218	14	.	.	PUNCT
iajs-3043	219	1	modem	modem	ADJ
iajs-3043	219	2	practical	practical	ADJ
iajs-3043	219	3	medicine	medicine	NOUN
iajs-3043	219	4	,	,	PUNCT
iajs-3043	219	5	2017	2017	NUM
iajs-3043	219	6	.	.	PUNCT
iajs-3043	220	1	29	29	NUM
iajs-3043	220	2	,	,	PUNCT
iajs-3043	220	3	11	11	NUM
iajs-3043	220	4	,	,	PUNCT
iajs-3043	220	5	14401441	14401441	NUM
iajs-3043	220	6	,	,	PUNCT
iajs-3043	220	7	2017	2017	NUM
iajs-3043	220	8	.	.	PUNCT
iajs-3043	221	1	34	34	NUM
iajs-3043	221	2	.	.	PUNCT
iajs-3043	221	3	hu	hu	PROPN
iajs-3043	221	4	,	,	PUNCT
iajs-3043	221	5	jie	jie	PROPN
iajs-3043	221	6	,	,	PUNCT
iajs-3043	221	7	et	et	PROPN
iajs-3043	221	8	al	al	PROPN
iajs-3043	221	9	.	.	PROPN
iajs-3043	222	1	circulating	circulate	VERB
iajs-3043	222	2	irisin	irisin	PROPN
iajs-3043	222	3	levels	level	NOUN
iajs-3043	222	4	in	in	ADP
iajs-3043	222	5	patients	patient	NOUN
iajs-3043	222	6	with	with	ADP
iajs-3043	222	7	nonalcoholic	nonalcoholic	NOUN
iajs-3043	222	8	fatty	fatty	NOUN
iajs-3043	222	9	liver	liver	NOUN
iajs-3043	222	10	disease	disease	NOUN
iajs-3043	222	11	:	:	PUNCT
iajs-3043	222	12	a	a	DET
iajs-3043	222	13	systematic	systematic	ADJ
iajs-3043	222	14	review	review	NOUN
iajs-3043	222	15	and	and	CCONJ
iajs-3043	222	16	meta	meta	ADJ
iajs-3043	222	17	-	-	PUNCT
iajs-3043	222	18	analysis	analysis	NOUN
iajs-3043	222	19	.	.	PUNCT
iajs-3043	223	1	gastroenterology	gastroenterology	NOUN
iajs-3043	223	2	research	research	NOUN
iajs-3043	223	3	and	and	CCONJ
iajs-3043	223	4	practice	practice	NOUN
iajs-3043	223	5	,	,	PUNCT
iajs-3043	223	6	2020	2020	NUM
iajs-3043	223	7	,	,	PUNCT
iajs-3043	223	8	2020	2020	NUM
iajs-3043	223	9	.	.	PUNCT
iajs-3043	224	1	35	35	NUM
iajs-3043	224	2	.	.	PUNCT
iajs-3043	224	3	karatayli	karatayli	PROPN
iajs-3043	224	4	,	,	PUNCT
iajs-3043	224	5	ersin	ersin	PROPN
iajs-3043	224	6	;	;	PUNCT
iajs-3043	224	7	stokes	stokes	PROPN
iajs-3043	224	8	,	,	PUNCT
iajs-3043	224	9	caroline	caroline	PROPN
iajs-3043	224	10	s.	s.	PROPN
iajs-3043	224	11	;	;	PUNCT
iajs-3043	224	12	lammert	lammert	PROPN
iajs-3043	224	13	,	,	PUNCT
iajs-3043	224	14	frank	frank	PROPN
iajs-3043	224	15	.	.	PUNCT
iajs-3043	225	1	vitamin	vitamin	NOUN
iajs-3043	225	2	d	d	NOUN
iajs-3043	225	3	in	in	ADP
iajs-3043	225	4	preclinical	preclinical	ADJ
iajs-3043	225	5	models	model	NOUN
iajs-3043	225	6	of	of	ADP
iajs-3043	225	7	fatty	fatty	ADJ
iajs-3043	225	8	liver	liver	NOUN
iajs-3043	225	9	disease	disease	NOUN
iajs-3043	225	10	.	.	PUNCT
iajs-3043	226	1	anticancer	anticancer	NOUN
iajs-3043	226	2	research	research	NOUN
iajs-3043	226	3	,	,	PUNCT
iajs-3043	226	4	2020	2020	NUM
iajs-3043	226	5	,	,	PUNCT
iajs-3043	226	6	40.1	40.1	NUM
iajs-3043	226	7	:	:	PUNCT
iajs-3043	226	8	527	527	NUM
iajs-3043	226	9	-	-	SYM
iajs-3043	226	10	534	534	NUM
iajs-3043	226	11	.	.	X
iajs-3043	227	1	36	36	NUM
iajs-3043	227	2	.	.	PUNCT
iajs-3043	228	1	barchetta	barchetta	PROPN
iajs-3043	228	2	,	,	PUNCT
iajs-3043	228	3	ilaria	ilaria	PROPN
iajs-3043	228	4	,	,	PUNCT
iajs-3043	228	5	et	et	PROPN
iajs-3043	228	6	al	al	PROPN
iajs-3043	228	7	.	.	PUNCT
iajs-3043	228	8	strong	strong	ADJ
iajs-3043	228	9	association	association	NOUN
iajs-3043	228	10	between	between	ADP
iajs-3043	228	11	non	non	ADJ
iajs-3043	228	12	alcoholic	alcoholic	ADJ
iajs-3043	228	13	fatty	fatty	NOUN
iajs-3043	228	14	liver	liver	NOUN
iajs-3043	228	15	disease	disease	NOUN
iajs-3043	228	16	(	(	PUNCT
iajs-3043	228	17	nafld	nafld	ADV
iajs-3043	228	18	)	)	PUNCT
iajs-3043	228	19	and	and	CCONJ
iajs-3043	228	20	low	low	ADJ
iajs-3043	228	21	25	25	NUM
iajs-3043	228	22	(	(	PUNCT
iajs-3043	228	23	oh	oh	INTJ
iajs-3043	228	24	)	)	PUNCT
iajs-3043	228	25	vitamin	vitamin	NOUN
iajs-3043	228	26	d	d	NOUN
iajs-3043	228	27	levels	level	NOUN
iajs-3043	228	28	in	in	ADP
iajs-3043	228	29	an	an	DET
iajs-3043	228	30	adult	adult	NOUN
iajs-3043	228	31	population	population	NOUN
iajs-3043	228	32	with	with	ADP
iajs-3043	228	33	normal	normal	ADJ
iajs-3043	228	34	serum	serum	NOUN
iajs-3043	228	35	liver	liver	NOUN
iajs-3043	228	36	enzymes	enzyme	NOUN
iajs-3043	228	37	.	.	PUNCT
iajs-3043	229	1	bmc	bmc	ADJ
iajs-3043	229	2	medicine	medicine	NOUN
iajs-3043	229	3	,	,	PUNCT
iajs-3043	229	4	2011	2011	NUM
iajs-3043	229	5	,	,	PUNCT
iajs-3043	229	6	9.1	9.1	NUM
iajs-3043	229	7	:	:	SYM
iajs-3043	229	8	1	1	NUM
iajs-3043	229	9	-	-	SYM
iajs-3043	229	10	7	7	NUM
iajs-3043	229	11	.	.	PUNCT
iajs-3043	229	12	ihjpas	ihjpas	PROPN
iajs-3043	229	13	.	.	PUNCT
iajs-3043	230	1	36(2)2023	36(2)2023	NUM
iajs-3043	230	2	249	249	NUM
iajs-3043	230	3	37	37	NUM
iajs-3043	230	4	.	.	PUNCT
iajs-3043	231	1	dasarathy	dasarathy	PROPN
iajs-3043	231	2	j	j	PROPN
iajs-3043	231	3	;	;	PUNCT
iajs-3043	231	4	periyalwar	periyalwar	ADJ
iajs-3043	231	5	p;allampati	p;allampati	X
iajs-3043	231	6	s	s	PART
iajs-3043	231	7	;	;	PUNCT
iajs-3043	231	8	bhinder	bhinder	ADJ
iajs-3043	231	9	v	v	PROPN
iajs-3043	231	10	,	,	PUNCT
iajs-3043	231	11	hawkins	hawkins	PROPN
iajs-3043	231	12	c	c	PROPN
iajs-3043	231	13	,	,	PUNCT
iajs-3043	231	14	brandt	brandt	PROPN
iajs-3043	231	15	p	p	PROPN
iajs-3043	231	16	,	,	PUNCT
iajs-3043	231	17	khiyami	khiyami	PROPN
iajs-3043	231	18	a;mccullough	a;mccullough	PROPN
iajs-3043	231	19	aj	aj	PROPN
iajs-3043	231	20	and	and	CCONJ
iajs-3043	232	1	dasarathy	dasarathy	PROPN
iajs-3043	232	2	s.	s.	PROPN
iajs-3043	232	3	hypovitaminosis	hypovitaminosis	PROPN
iajs-3043	232	4	d	d	PROPN
iajs-3043	232	5	is	be	AUX
iajs-3043	232	6	associated	associate	VERB
iajs-3043	232	7	with	with	ADP
iajs-3043	232	8	increased	increase	VERB
iajs-3043	232	9	whole	whole	ADJ
iajs-3043	232	10	body	body	NOUN
iajs-3043	232	11	fat	fat	ADJ
iajs-3043	232	12	mass	mass	NOUN
iajs-3043	232	13	and	and	CCONJ
iajs-3043	232	14	greater	great	ADJ
iajs-3043	232	15	severity	severity	NOUN
iajs-3043	232	16	of	of	ADP
iajs-3043	232	17	non	non	ADJ
iajs-3043	232	18	-	-	ADJ
iajs-3043	232	19	alcoholic	alcoholic	ADJ
iajs-3043	232	20	fatty	fatty	NOUN
iajs-3043	232	21	liver	liver	NOUN
iajs-3043	232	22	disease	disease	NOUN
iajs-3043	232	23	.	.	PUNCT
iajs-3043	233	1	liver	liver	NOUN
iajs-3043	233	2	int	int	PROPN
iajs-3043	233	3	.2014	.2014	PROPN
iajs-3043	233	4	.	.	PUNCT
iajs-3043	234	1	34(6	34(6	NUM
iajs-3043	234	2	):	):	PUNCT
iajs-3043	234	3	1	1	NUM
iajs-3043	234	4	38	38	NUM
iajs-3043	234	5	.	.	PUNCT
iajs-3043	235	1	nelson	nelson	PROPN
iajs-3043	235	2	je	je	PROPN
iajs-3043	235	3	;	;	PUNCT
iajs-3043	235	4	roth	roth	PROPN
iajs-3043	235	5	cl;wilson	cl;wilson	NOUN
iajs-3043	235	6	la;yates	la;yates	PROPN
iajs-3043	235	7	kp	kp	PROPN
iajs-3043	235	8	;	;	PUNCT
iajs-3043	235	9	aouizerat	aouizerat	PROPN
iajs-3043	235	10	b	b	PROPN
iajs-3043	235	11	;	;	PUNCT
iajs-3043	235	12	morganstevenson	morganstevenson	NOUN
iajs-3043	235	13	v	v	NOUN
iajs-3043	235	14	;	;	PUNCT
iajs-3043	235	15	whalen	whalen	PROPN
iajs-3043	235	16	e	e	PROPN
iajs-3043	235	17	,	,	PUNCT
iajs-3043	235	18	hoofnagle	hoofnagle	VERB
iajs-3043	235	19	a	a	PRON
iajs-3043	235	20	,	,	PUNCT
iajs-3043	235	21	mason	mason	PROPN
iajs-3043	235	22	m	m	PROPN
iajs-3043	235	23	,	,	PUNCT
iajs-3043	235	24	gersuk	gersuk	NOUN
iajs-3043	235	25	v	v	NOUN
iajs-3043	235	26	,	,	PUNCT
iajs-3043	235	27	yeh	yeh	PROPN
iajs-3043	235	28	mm	mm	PROPN
iajs-3043	235	29	and	and	CCONJ
iajs-3043	235	30	kowdley	kowdley	PROPN
iajs-3043	235	31	kv	kv	PROPN
iajs-3043	235	32	.	.	PUNCT
iajs-3043	236	1	vitamin	vitamin	NOUN
iajs-3043	236	2	d	d	NOUN
iajs-3043	236	3	deficiency	deficiency	NOUN
iajs-3043	236	4	is	be	AUX
iajs-3043	236	5	associated	associate	VERB
iajs-3043	236	6	with	with	ADP
iajs-3043	236	7	increased	increase	VERB
iajs-3043	236	8	risk	risk	NOUN
iajs-3043	236	9	of	of	ADP
iajs-3043	236	10	non	non	ADJ
iajs-3043	236	11	-	-	ADJ
iajs-3043	236	12	alcoholic	alcoholic	ADJ
iajs-3043	236	13	steatohepatitis	steatohepatitis	NOUN
iajs-3043	236	14	in	in	ADP
iajs-3043	236	15	adults	adult	NOUN
iajs-3043	236	16	with	with	ADP
iajs-3043	236	17	nonalcoholic	nonalcoholic	NOUN
iajs-3043	236	18	fatty	fatty	NOUN
iajs-3043	236	19	liver	liver	NOUN
iajs-3043	236	20	disease	disease	NOUN
iajs-3043	236	21	:	:	PUNCT
iajs-3043	236	22	possible	possible	ADJ
iajs-3043	236	23	role	role	NOUN
iajs-3043	236	24	for	for	ADP
iajs-3043	236	25	mapk	mapk	NOUN
iajs-3043	236	26	and	and	CCONJ
iajs-3043	236	27	nf	nf	NOUN
iajs-3043	236	28	-	-	PUNCT
iajs-3043	236	29	kappab	kappab	NOUN
iajs-3043	236	30	?	?	PUNCT
iajs-3043	237	1	am	be	AUX
iajs-3043	237	2	j	j	PROPN
iajs-3043	237	3	gastroenterol	gastroenterol	NOUN
iajs-3043	237	4	.	.	PUNCT
iajs-3043	238	1	2016.111(6	2016.111(6	NUM
iajs-3043	238	2	):	):	PUNCT
iajs-3043	238	3	852	852	NUM
iajs-3043	238	4	-	-	SYM
iajs-3043	238	5	863	863	NUM
iajs-3043	238	6	.	.	PUNCT
iajs-3043	239	1	39	39	NUM
iajs-3043	239	2	.	.	PUNCT
iajs-3043	240	1	nobili	nobili	PROPN
iajs-3043	240	2	v	v	PROPN
iajs-3043	240	3	;	;	PUNCT
iajs-3043	240	4	giorgio	giorgio	PROPN
iajs-3043	240	5	v	v	NOUN
iajs-3043	240	6	;	;	PUNCT
iajs-3043	240	7	liccardo	liccardo	NOUN
iajs-3043	240	8	d	d	NOUN
iajs-3043	240	9	;	;	PUNCT
iajs-3043	240	10	bedogni	bedogni	NOUN
iajs-3043	240	11	g	g	NOUN
iajs-3043	240	12	;	;	PUNCT
iajs-3043	240	13	morino	morino	VERB
iajs-3043	240	14	g	g	NOUN
iajs-3043	240	15	;	;	PUNCT
iajs-3043	240	16	alisi	alisi	ADJ
iajs-3043	240	17	a	a	PRON
iajs-3043	240	18	and	and	CCONJ
iajs-3043	240	19	cianfarani	cianfarani	PROPN
iajs-3043	240	20	s.	s.	PROPN
iajs-3043	240	21	vitamin	vitamin	PROPN
iajs-3043	240	22	d	d	PROPN
iajs-3043	240	23	levels	level	NOUN
iajs-3043	240	24	and	and	CCONJ
iajs-3043	240	25	liver	liver	NOUN
iajs-3043	240	26	histological	histological	ADJ
iajs-3043	240	27	alterations	alteration	NOUN
iajs-3043	240	28	in	in	ADP
iajs-3043	240	29	children	child	NOUN
iajs-3043	240	30	with	with	ADP
iajs-3043	240	31	nonalcoholic	nonalcoholic	NOUN
iajs-3043	240	32	fatty	fatty	NOUN
iajs-3043	240	33	liver	liver	NOUN
iajs-3043	240	34	disease	disease	NOUN
iajs-3043	240	35	.	.	PUNCT
iajs-3043	241	1	eur	eur	PROPN
iajs-3043	241	2	j	j	PROPN
iajs-3043	241	3	endocrinol.2014,170(4	endocrinol.2014,170(4	PROPN
iajs-3043	241	4	):	):	PUNCT
iajs-3043	241	5	547	547	NUM
iajs-3043	241	6	-	-	SYM
iajs-3043	241	7	553	553	NUM
iajs-3043	241	8	.	.	NOUN
iajs-3043	241	9	40	40	NUM
iajs-3043	241	10	.	.	PUNCT
iajs-3043	242	1	targher	targher	PROPN
iajs-3043	242	2	g	g	PROPN
iajs-3043	242	3	,	,	PUNCT
iajs-3043	242	4	bertolini	bertolini	PROPN
iajs-3043	242	5	l	l	PROPN
iajs-3043	242	6	,	,	PUNCT
iajs-3043	242	7	scala	scala	PROPN
iajs-3043	242	8	l	l	PROPN
iajs-3043	242	9	,	,	PUNCT
iajs-3043	242	10	cigolini	cigolini	PROPN
iajs-3043	242	11	m	m	NOUN
iajs-3043	242	12	,	,	PUNCT
iajs-3043	242	13	zenari	zenari	PROPN
iajs-3043	242	14	l	l	NOUN
iajs-3043	242	15	,	,	PUNCT
iajs-3043	242	16	falezza	falezza	NOUN
iajs-3043	242	17	g	g	NOUN
iajs-3043	242	18	and	and	CCONJ
iajs-3043	242	19	arcaro	arcaro	VERB
iajs-3043	242	20	g	g	NOUN
iajs-3043	242	21	:	:	PUNCT
iajs-3043	242	22	associations	association	NOUN
iajs-3043	242	23	between	between	ADP
iajs-3043	242	24	serum	serum	NOUN
iajs-3043	242	25	25	25	NUM
iajs-3043	242	26	-	-	PUNCT
iajs-3043	242	27	hydroxyvitamin	hydroxyvitamin	NOUN
iajs-3043	242	28	d3	d3	PROPN
iajs-3043	242	29	concentrations	concentration	NOUN
iajs-3043	242	30	and	and	CCONJ
iajs-3043	242	31	liver	liver	NOUN
iajs-3043	242	32	histology	histology	NOUN
iajs-3043	242	33	in	in	ADP
iajs-3043	242	34	patients	patient	NOUN
iajs-3043	242	35	with	with	ADP
iajs-3043	242	36	nonalcoholic	nonalcoholic	NOUN
iajs-3043	242	37	fatty	fatty	NOUN
iajs-3043	242	38	liver	liver	NOUN
iajs-3043	242	39	disease	disease	NOUN
iajs-3043	242	40	.	.	PUNCT
iajs-3043	243	1	nutr	nutr	PROPN
iajs-3043	243	2	metab	metab	PROPN
iajs-3043	243	3	cardiovasc	cardiovasc	PROPN
iajs-3043	243	4	dis	dis	PROPN
iajs-3043	243	5	.2007.17(7	.2007.17(7	PROPN
iajs-3043	243	6	):	):	PUNCT
iajs-3043	243	7	517	517	NUM
iajs-3043	243	8	-	-	SYM
iajs-3043	243	9	524	524	NUM
iajs-3043	243	10	.	.	NOUN
iajs-3043	243	11	41	41	NUM
iajs-3043	243	12	.	.	PUNCT
iajs-3043	244	1	chung	chung	PROPN
iajs-3043	244	2	ge	ge	PROPN
iajs-3043	244	3	,	,	PUNCT
iajs-3043	244	4	kim	kim	PROPN
iajs-3043	244	5	d	d	PROPN
iajs-3043	244	6	,	,	PUNCT
iajs-3043	244	7	kwak	kwak	PROPN
iajs-3043	244	8	ms	ms	PROPN
iajs-3043	244	9	,	,	PUNCT
iajs-3043	244	10	yang	yang	PROPN
iajs-3043	244	11	ji	ji	PROPN
iajs-3043	244	12	,	,	PUNCT
iajs-3043	244	13	yim	yim	PROPN
iajs-3043	244	14	jy	jy	PROPN
iajs-3043	244	15	,	,	PUNCT
iajs-3043	244	16	lim	lim	PROPN
iajs-3043	244	17	sh	sh	PROPN
iajs-3043	244	18	;	;	PUNCT
iajs-3043	244	19	itani	itani	PROPN
iajs-3043	244	20	m	m	PROPN
iajs-3043	244	21	:	:	PUNCT
iajs-3043	244	22	the	the	DET
iajs-3043	244	23	serum	serum	NOUN
iajs-3043	244	24	vitamin	vitamin	NOUN
iajs-3043	244	25	d	d	NOUN
iajs-3043	244	26	level	level	NOUN
iajs-3043	244	27	is	be	AUX
iajs-3043	244	28	inversely	inversely	ADV
iajs-3043	244	29	correlated	correlate	VERB
iajs-3043	244	30	with	with	ADP
iajs-3043	244	31	nonalcoholic	nonalcoholic	NOUN
iajs-3043	244	32	fatty	fatty	NOUN
iajs-3043	244	33	liver	liver	NOUN
iajs-3043	244	34	disease	disease	NOUN
iajs-3043	244	35	.	.	PUNCT
iajs-3043	245	1	clin	clin	PROPN
iajs-3043	245	2	mol	mol	ADP
iajs-3043	246	1	hepatol.2016	hepatol.2016	PRON
iajs-3043	246	2	22(1	22(1	NUM
iajs-3043	246	3	):	):	PUNCT
iajs-3043	246	4	146151	146151	NUM
iajs-3043	246	5	.	.	PUNCT
iajs-3043	247	1	42	42	NUM
iajs-3043	247	2	.	.	PUNCT
iajs-3043	248	1	bril	bril	PROPN
iajs-3043	248	2	f	f	PROPN
iajs-3043	248	3	,	,	PUNCT
iajs-3043	248	4	maximos	maximos	PROPN
iajs-3043	248	5	m	m	PROPN
iajs-3043	248	6	,	,	PUNCT
iajs-3043	248	7	portillo	portillo	PROPN
iajs-3043	248	8	-	-	PUNCT
iajs-3043	248	9	sanchez	sanchez	PROPN
iajs-3043	248	10	p	p	NOUN
iajs-3043	248	11	,	,	PUNCT
iajs-3043	248	12	biernacki	biernacki	NOUN
iajs-3043	248	13	d	d	NOUN
iajs-3043	248	14	,	,	PUNCT
iajs-3043	248	15	lomonaco	lomonaco	ADJ
iajs-3043	248	16	r	r	NOUN
iajs-3043	248	17	,	,	PUNCT
iajs-3043	248	18	subbarayan	subbarayan	PROPN
iajs-3043	248	19	s	s	PROPN
iajs-3043	248	20	,	,	PUNCT
iajs-3043	248	21	correa	correa	PROPN
iajs-3043	248	22	m	m	PROPN
iajs-3043	248	23	,	,	PUNCT
iajs-3043	248	24	lo	lo	PROPN
iajs-3043	248	25	m	m	PROPN
iajs-3043	248	26	,	,	PUNCT
iajs-3043	248	27	suman	suman	PROPN
iajs-3043	248	28	a	a	PROPN
iajs-3043	248	29	and	and	CCONJ
iajs-3043	248	30	cusi	cusi	PROPN
iajs-3043	248	31	k.	k.	PROPN
iajs-3043	248	32	relationship	relationship	NOUN
iajs-3043	248	33	of	of	ADP
iajs-3043	248	34	vitamin	vitamin	NOUN
iajs-3043	248	35	d	d	NOUN
iajs-3043	248	36	with	with	ADP
iajs-3043	248	37	insulin	insulin	NOUN
iajs-3043	248	38	resistance	resistance	NOUN
iajs-3043	248	39	and	and	CCONJ
iajs-3043	248	40	disease	disease	NOUN
iajs-3043	248	41	severity	severity	NOUN
iajs-3043	248	42	in	in	ADP
iajs-3043	248	43	non	non	ADJ
iajs-3043	248	44	-	-	ADJ
iajs-3043	248	45	alcoholic	alcoholic	ADJ
iajs-3043	248	46	steatohepatitis	steatohepatitis	NOUN
iajs-3043	248	47	.	.	PUNCT
iajs-3043	249	1	j	j	PROPN
iajs-3043	249	2	hepatol	hepatol	ADV
iajs-3043	249	3	,	,	PUNCT
iajs-3043	249	4	2015.62(2	2015.62(2	NUM
iajs-3043	249	5	):	):	PUNCT
iajs-3043	249	6	405	405	NUM
iajs-3043	249	7	-	-	SYM
iajs-3043	249	8	411	411	NUM
iajs-3043	249	9	.	.	PUNCT
iajs-3043	250	1	43	43	NUM
iajs-3043	250	2	.	.	PUNCT
iajs-3043	251	1	ilaria	ilaria	PROPN
iajs-3043	251	2	barchetta	barchetta	PROPN
iajs-3043	251	3	,	,	PUNCT
iajs-3043	251	4	francesco	francesco	PROPN
iajs-3043	251	5	angelico	angelico	PROPN
iajs-3043	251	6	,	,	PUNCT
iajs-3043	251	7	maria	maria	PROPN
iajs-3043	251	8	del	del	PROPN
iajs-3043	251	9	ben	ben	PROPN
iajs-3043	251	10	,	,	PUNCT
iajs-3043	251	11	marco	marco	PROPN
iajs-3043	251	12	giorgio	giorgio	PROPN
iajs-3043	251	13	baroni	baroni	PROPN
iajs-3043	251	14	,	,	PUNCT
iajs-3043	251	15	paolo	paolo	PROPN
iajs-3043	251	16	pozzilli	pozzilli	PROPN
iajs-3043	251	17	,	,	PUNCT
iajs-3043	251	18	sergio	sergio	PROPN
iajs-3043	251	19	morini;maria	morini;maria	PROPN
iajs-3043	251	20	gisella	gisella	PROPN
iajs-3043	251	21	cavallo	cavallo	NOUN
iajs-3043	251	22	.	.	PUNCT
iajs-3043	252	1	strong	strong	ADJ
iajs-3043	252	2	association	association	NOUN
iajs-3043	252	3	between	between	ADP
iajs-3043	252	4	non	non	ADJ
iajs-3043	252	5	alcoholic	alcoholic	ADJ
iajs-3043	252	6	fatty	fatty	NOUN
iajs-3043	252	7	liver	liver	NOUN
iajs-3043	252	8	disease	disease	NOUN
iajs-3043	252	9	(	(	PUNCT
iajs-3043	252	10	nafld	nafld	ADV
iajs-3043	252	11	)	)	PUNCT
iajs-3043	252	12	and	and	CCONJ
iajs-3043	252	13	low	low	ADJ
iajs-3043	252	14	25(oh	25(oh	NOUN
iajs-3043	252	15	)	)	PUNCT
iajs-3043	252	16	vitamin	vitamin	NOUN
iajs-3043	252	17	d	d	NOUN
iajs-3043	252	18	levels	level	NOUN
iajs-3043	252	19	in	in	ADP
iajs-3043	252	20	an	an	DET
iajs-3043	252	21	adult	adult	NOUN
iajs-3043	252	22	population	population	NOUN
iajs-3043	252	23	with	with	ADP
iajs-3043	252	24	normal	normal	ADJ
iajs-3043	252	25	serum	serum	NOUN
iajs-3043	252	26	liver	liver	NOUN
iajs-3043	252	27	enzymes	enzyme	NOUN
iajs-3043	252	28	.	.	PUNCT
iajs-3043	253	1	bmc	bmc	ADJ
iajs-3043	253	2	medicine	medicine	NOUN
iajs-3043	253	3	.	.	PUNCT
iajs-3043	254	1	2011	2011	NUM
iajs-3043	254	2	,	,	PUNCT
iajs-3043	254	3	9:85	9:85	NUM
iajs-3043	254	4	44	44	NUM
iajs-3043	254	5	.	.	PUNCT
iajs-3043	255	1	eliades	eliade	NOUN
iajs-3043	255	2	m	m	PRON
iajs-3043	255	3	,	,	PUNCT
iajs-3043	255	4	spyrou	spyrou	ADJ
iajs-3043	255	5	e	e	NOUN
iajs-3043	255	6	,	,	PUNCT
iajs-3043	255	7	agrawal	agrawal	PROPN
iajs-3043	255	8	n	n	CCONJ
iajs-3043	255	9	,	,	PUNCT
iajs-3043	255	10	et	et	PROPN
iajs-3043	255	11	al	al	PROPN
iajs-3043	255	12	.	.	PUNCT
iajs-3043	256	1	meta	meta	ADJ
iajs-3043	256	2	-	-	PUNCT
iajs-3043	256	3	analysis	analysis	NOUN
iajs-3043	256	4	:	:	PUNCT
iajs-3043	256	5	vitamin	vitamin	NOUN
iajs-3043	256	6	d	d	NOUN
iajs-3043	256	7	and	and	CCONJ
iajs-3043	256	8	non	non	ADJ
iajs-3043	256	9	-	-	ADJ
iajs-3043	256	10	alcoholic	alcoholic	ADJ
iajs-3043	256	11	fatty	fatty	NOUN
iajs-3043	256	12	liver	liver	NOUN
iajs-3043	256	13	disease	disease	NOUN
iajs-3043	256	14	.	.	PUNCT
iajs-3043	257	1	aliment	aliment	NOUN
iajs-3043	257	2	pharmacol	pharmacol	VERB
iajs-3043	257	3	ther	ther	ADV
iajs-3043	257	4	.	.	PUNCT
iajs-3043	258	1	2013;38	2013;38	NUM
iajs-3043	258	2	(	(	PUNCT
iajs-3043	258	3	3):246–254	3):246–254	PROPN
iajs-3043	258	4	.	.	PUNCT
iajs-3043	259	1	45	45	NUM
iajs-3043	259	2	.	.	PUNCT
iajs-3043	260	1	liangpunsakul	liangpunsakul	PROPN
iajs-3043	260	2	s	s	PROPN
iajs-3043	260	3	and	and	CCONJ
iajs-3043	260	4	chalasani	chalasani	PROPN
iajs-3043	260	5	n.	n.	PROPN
iajs-3043	260	6	serum	serum	NOUN
iajs-3043	260	7	vitamin	vitamin	NOUN
iajs-3043	260	8	d	d	NOUN
iajs-3043	260	9	concentrations	concentration	NOUN
iajs-3043	260	10	and	and	CCONJ
iajs-3043	260	11	unexplained	unexplained	ADJ
iajs-3043	260	12	elevation	elevation	NOUN
iajs-3043	260	13	in	in	ADP
iajs-3043	260	14	alt	alt	NOUN
iajs-3043	260	15	among	among	ADP
iajs-3043	260	16	us	us	PROPN
iajs-3043	260	17	adults	adult	NOUN
iajs-3043	260	18	.	.	PUNCT
iajs-3043	261	1	dig	dig	VERB
iajs-3043	261	2	dis	dis	PROPN
iajs-3043	261	3	sci	sci	PROPN
iajs-3043	261	4	.	.	PUNCT
iajs-3043	262	1	2011;56	2011;56	PROPN
iajs-3043	262	2	(	(	PUNCT
iajs-3043	262	3	7):2124–2129	7):2124–2129	PROPN
iajs-3043	262	4	.	.	PROPN
iajs-3043	262	5	46	46	NUM
iajs-3043	262	6	.	.	PUNCT
iajs-3043	263	1	eliades	eliade	NOUN
iajs-3043	263	2	m	m	PRON
iajs-3043	263	3	,	,	PUNCT
iajs-3043	263	4	spyrou	spyrou	ADJ
iajs-3043	263	5	e.	e.	PROPN
iajs-3043	263	6	vitamin	vitamin	PROPN
iajs-3043	264	1	d	d	X
iajs-3043	264	2	:	:	PUNCT
iajs-3043	264	3	a	a	DET
iajs-3043	264	4	new	new	ADJ
iajs-3043	264	5	player	player	NOUN
iajs-3043	264	6	in	in	ADP
iajs-3043	264	7	non	non	ADJ
iajs-3043	264	8	-	-	ADJ
iajs-3043	264	9	alcoholic	alcoholic	ADJ
iajs-3043	264	10	fatty	fatty	NOUN
iajs-3043	264	11	liver	liver	NOUN
iajs-3043	264	12	disease	disease	NOUN
iajs-3043	264	13	?	?	PUNCT
iajs-3043	264	14	world.j.gastroenterol.2015;21(6):1718–1727	world.j.gastroenterol.2015;21(6):1718–1727	NOUN
iajs-3043	264	15	.	.	PUNCT
iajs-3043	265	1	47.yunkoo	47.yunkoo	X
iajs-3043	265	2	kang	kang	PROPN
iajs-3043	265	3	.	.	PROPN
iajs-3043	265	4	,	,	PUNCT
iajs-3043	265	5	sowon	sowon	VERB
iajs-3043	265	6	park	park	NOUN
iajs-3043	265	7	,	,	PUNCT
iajs-3043	265	8	seung	seung	PROPN
iajs-3043	265	9	kim	kim	PROPN
iajs-3043	265	10	;	;	PUNCT
iajs-3043	265	11	hog	hog	PROPN
iajs-3043	265	12	koh	koh	PROPN
iajs-3043	265	13	.	.	PUNCT
iajs-3043	266	1	normal	normal	ADJ
iajs-3043	266	2	serum	serum	NOUN
iajs-3043	266	3	alanine	alanine	PROPN
iajs-3043	266	4	aminotrasferase	aminotrasferase	NOUN
iajs-3043	266	5	and	and	CCONJ
iajs-3043	266	6	non	non	ADJ
iajs-3043	266	7	-	-	ADJ
iajs-3043	266	8	alcoholic	alcoholic	ADJ
iajs-3043	266	9	fatty	fatty	NOUN
iajs-3043	266	10	liver	liver	NOUN
iajs-3043	266	11	disease	disease	NOUN
iajs-3043	266	12	among	among	ADP
iajs-3043	266	13	korean	korean	ADJ
iajs-3043	266	14	adolescents	adolescent	NOUN
iajs-3043	266	15	:	:	PUNCT
iajs-3043	266	16	a	a	DET
iajs-3043	266	17	cross	cross	ADJ
iajs-3043	266	18	-	-	ADJ
iajs-3043	266	19	sectional	sectional	ADJ
iajs-3043	266	20	study	study	NOUN
iajs-3043	266	21	using	use	VERB
iajs-3043	266	22	data	datum	NOUN
iajs-3043	266	23	from	from	ADP
iajs-3043	266	24	knhanes	knhane	NOUN
iajs-3043	266	25	2010	2010	NUM
iajs-3043	266	26	-	-	SYM
iajs-3043	266	27	2015	2015	NUM
iajs-3043	266	28	.	.	PUNCT
iajs-3043	267	1	bmc	bmc	ADJ
iajs-3043	267	2	pediatrics	pediatric	NOUN
iajs-3043	267	3	.	.	PUNCT
iajs-3043	268	1	2018	2018	NUM
iajs-3043	268	2	.	.	PUNCT
iajs-3043	269	1	18	18	NUM
iajs-3043	269	2	:	:	SYM
iajs-3043	269	3	215	215	NUM
iajs-3043	269	4	.	.	X
iajs-3043	270	1	48	48	NUM
iajs-3043	270	2	.	.	PUNCT
iajs-3043	271	1	martin	martin	PROPN
iajs-3043	271	2	-	-	PUNCT
iajs-3043	271	3	rodriguez	rodriguez	PROPN
iajs-3043	271	4	jl	jl	PROPN
iajs-3043	271	5	,	,	PUNCT
iajs-3043	271	6	gonzalez	gonzalez	PROPN
iajs-3043	271	7	-	-	PUNCT
iajs-3043	271	8	cantero	cantero	PROPN
iajs-3043	271	9	j	j	PROPN
iajs-3043	271	10	,	,	PUNCT
iajs-3043	271	11	gonzalezcantero	gonzalezcantero	PROPN
iajs-3043	271	12	a	a	X
iajs-3043	271	13	,	,	PUNCT
iajs-3043	271	14	arrebola	arrebola	PROPN
iajs-3043	271	15	jp	jp	NOUN
iajs-3043	271	16	and	and	CCONJ
iajs-3043	271	17	gonzalez	gonzalez	PROPN
iajs-3043	271	18	calvin	calvin	PROPN
iajs-3043	271	19	jl	jl	PROPN
iajs-3043	271	20	.	.	PUNCT
iajs-3043	272	1	diagnostic	diagnostic	ADJ
iajs-3043	272	2	accuracy	accuracy	NOUN
iajs-3043	272	3	of	of	ADP
iajs-3043	272	4	serum	serum	NOUN
iajs-3043	272	5	alanin	alanin	PROPN
iajs-3043	272	6	aminotransferase	aminotransferase	PROPN
iajs-3043	272	7	as	as	ADP
iajs-3043	272	8	biomarker	biomarker	NOUN
iajs-3043	272	9	for	for	ADP
iajs-3043	272	10	nonalcoholic	nonalcoholic	NOUN
iajs-3043	272	11	fatty	fatty	NOUN
iajs-3043	272	12	liver	liver	NOUN
iajs-3043	272	13	desaes	desaes	NOUN
iajs-3043	272	14	and	and	CCONJ
iajs-3043	272	15	insulin	insulin	NOUN
iajs-3043	272	16	resistance	resistance	NOUN
iajs-3043	272	17	in	in	ADP
iajs-3043	272	18	healthy	healthy	ADJ
iajs-3043	272	19	subjects	subject	NOUN
iajs-3043	272	20	using	use	VERB
iajs-3043	272	21	3	3	NUM
iajs-3043	272	22	t	t	NOUN
iajs-3043	272	23	mr	mr	PROPN
iajs-3043	272	24	spectroscopy	spectroscopy	NOUN
iajs-3043	272	25	.	.	PUNCT
iajs-3043	273	1	medicine	medicine	NOUN
iajs-3043	273	2	(	(	PUNCT
iajs-3043	273	3	baltimore	baltimore	PROPN
iajs-3043	273	4	)	)	PUNCT
iajs-3043	273	5	.	.	PUNCT
iajs-3043	274	1	2017	2017	NUM
iajs-3043	274	2	;	;	PUNCT
iajs-3043	274	3	96	96	NUM
iajs-3043	274	4	:	:	PUNCT
iajs-3043	274	5	e6770	e6770	NOUN
iajs-3043	274	6	49	49	NUM
iajs-3043	274	7	.	.	PUNCT
iajs-3043	275	1	isaken	isaken	VERB
iajs-3043	275	2	vt	vt	PROPN
iajs-3043	275	3	.	.	PROPN
iajs-3043	276	1	larsen	larsen	PROPN
iajs-3043	276	2	ma	ma	PROPN
iajs-3043	276	3	,	,	PUNCT
iajs-3043	276	4	goll	goll	PROPN
iajs-3043	276	5	r	r	PROPN
iajs-3043	276	6	,	,	PUNCT
iajs-3043	276	7	florholmen	florholman	NOUN
iajs-3043	276	8	jr	jr	PROPN
iajs-3043	276	9	and	and	CCONJ
iajs-3043	276	10	paulssen	paulssen	ADJ
iajs-3043	276	11	ej	ej	PROPN
iajs-3043	276	12	.	.	PUNCT
iajs-3043	276	13	hepatic	hepatic	ADJ
iajs-3043	276	14	steatosis	steatosis	NOUN
iajs-3043	276	15	,	,	PUNCT
iajs-3043	276	16	detected	detect	VERB
iajs-3043	276	17	by	by	ADP
iajs-3043	276	18	hepatorenal	hepatorenal	ADJ
iajs-3043	276	19	index	index	NOUN
iajs-3043	276	20	in	in	ADP
iajs-3043	276	21	ultrasonography	ultrasonography	NOUN
iajs-3043	276	22	,	,	PUNCT
iajs-3043	276	23	as	as	ADP
iajs-3043	276	24	a	a	DET
iajs-3043	276	25	predictor	predictor	NOUN
iajs-3043	276	26	of	of	ADP
iajs-3043	276	27	insulin	insulin	NOUN
iajs-3043	276	28	resistance	resistance	NOUN
iajs-3043	276	29	in	in	ADP
iajs-3043	276	30	obese	obese	ADJ
iajs-3043	276	31	subjects	subject	NOUN
iajs-3043	276	32	.	.	PUNCT
iajs-3043	277	1	bmc	bmc	PROPN
iajs-3043	277	2	obes	obes	PROPN
iajs-3043	277	3	.	.	PUNCT
iajs-3043	278	1	2016,3:39	2016,3:39	VERB
iajs-3043	278	2	.	.	PUNCT
iajs-3043	279	1	50	50	NUM
iajs-3043	279	2	.	.	PUNCT
iajs-3043	279	3	bishnu	bishnu	PROPN
iajs-3043	279	4	jwarchan	jwarchan	PROPN
iajs-3043	279	5	,	,	PUNCT
iajs-3043	279	6	subita	subita	PROPN
iajs-3043	279	7	lalchan	lalchan	PROPN
iajs-3043	279	8	,	,	PUNCT
iajs-3043	279	9	anil	anil	PROPN
iajs-3043	279	10	dhakal	dhakal	PROPN
iajs-3043	279	11	and	and	CCONJ
iajs-3043	279	12	ramesh	ramesh	PROPN
iajs-3043	279	13	r	r	PROPN
iajs-3043	279	14	acharya	acharya	PROPN
iajs-3043	279	15	.	.	PUNCT
iajs-3043	280	1	comparison	comparison	NOUN
iajs-3043	280	2	of	of	ADP
iajs-3043	280	3	liver	liver	NOUN
iajs-3043	280	4	enzymes	enzyme	NOUN
iajs-3043	280	5	and	and	CCONJ
iajs-3043	280	6	sonological	sonological	ADJ
iajs-3043	280	7	grading	grading	NOUN
iajs-3043	280	8	in	in	ADP
iajs-3043	280	9	nonalcoholic	nonalcoholic	ADJ
iajs-3043	280	10	fatty	fatty	NOUN
iajs-3043	280	11	liver	liver	NOUN
iajs-3043	280	12	.	.	PUNCT
iajs-3043	281	1	asian	asian	PROPN
iajs-3043	281	2	j	j	PROPN
iajs-3043	281	3	medical	medical	PROPN
iajs-3043	281	4	sciences	sciences	PROPN
iajs-3043	281	5	.	.	PUNCT
iajs-3043	282	1	2020	2020	NUM
iajs-3043	282	2	,	,	PUNCT
iajs-3043	282	3	11	11	NUM
iajs-3043	282	4	:	:	SYM
iajs-3043	282	5	2	2	NUM
iajs-3043	282	6	ihjpas	ihjpa	NOUN
iajs-3043	282	7	.	.	PUNCT
iajs-3043	283	1	36(2)2023	36(2)2023	NUM
iajs-3043	283	2	250	250	NUM
iajs-3043	283	3	51	51	NUM
iajs-3043	283	4	.	.	PUNCT
iajs-3043	284	1	eri	eri	PROPN
iajs-3043	284	2	ozaki	ozaki	PROPN
iajs-3043	284	3	,	,	PUNCT
iajs-3043	284	4	hirotaka	hirotaka	NOUN
iajs-3043	284	5	ochiai	ochiai	PROPN
iajs-3043	284	6	,	,	PUNCT
iajs-3043	284	7	takako	takako	PROPN
iajs-3043	284	8	shirasawa	shirasawa	PROPN
iajs-3043	284	9	,	,	PUNCT
iajs-3043	284	10	et	et	PROPN
iajs-3043	284	11	al	al	PROPN
iajs-3043	284	12	.	.	PUNCT
iajs-3043	285	1	eating	eat	VERB
iajs-3043	285	2	quickly	quickly	ADV
iajs-3043	285	3	is	be	AUX
iajs-3043	285	4	associated	associate	VERB
iajs-3043	285	5	with	with	ADP
iajs-3043	285	6	a	a	DET
iajs-3043	285	7	low	low	ADJ
iajs-3043	285	8	aspartate	aspartate	NOUN
iajs-3043	285	9	aminotrasferase	aminotrasferase	NOUN
iajs-3043	285	10	to	to	ADP
iajs-3043	285	11	alanine	alanine	PROPN
iajs-3043	285	12	aminotrasferase	aminotrasferase	PROPN
iajs-3043	285	13	ratio	ratio	PROPN
iajs-3043	285	14	in	in	ADP
iajs-3043	285	15	middle	middle	ADJ
iajs-3043	285	16	-	-	PUNCT
iajs-3043	285	17	age	age	NOUN
iajs-3043	285	18	adults	adult	NOUN
iajs-3043	285	19	:	:	PUNCT
iajs-3043	285	20	a	a	DET
iajs-3043	285	21	large	large	ADJ
iajs-3043	285	22	-	-	PUNCT
iajs-3043	285	23	scale	scale	NOUN
iajs-3043	285	24	cross	cross	ADJ
iajs-3043	285	25	-	-	ADJ
iajs-3043	285	26	sectional	sectional	ADJ
iajs-3043	285	27	survey	survey	NOUN
iajs-3043	285	28	in	in	ADP
iajs-3043	285	29	japan	japan	PROPN
iajs-3043	285	30	.	.	PUNCT
iajs-3043	286	1	arch	arch	PROPN
iajs-3043	286	2	.	.	PUNCT
iajs-3043	287	1	pub	pub	NOUN
iajs-3043	287	2	health	health	NOUN
iajs-3043	287	3	.	.	PUNCT
iajs-3043	288	1	2020	2020	NUM
iajs-3043	288	2	,	,	PUNCT
iajs-3043	288	3	78	78	NUM
iajs-3043	288	4	:	:	SYM
iajs-3043	289	1	101	101	NUM
iajs-3043	289	2	.	.	NOUN
iajs-3043	290	1	52	52	NUM
iajs-3043	290	2	.	.	PUNCT
iajs-3043	290	3	yu	yu	PROPN
iajs-3043	290	4	z	z	PROPN
iajs-3043	290	5	hang	hang	PROPN
iajs-3043	290	6	,	,	PUNCT
iajs-3043	290	7	he	he	PRON
iajs-3043	291	1	he	he	PRON
iajs-3043	291	2	,	,	PUNCT
iajs-3043	291	3	yu	yu	PROPN
iajs-3043	291	4	-	-	PROPN
iajs-3043	291	5	ping	ping	PROPN
iajs-3043	291	6	zeng	zeng	PROPN
iajs-3043	291	7	,	,	PUNCT
iajs-3043	291	8	li	li	PROPN
iajs-3043	291	9	-	-	PROPN
iajs-3043	291	10	dan	dan	PROPN
iajs-3043	291	11	yang	yang	PROPN
iajs-3043	291	12	,	,	PUNCT
iajs-3043	291	13	dan	dan	PROPN
iajs-3043	291	14	jia	jia	PROPN
iajs-3043	291	15	,	,	PUNCT
iajs-3043	291	16	zhen	zhen	PROPN
iajs-3043	291	17	-	-	PUNCT
iajs-3043	291	18	mei	mei	PROPN
iajs-3043	291	19	an	an	PRON
iajs-3043	291	20	and	and	CCONJ
iajs-3043	291	21	wei	wei	PROPN
iajs-3043	291	22	-	-	PROPN
iajs-3043	291	23	guo	guo	PROPN
iajs-3043	291	24	jia	jia	PROPN
iajs-3043	291	25	.	.	PROPN
iajs-3043	291	26	lipoprotein	lipoprotein	PROPN
iajs-3043	291	27	a	a	DET
iajs-3043	291	28	combined	combine	VERB
iajs-3043	291	29	with	with	ADP
iajs-3043	291	30	alanine	alanine	NOUN
iajs-3043	291	31	aminotransferase	aminotransferase	PROPN
iajs-3043	291	32	and	and	CCONJ
iajs-3043	291	33	aspartate	aspartate	NOUN
iajs-3043	291	34	aminotransferase	aminotransferase	NOUN
iajs-3043	291	35	,	,	PUNCT
iajs-3043	291	36	contributes	contribute	VERB
iajs-3043	291	37	to	to	ADP
iajs-3043	291	38	predicting	predict	VERB
iajs-3043	291	39	the	the	DET
iajs-3043	291	40	occurrence	occurrence	NOUN
iajs-3043	291	41	of	of	ADP
iajs-3043	291	42	nash	nash	NOUN
iajs-3043	291	43	:	:	PUNCT
iajs-3043	291	44	a	a	DET
iajs-3043	291	45	cross	cross	ADJ
iajs-3043	291	46	-	-	ADJ
iajs-3043	291	47	sectional	sectional	ADJ
iajs-3043	291	48	study	study	NOUN
iajs-3043	291	49	.	.	PUNCT
iajs-3043	292	1	lipids	lipid	NOUN
iajs-3043	292	2	in	in	ADP
iajs-3043	292	3	health	health	NOUN
iajs-3043	292	4	and	and	CCONJ
iajs-3043	292	5	disease	disease	NOUN
iajs-3043	292	6	.	.	PUNCT
iajs-3043	293	1	2020	2020	NUM
iajs-3043	293	2	,	,	PUNCT
iajs-3043	293	3	19	19	NUM
iajs-3043	293	4	:	:	SYM
iajs-3043	293	5	134	134	NUM
iajs-3043	293	6	.	.	X
iajs-3043	294	1	53	53	NUM
iajs-3043	294	2	.	.	PUNCT
iajs-3043	295	1	elizabeth	elizabeth	PROPN
iajs-3043	295	2	e	e	PROPN
iajs-3043	295	3	powell	powell	PROPN
iajs-3043	295	4	,	,	PUNCT
iajs-3043	295	5	vincent	vincent	PROPN
iajs-3043	295	6	wai	wai	PROPN
iajs-3043	295	7	-	-	PUNCT
iajs-3043	295	8	sun	sun	PROPN
iajs-3043	295	9	wong	wong	PROPN
iajs-3043	295	10	,	,	PUNCT
iajs-3043	295	11	mary	mary	PROPN
iajs-3043	295	12	rinella	rinella	PROPN
iajs-3043	295	13	.	.	PUNCT
iajs-3043	296	1	non	non	ADJ
iajs-3043	296	2	-	-	ADJ
iajs-3043	296	3	alcoholic	alcoholic	ADJ
iajs-3043	296	4	fatty	fatty	NOUN
iajs-3043	296	5	liver	liver	NOUN
iajs-3043	296	6	disease	disease	NOUN
iajs-3043	296	7	.	.	PUNCT
iajs-3043	297	1	lancet	lancet	PROPN
iajs-3043	297	2	.2021	.2021	PROPN
iajs-3043	297	3	;	;	PUNCT
iajs-3043	297	4	397	397	NUM
iajs-3043	297	5	:	:	PUNCT
iajs-3043	297	6	2212–24	2212–24	NUM
iajs-3043	297	7	54	54	NUM
iajs-3043	297	8	.	.	PUNCT
iajs-3043	298	1	chalasani	chalasani	PROPN
iajs-3043	298	2	n.	n.	PROPN
iajs-3043	298	3	,	,	PUNCT
iajs-3043	298	4	younossi	younossi	PROPN
iajs-3043	298	5	z.	z.	PROPN
iajs-3043	298	6	,	,	PUNCT
iajs-3043	298	7	lavine	lavine	PROPN
iajs-3043	298	8	je	je	PROPN
iajs-3043	298	9	.	.	PROPN
iajs-3043	298	10	,	,	PUNCT
iajs-3043	298	11	charlton	charlton	PROPN
iajs-3043	298	12	m.	m.	NOUN
iajs-3043	298	13	,	,	PUNCT
iajs-3043	298	14	cui	cui	PROPN
iajs-3043	298	15	k.	k.	PROPN
iajs-3043	298	16	,	,	PUNCT
iajs-3043	298	17	rinella	rinella	NOUN
iajs-3043	298	18	m.	m.	NOUN
iajs-3043	298	19	,	,	PUNCT
iajs-3043	298	20	harrison	harrison	PROPN
iajs-3043	298	21	sa	sa	PROPN
iajs-3043	298	22	.	.	PROPN
iajs-3043	298	23	,	,	PUNCT
iajs-3043	298	24	et	et	PROPN
iajs-3043	298	25	al	al	PROPN
iajs-3043	298	26	the	the	DET
iajs-3043	298	27	diagnosis	diagnosis	NOUN
iajs-3043	298	28	and	and	CCONJ
iajs-3043	298	29	management	management	NOUN
iajs-3043	298	30	of	of	ADP
iajs-3043	298	31	nonalcoholic	nonalcoholic	NOUN
iajs-3043	298	32	fatty	fatty	NOUN
iajs-3043	298	33	liver	liver	NOUN
iajs-3043	298	34	disease	disease	NOUN
iajs-3043	298	35	:	:	PUNCT
iajs-3043	298	36	practice	practice	NOUN
iajs-3043	298	37	guidance	guidance	NOUN
iajs-3043	298	38	from	from	ADP
iajs-3043	298	39	the	the	DET
iajs-3043	298	40	american	american	PROPN
iajs-3043	298	41	association	association	PROPN
iajs-3043	298	42	for	for	ADP
iajs-3043	298	43	the	the	DET
iajs-3043	298	44	study	study	NOUN
iajs-3043	298	45	of	of	ADP
iajs-3043	298	46	liver	liver	NOUN
iajs-3043	298	47	diseases	disease	NOUN
iajs-3043	298	48	.	.	PUNCT
iajs-3043	299	1	hepatology	hepatology	NOUN
iajs-3043	299	2	.	.	PUNCT
iajs-3043	300	1	2018	2018	NUM
iajs-3043	300	2	,	,	PUNCT
iajs-3043	300	3	67	67	NUM
iajs-3043	300	4	:	:	SYM
iajs-3043	300	5	328	328	NUM
iajs-3043	300	6	-	-	SYM
iajs-3043	300	7	357	357	NUM
iajs-3043	300	8	.	.	PUNCT
iajs-3043	301	1	55	55	NUM
iajs-3043	301	2	.	.	PUNCT
iajs-3043	302	1	xuefeng	xuefeng	PROPN
iajs-3043	302	2	ma	ma	PROPN
iajs-3043	302	3	,	,	PUNCT
iajs-3043	302	4	shousheng	shousheng	PROPN
iajs-3043	302	5	liu	liu	PROPN
iajs-3043	302	6	,	,	PUNCT
iajs-3043	302	7	jie	jie	PROPN
iajs-3043	302	8	zhang	zhang	PROPN
iajs-3043	302	9	,	,	PUNCT
iajs-3043	302	10	mengzhen	mengzhen	PROPN
iajs-3043	302	11	dong	dong	PROPN
iajs-3043	302	12	,	,	PUNCT
iajs-3043	302	13	yifen	yifen	PROPN
iajs-3043	302	14	wang	wang	PROPN
iajs-3043	302	15	,	,	PUNCT
iajs-3043	302	16	mengke	mengke	PROPN
iajs-3043	302	17	wang	wang	PROPN
iajs-3043	302	18	and	and	CCONJ
iajs-3043	302	19	yongning	yongne	VERB
iajs-3043	302	20	xin	xin	PROPN
iajs-3043	302	21	.	.	PUNCT
iajs-3043	303	1	proportion	proportion	NOUN
iajs-3043	303	2	of	of	ADP
iajs-3043	303	3	nafld	nafld	ADJ
iajs-3043	303	4	patients	patient	NOUN
iajs-3043	303	5	with	with	ADP
iajs-3043	303	6	normal	normal	ADJ
iajs-3043	303	7	alt	alt	NOUN
iajs-3043	303	8	value	value	NOUN
iajs-3043	303	9	in	in	ADP
iajs-3043	303	10	overall	overall	ADJ
iajs-3043	303	11	nafld	nafld	ADJ
iajs-3043	303	12	patients	patient	NOUN
iajs-3043	303	13	:	:	PUNCT
iajs-3043	303	14	a	a	DET
iajs-3043	303	15	systematic	systematic	ADJ
iajs-3043	303	16	review	review	NOUN
iajs-3043	303	17	and	and	CCONJ
iajs-3043	303	18	meta	meta	ADJ
iajs-3043	303	19	-	-	PUNCT
iajs-3043	303	20	analysis	analysis	NOUN
iajs-3043	303	21	.	.	PUNCT
iajs-3043	304	1	bmc	bmc	ADJ
iajs-3043	304	2	gastroenterology	gastroenterology	NOUN
iajs-3043	304	3	.	.	PUNCT
iajs-3043	305	1	20	20	NUM
iajs-3043	305	2	,	,	PUNCT
iajs-3043	305	3	10	10	NUM
iajs-3043	305	4	,	,	PUNCT
iajs-3043	305	5	2020	2020	NUM
iajs-3043	305	6	.	.	PUNCT